RXNORM_id	name	moa	parents	pe
1363268	cabozantinib	Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	C [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1363267	cabozantinib s-malate	Tyrosine Kinase Inhibitors	C [Preparations]	Cellular Proliferation Alteration
1603296	lenvatinib	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	L [Preparations]|Kinase Inhibitor	Decreased Endothelial Proliferation
1604346	lenvatinib mesylate	Receptor Tyrosine Kinase Inhibitors	L [Preparations]	Decreased Endothelial Proliferation
2534233	tivozanib	Tyrosine Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	T [Preparations]|Kinase Inhibitor	
5552	hydroxyurea	Nucleic Acid Synthesis Inhibitors|Ribonucleotide Reductase Inhibitors	Antimetabolite|H [Preparations]	Decreased DNA Integrity
5879	interferon alfa-2a	Biological Response Modifiers	I [Preparations]	Cellular Growth Phase Arrest|Increased Cytokine Activity
5880	interferon alfa-2b	Biological Response Modifiers	Interferon alpha|I [Preparations]	Cellular Growth Phase Arrest|Increased Cytokine Activity
5882	interferon gamma-1b	Transcription Factor Activity|Biological Response Modifiers	Interferon gamma|I [Preparations]	Cellular Growth Phase Arrest|Increased Cytokine Activity
732187	pazopanib hydrochloride	Platelet-derived Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Receptor Inhibitors	P [Preparations]	Decreased Endothelial Proliferation|Vascular Growth Decrease
714438	pazopanib	Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 2C8 Inhibitors|Protein Kinase Inhibitors|Platelet-derived Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Receptor Inhibitors	P [Preparations]|Kinase Inhibitor	Decreased Endothelial Proliferation|Vascular Growth Decrease
597744	sorafenib tosylate	Kinase Inhibitors	S [Preparations]	Cellular Proliferation Alteration
495881	sorafenib	Protein Kinase Inhibitors|Kinase Inhibitors	S [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
616275	sunitinib malate	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	S [Preparations]	Vascular Growth Decrease
1242999	axitinib	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	A [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
657797	temsirolimus	Protein Kinase Inhibitors|mTOR Inhibitors	T [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
357977	sunitinib	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	S [Preparations]|Kinase Inhibitor	Vascular Growth Decrease
314687	interferon alfa-3n,human leukocyte derived	Biological Response Modifiers	I [Preparations]	Cellular Growth Phase Arrest|Immunologically Active Molecule Activity Alteration|Increased Cytokine Activity
253453	peginterferon alfa-2b	Biological Response Modifiers	P [Preparations]	Vascular Growth Decrease|Cellular Growth Phase Arrest|Increased Cytokine Activity
120608	peginterferon alfa-2a	Biological Response Modifiers|RNA Replicase Inhibitors	Interferon alpha|P [Preparations]	Cellular Growth Phase Arrest|Increased Cytokine Activity|RNA Replication Alteration
72258	recombinant interferon beta-1b	Biological Response Modifiers|Unknown Cellular or Molecular Interaction	R [Preparations]	Increased Lymphocyte Activation|Cellular Growth Phase Arrest|Immunologically Active Molecule Activity Alteration|Increased Cytokine Activity|Increased Phagocytosis|Increased Transcription to RNA
70223	aldesleukin	Interferon Inducers|Interleukin 2 Receptor Agonists	Lymphocyte Growth Factor|A [Preparations]	Increased Lymphocyte Activation|Increased Cytokine Production|Increased Cytokine Activity|Increased Lymphocyte Cell Production
59744	interferon alfacon-1	Biological Response Modifiers	I [Preparations]	Cellular Growth Phase Arrest|Increased Cytokine Activity
10432	thalidomide	Tumor Necrosis Factor alpha Receptor Blocking Activity|Unknown Cellular or Molecular Interaction	T [Preparations]	Decreased Endothelial Proliferation|Decreased Immunologically Active Molecule Activity
1000112	medroxyprogesterone acetate	Progestational Hormone Receptor Agonists	M [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased Growth Hormone Secretion|Gonadotropin Releasing Hormone Alteration|Inhibit Ovarian Follicular Phase|Stimulate Breast Glandular Development|Inhibit Ovulation
2534245	tivozanib hydrochloride	Receptor Tyrosine Kinase Inhibitors	T [Preparations]	
6691	medroxyprogesterone	Progestational Hormone Receptor Agonists	Progestin|M [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased Growth Hormone Secretion|Gonadotropin Releasing Hormone Alteration|Inhibit Ovarian Follicular Phase|Stimulate Breast Glandular Development|Inhibit Ovulation
203132	papaverine hydrochloride	Unknown Cellular or Molecular Interaction	P [Preparations]	Vasodilation|Smooth Muscle Tone Alteration
203210	prazosin hydrochloride	Adrenergic alpha-Antagonists	P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
158387	papaverine codecarboxylate	Unknown Cellular or Molecular Interaction	P [Preparations]	Vasodilation|Smooth Muscle Tone Alteration
153679	lercanidipine hydrochloride	Calcium Channel Antagonists	L [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
235450	tolazoline hydrochloride	Adrenergic alpha-Antagonists	T [Preparations]	Systemic Arterial Vasodilation
135056	lercanidipine	Calcium Channel Antagonists	L [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
82033	isoxsuprine hydrochloride	Adrenergic beta-Agonists	I [Preparations]	Decreased Smooth Muscle Organized Electrical Activity|Systemic Arterial Vasodilation
82060	nylidrin hydrochloride	Calcium Channel Antagonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists	N [Preparations]	Arterial Vasodilation
1998	captopril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|C [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
10634	tolazoline	Adrenergic alpha-Antagonists	T [Preparations]	Systemic Arterial Vasodilation
7895	papaverine	Unknown Cellular or Molecular Interaction	P [Preparations]	Vasodilation|Smooth Muscle Tone Alteration
8629	prazosin	Adrenergic alpha-Antagonists	alpha-Adrenergic Blocker|P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
7595	nylidrin	Calcium Channel Antagonists|Adrenergic beta-Agonists	N [Preparations]	Arterial Vasodilation
6066	isoxsuprine	Adrenergic beta-Agonists	I [Preparations]	Decreased Smooth Muscle Organized Electrical Activity|Systemic Arterial Vasodilation
1487143	sucralfate malate	Binding Activity	S [Preparations]	Gastric Acid Alteration
1435522	esomeprazole strontium	Proton Pump Inhibitors	E [Preparations]	Inhibition Gastric Acid Secretion
1297882	amoxicillin anhydrous	Transpeptidase Inhibitors	Penicillin-class Antibacterial|A [Preparations]	Decreased Cell Wall Synthesis & Repair
4278	famotidine	Histamine H2 Receptor Antagonists	Histamine-2 Receptor Antagonist|F [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
1294569	esomeprazole sodium	Proton Pump Inhibitors	E [Preparations]	Inhibition Gastric Acid Secretion
283562	esomeprazole magnesium	Proton Pump Inhibitors	E [Preparations]	Inhibition Gastric Acid Secretion
283742	esomeprazole	Cytochrome P450 2C19 Inhibitors|Proton Pump Inhibitors	Proton Pump Inhibitor|E [Preparations]	Inhibition Gastric Acid Secretion
236328	maprotiline mesylate	Norepinephrine Uptake Inhibitors	M [Preparations]	Increased Norepinephrine Activity
236486	omeprazole magnesium	Proton Pump Inhibitors	O [Preparations]	Inhibition Gastric Acid Secretion
267360	amoxicillin sodium	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
203126	maprotiline hydrochloride	Norepinephrine Uptake Inhibitors	M [Preparations]	Increased Norepinephrine Activity
203136	ranitidine hydrochloride	Histamine H2 Receptor Antagonists	R [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
226868	rabeprazole sodium	Proton Pump Inhibitors	R [Preparations]	Inhibition Gastric Acid Secretion
235775	pirenzepine hydrochloride	Cholinergic Muscarinic Antagonists	P [Preparations]	Inhibition Gastric Mucous Secretion
1792108	omeprazole sodium	Proton Pump Inhibitors	O [Preparations]	Inhibition Gastric Acid Secretion
133008	amoxicillin trihydrate	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
114979	rabeprazole	Proton Pump Inhibitors	Proton Pump Inhibitor|R [Preparations]	Inhibition Gastric Acid Secretion
2541	cimetidine	Histamine H2 Receptor Antagonists	Histamine-2 Receptor Antagonist|C [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
81948	aluminum hydroxide, dried (USP)	Electrolyte Activity|Acid-Base Activity	A [Preparations]	Antacid|Increased Renal PO4-- Excretion
89858	aluminum carbonate	Electrolyte Activity|Acid-Base Activity	A [Preparations]	Antacid|Increased Renal PO4-- Excretion
91251	cimetidine hydrochloride	Histamine H2 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
1897	calcium carbonate	Phosphate Chelating Activity|Acid-Base Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Gastric Acid Alteration|Increased Renal PO4-- Excretion
47618	calcium gluceptate	Phosphate Chelating Activity|Electrolyte Activity|Acid-Base Activity	C [Preparations]	Bone Resorption Alteration|Gastric Acid Alteration|Increased Renal PO4-- Excretion
18789	basic aluminum carbonate gel	Acid-Base Activity|Electrolyte Activity	B [Preparations]	Antacid|Increased Renal PO4-- Excretion
55471	ranitidine bismuth citrate	Histamine H2 Receptor Antagonists	R [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
21212	clarithromycin	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A Inhibitors|Protein Synthesis Inhibitors	Macrolide Antimicrobial|C [Preparations]	Decreased Protein Synthesis
23163	dihydroxyaluminum sodium carbonate	Acid-Base Activity|Electrolyte Activity	D [Preparations]	Gastric Acid Alteration|Increased Renal PO4-- Excretion
42319	nizatidine	Histamine H2 Receptor Antagonists	Histamine-2 Receptor Antagonist|N [Preparations]	Inhibition Gastric Acid Secretion
29151	magaldrate	Electrolyte Activity|Acid-Base Activity	M [Preparations]	Gastric Acid Alteration
9143	ranitidine	Histamine H2 Receptor Antagonists	Histamine-2 Receptor Antagonist|R [Preparations]	Decreased Histamine Activity|Inhibition Gastric Acid Secretion
17128	lansoprazole	Proton Pump Inhibitors	Proton Pump Inhibitor|L [Preparations]	Inhibition Gastric Acid Secretion
8627	prazepam	GABA A Modulators	P [Preparations]	Increased Central Nervous System GABA Activity
10156	sucralfate	Binding Activity	Aluminum Complex|S [Preparations]	Gastric Acid Alteration
8352	pirenzepine	Cholinergic Muscarinic Antagonists	P [Preparations]	Inhibition Gastric Mucous Secretion
7646	omeprazole	Cytochrome P450 2C19 Inhibitors|Proton Pump Inhibitors	Proton Pump Inhibitor|O [Preparations]	Inhibition Gastric Acid Secretion
6581	magnesium hydroxide	Acid-Base Activity|Electrolyte Activity|Osmotic Activity|Enzyme Interactions	M [Preparations]	Cellular Activity Alteration|Gastric Acid Alteration|Small Intestine Fluid/Electrolyte Absorption Alteration
6646	maprotiline	Norepinephrine Uptake Inhibitors	M [Preparations]	Increased Norepinephrine Activity
1806902	aluminum hydroxide sulfate (Al(OH)(SO4))	Acid-Base Activity|Electrolyte Activity	A [Preparations]	Antacid|Increased Renal PO4-- Excretion
612	aluminum hydroxide	Acid-Base Activity|Electrolyte Activity	A [Preparations]	Antacid|Increased Renal PO4-- Excretion
613	aluminum hydroxide gel	Electrolyte Activity|Acid-Base Activity	A [Preparations]	Antacid|Increased Renal PO4-- Excretion
1601995	esomeprazole magnesium dihydrate	Proton Pump Inhibitors	E [Preparations]	Inhibition Gastric Acid Secretion
723	amoxicillin	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
1299236	lidocaine hydrochloride anhydrous	Sodium Channel Interactions	L [Preparations]	Local Anesthesia|Cardiac Rhythm Alteration|Decreased Cardiac Muscle Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
1299924	edetate disodium, anhydrous	Lead Chelating Activity|Calcium Chelating Activity	E [Preparations]	
11149	vasopressin (USP)	Pituitary Hormone Receptor Agonists	V [Preparations]	Vasoconstriction|Decreased Diuresis|Increased Collecting Duct Water Permeability|Increased GI Smooth Muscle Tone
4441	flecainide	Ion Channel Interactions	Antiarrhythmic|F [Preparations]	Cardiac Rhythm Alteration|Negative Inotropy
314610	racepinephrine hydrochloride	Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Adrenergic beta1-Agonists|Adrenergic beta2-Agonists	R [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Decreased Uterine Smooth Muscle Contraction or Tone|Hemostasis Alteration|Positive Chronotropy|Positive Inotropy|Decreased Intraocular Aqueous Secretion
236903	bopindolol hydrogen malonate	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Chronotropy
3755	edetic acid	Lead Chelating Activity|Calcium Chelating Activity	Anti-coagulant|Lead Chelator|E [Preparations]	Decreased Coagulation Factor Activity
3992	epinephrine	Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	Catecholamine|alpha-Adrenergic Agonist|beta-Adrenergic Agonist|E [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Decreased Uterine Smooth Muscle Contraction or Tone|Hemostasis Alteration|Positive Inotropy|Positive Chronotropy|Decreased Intraocular Aqueous Secretion
203180	epinephrine bitartrate	Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	E [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Hemostasis Alteration|Decreased Uterine Smooth Muscle Contraction or Tone|Positive Chronotropy|Decreased Intraocular Aqueous Secretion|Positive Inotropy
203191	metoprolol tartrate	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	M [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
203222	esmolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic alpha1-Antagonists	E [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy
155056	procainamide hydrochloride	Unknown Cellular or Molecular Interaction	P [Preparations]	Cardiac Rhythm Alteration|Increased Cardiac Muscle Organized Electrical Activity|Negative Inotropy
1422486	magnesium disodium EDTA	Lead Chelating Activity|Calcium Chelating Activity	M [Preparations]	
221124	metoprolol succinate	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	M [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
221126	moricizine hydrochloride	Sodium Channel Interactions	M [Preparations]	Cardiac Rhythm Alteration
3539	edetate disodium	Lead Chelating Activity|Calcium Chelating Activity|Chelating Activity	E [Preparations]	Increased Renal Ca++ Excretion|Unknown Physiological Effect
142130	acebutolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	A [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
142440	lidocaine hydrochloride	Sodium Channel Interactions	L [Preparations]	Local Anesthesia|Cardiac Rhythm Alteration|Decreased Cardiac Muscle Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
102313	metoprolol fumarate	Adrenergic beta1-Antagonists	M [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy
105745	trisodium edetate	Lead Chelating Activity|Calcium Chelating Activity|Chelating Activity	T [Preparations]	Unknown Physiological Effect
82084	propranolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	P [Preparations]	Bronchoconstriction|Decreased Blood Pressure|Cardiac Rhythm Alteration|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
1737	bretylium tosylate	Adrenergic Antagonists|Potassium Channel Antagonists	B [Preparations]	Atrial Repolarization|Negative Chronotropy|Ventricular Repolarization
42686	flecainide acetate	Ion Channel Interactions	F [Preparations]	Cardiac Rhythm Alteration|Negative Inotropy
49737	esmolol	Adrenergic beta-Antagonists|Adrenergic alpha1-Antagonists	beta-Adrenergic Blocker|E [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
19605	bopindolol	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Chronotropy
19685	bretylium	Adrenergic Antagonists|Potassium Channel Antagonists	B [Preparations]	Atrial Repolarization|Negative Chronotropy|Ventricular Repolarization
40169	moricizine	Sodium Channel Interactions	M [Preparations]	Cardiac Rhythm Alteration
1249590	epinephrine sulfate	Adrenergic alpha-Agonists|Adrenergic beta1-Agonists|Adrenergic beta2-Agonists	E [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Hemostasis Alteration|Decreased Uterine Smooth Muscle Contraction or Tone|Positive Chronotropy|Positive Inotropy|Decreased Intraocular Aqueous Secretion
24255	epinephryl borate	Adrenergic beta-Agonists|Adrenergic alpha-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	E [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Hemostasis Alteration|Decreased Uterine Smooth Muscle Contraction or Tone|Positive Chronotropy|Decreased Intraocular Aqueous Secretion|Positive Inotropy
1202	atenolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|A [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
9947	sotalol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	Antiarrhythmic|S [Preparations]	Cardiac Rhythm Alteration|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
8700	procainamide	Unknown Cellular or Molecular Interaction	Antiarrhythmic|P [Preparations]	Cardiac Rhythm Alteration|Increased Cardiac Muscle Organized Electrical Activity|Negative Inotropy
8787	propranolol	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|P [Preparations]	Bronchoconstriction|Decreased Blood Pressure|Arterial Vasodilation|Cardiac Rhythm Alteration|Negative Inotropy|Negative Chronotropy
6918	metoprolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|M [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
7008	sotalol hydrochloride	Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	S [Preparations]	Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
149	acebutolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|A [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy
362	epinephrine hydrochloride	Adrenergic beta-Agonists|Adrenergic alpha-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	E [Preparations]	Increased Blood Pressure|Pupillary Dilation|Bronchodilation|Arterial Vasoconstriction|Decreased Uterine Smooth Muscle Contraction or Tone|Hemostasis Alteration|Positive Chronotropy|Positive Inotropy|Decreased Intraocular Aqueous Secretion
6387	lidocaine	Sodium Channel Interactions	Antiarrhythmic|Amide Local Anesthetic|L [Preparations]	Local Anesthesia|Cardiac Rhythm Alteration|Decreased Cardiac Muscle Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
266573	topotecan hydrochloride	Topoisomerase Inhibitors	T [Preparations]	Decreased DNA Replication
57308	topotecan	Topoisomerase Inhibitors	Topoisomerase Inhibitor|T [Preparations]	Decreased DNA Replication
2374729	lurbinectedin	Alkylating Activity	Alkylating Drug|L [Preparations]	Cellular Cycle Alteration|Decreased DNA Integrity|Increased Cellular Death
236960	drotaverine hydrochloride	Phosphodiesterase 4 Inhibitors	D [Preparations]	Smooth Muscle Tone Alteration
23684	drotaverin	Phosphodiesterase 4 Inhibitors	D [Preparations]	Smooth Muscle Tone Alteration
1375412	bupivacaine hydrochloride anhydrous	Prostaglandin Receptor Antagonists|Sodium Channel Interactions	B [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
5489	hydrocodone	Full Opioid Agonists|Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]|Opioid Agonist	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
5640	ibuprofen	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|I [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Activating Factor Production|Decreased Thromboxane Production
1298851	ropivacaine hydrochloride monohydrate	Sodium Channel Interactions	R [Preparations]	Decreased Organized Electrical Activity
597355	hydrocodone tannate	Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
314667	hydrocodone resin complex	Full Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
236539	ropivacaine hydrochloride	Sodium Channel Interactions	R [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
236931	hydrocodone hydrochloride	Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
1429044	ibuprofen, sodium salt	Cyclooxygenase Inhibitors	I [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production
267396	bupivacaine hydrochloride	Prostaglandin Receptor Antagonists|Sodium Channel Interactions	B [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
4171	etidocaine	Sodium Channel Interactions	E [Preparations]	Decreased Organized Electrical Activity
203177	hydromorphone hydrochloride	Full Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Organized Electrical Activity
227221	etidocaine hydrochloride	Sodium Channel Interactions	E [Preparations]	Decreased Organized Electrical Activity
154985	nalbuphine hydrochloride	Competitive Opioid Antagonists|Partial Opioid Agonists|Opioid Agonists	N [Preparations]	Analgesia|Decreased Organized Electrical Activity
159821	oxycodone terephthalate	Full Opioid Agonists	O [Preparations]	Analgesia|Decreased GI Motility|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity|Increased Histamine Production
221107	hydrocodone polistirex	Full Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
3423	hydromorphone	Full Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
142439	hydrocodone bitartrate	Full Opioid Agonists|Opioid mu-Receptor Agonists	H [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
82063	oxycodone hydrochloride	Full Opioid Agonists	O [Preparations]	Analgesia|Decreased GI Motility|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity|Increased Histamine Production
1815	bupivacaine	Prostaglandin Receptor Antagonists|Sodium Channel Interactions	Amide Local Anesthetic|B [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
36761	ibuprofen lysine	Cyclooxygenase Inhibitors	I [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production
47364	bromfenac sodium	Cyclooxygenase Inhibitors	B [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Aggregation
19737	bromfenac	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|B [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Aggregation
35780	ropivacaine	Sodium Channel Interactions	Amide Local Anesthetic|R [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
7804	oxycodone	Full Opioid Agonists	O [Preparations]|Opioid Agonist	Analgesia|Decreased GI Motility|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity|Increased Histamine Production
7238	nalbuphine	Competitive Opioid Antagonists|Partial Opioid Agonists|Opioid Agonists	Opioid Agonist/Antagonist|N [Preparations]	Analgesia|Decreased Organized Electrical Activity
2198974	ropivacaine hydrochloride anhydrous	Sodium Channel Interactions	R [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
284637	hylan G-F 20	Biological Macromolecular Activity	H [Preparations]	
1358492	tofacitinib citrate	Janus Kinase Inhibitors	T [Preparations]	Decreased Hematopoiesis|Decreased Immunologic Activity
5521	hydroxychloroquine	Enzyme Inhibitors|Physiochemical Activity	Antimalarial|Antirheumatic Agent|H [Preparations]	Decreased Endocytosis|Decreased Immunologically Active Molecule Activity
1357536	tofacitinib	Janus Kinase Inhibitors	T [Preparations]|Janus Kinase Inhibitor	Decreased Hematopoiesis|Decreased Immunologic Activity
5781	indomethacin	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|I [Preparations]	Decreased Prostaglandin Production
709271	certolizumab pegol	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	C [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
819300	golimumab	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	G [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
660767	oxaprozin potassium	Cyclooxygenase Inhibitors	O [Preparations]	Decreased Prostaglandin Production
1311190	gold	Unknown Cellular or Molecular Interaction	Standardized Chemical Allergen|G [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Prostaglandin Production
4980	aurothioglucose	Unknown Cellular or Molecular Interaction	A [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Prostaglandin Production
4981	gold sodium thiomalate	Unknown Cellular or Molecular Interaction	G [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Prostaglandin Production
484788	cyclosporine microemulsion	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Cytokine Production|Decreased Cytokine Activity|Decreased T Lymphocyte Production
612865	tocilizumab	Interleukin 6 Receptor Antagonists	Interleukin-6 Receptor Antagonist|T [Preparations]	Decreased Immunologic Activity
451796	chloroquine hydrochloride	Nucleic Acid Synthesis Inhibitors	C [Preparations]	Decreased Metabolic Rate|Decreased Prostaglandin Activity|Nucleic Acid Replication Alteration
614391	abatacept	CD80-directed Antibody Interactions|CD86-directed Antibody Interactions	Selective T Cell Costimulation Modulator|A [Preparations]	T Lymphocyte Costimulation Activity Modulation|T Lymphocyte Costimulation Activity Blockade|Decreased Cytokine Activity
4331	fenoprofen	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|F [Preparations]	Decreased Prostaglandin Production
4419	fish oils	Oxidation Activity|Unknown Cellular or Molecular Interaction	F [Preparations]	Cell Membrane Alteration|Arterial Vasodilation|Cellular Communication Alteration|Decreased Leukotriene Production|Decreased Lipogenesis|Increased Lipolysis|Decreased Platelet Aggregation
4502	flurbiprofen	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|F [Preparations]	Decreased Prostaglandin Production
287734	methotrexate sodium	Thymidylate Synthetase Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	M [Preparations]	Decreased Epithelial Proliferation|Decreased DNA Integrity|Decreased Immunologic Activity
327361	adalimumab	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
314293	acetylsalicylate sodium	Cyclooxygenase Inhibitors	A [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
1294612	indomethacin sodium	Cyclooxygenase Inhibitors	I [Preparations]	Decreased Prostaglandin Production
258329	indomethacin sodium trihydrate	Cyclooxygenase Inhibitors	I [Preparations]	Decreased Prostaglandin Production
3827	enalapril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|E [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
3829	enalaprilat	Angiotensin-converting Enzyme Inhibitors	E [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1545989	enalaprilat anhydrous	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|E [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
267171	fenoprofen calcium	Cyclooxygenase Inhibitors	F [Preparations]	Decreased Prostaglandin Production
267476	azathioprine sodium	Nucleic Acid Synthesis Inhibitors	A [Preparations]	Cellular Growth Phase Reduction|Decreased DNA Replication|Decreased Mitosis|Immunologic Activity Alteration
278567	valdecoxib	Cyclooxygenase 2 Inhibitors	V [Preparations]	Decreased Prostaglandin Production
203119	chloroquine sulfate	Nucleic Acid Synthesis Inhibitors	C [Preparations]	Decreased Metabolic Rate|Decreased Prostaglandin Activity|Nucleic Acid Replication Alteration
203123	enalapril maleate	Angiotensin-converting Enzyme Inhibitors	E [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
203214	diclofenac sodium	Cyclooxygenase Inhibitors	D [Preparations]	Decreased Prostaglandin Production
3008	cyclosporine	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Calcineurin Inhibitors|Unknown Cellular or Molecular Interaction	Calcineurin Inhibitor Immunosuppressant|C [Preparations]	Decreased Cytokine Activity|Decreased Cytokine Production|Decreased T Lymphocyte Production
191831	infliximab	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	I [Preparations]|Tumor Necrosis Factor Blocker	Decreased Vascular Permeability|Increased Adhesion Factor Production
214555	etanercept	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity|Tumor Necrosis Factor beta Receptor Blocking Activity	E [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
3355	diclofenac	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|D [Preparations]	Decreased Prostaglandin Production
3393	diflunisal	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|D [Preparations]	Decreased Prostaglandin Production
153972	hydroxychloroquine sulfate	Enzyme Inhibitors|Physiochemical Activity	H [Preparations]	Decreased Endocytosis|Decreased Immunologically Active Molecule Activity
236077	cyclosporine, modified	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Cytokine Activity|Decreased Cytokine Production|Decreased T Lymphocyte Production
140587	celecoxib	Cyclooxygenase Inhibitors|Cyclooxygenase 2 Inhibitors	Nonsteroidal Anti-inflammatory Drug|C [Preparations]	Decreased Prostaglandin Production
142442	naproxen sodium	Cyclooxygenase Inhibitors	N [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production
2393	chloroquine	Nucleic Acid Synthesis Inhibitors	Antimalarial|C [Preparations]	Decreased Metabolic Rate|Decreased Prostaglandin Activity|Nucleic Acid Replication Alteration
121191	rituximab	CD20-directed Antibody Interactions|Antibody-Receptor Interactions	CD20-directed Cytolytic Antibody|R [Preparations]	Increased Cellular Death
91351	flurbiprofen sodium	Cyclooxygenase Inhibitors	F [Preparations]	Decreased Prostaglandin Production
81997	diclofenac potassium	Cyclooxygenase Inhibitors	D [Preparations]	Decreased Prostaglandin Production
72435	anakinra	Enzyme Inhibitors|Interleukin 1 Receptor Antagonists	Interleukin-1 Receptor Antagonist|A [Preparations]	Bone Resorption Inhibition|Decreased Immunologically Active Molecule Activity
68115	piroxicam-beta-cyclodextrin	Cyclooxygenase Inhibitors	P [Preparations]	Decreased Prostaglandin Production
42935	tolmetin sodium	Cyclooxygenase Inhibitors	T [Preparations]	Decreased Prostaglandin Production
20863	chloroquine phosphate	Nucleic Acid Synthesis Inhibitors	C [Preparations]	Decreased Metabolic Rate|Decreased Prostaglandin Activity|Nucleic Acid Replication Alteration
20974	choline salicylate	Prostaglandin Receptor Antagonists	C [Preparations]	Decreased Prostaglandin Production|Hypothalamic Endocrine Activity Alteration
41493	meloxicam	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|M [Preparations]	Decreased Prostaglandin Production
24605	etodolac	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|E [Preparations]	Decreased Prostaglandin Production
10636	tolmetin	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|T [Preparations]	Decreased Prostaglandin Production
27169	leflunomide	Nucleic Acid Synthesis Inhibitors	Antirheumatic Agent|L [Preparations]	Immunologic Activity Alteration
1191	aspirin	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|Platelet Aggregation Inhibitor|A [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
28199	ketoprofen lysine	Cyclooxygenase Inhibitors	K [Preparations]	Decreased Prostaglandin Production
1227	auranofin	Unknown Cellular or Molecular Interaction	A [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Complement Activity|Decreased Lysosomal Function|Decreased Phagocytosis|Decreased Prostaglandin Production
1256	azathioprine	Nucleic Acid Synthesis Inhibitors	Purine Antimetabolite|A [Preparations]	Cellular Growth Phase Reduction|Decreased DNA Replication|Decreased Mitosis|Immunologic Activity Alteration
31448	nabumetone	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|N [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Activating Factor Production|Decreased Renal K+ Excretion|Decreased Renal Na+ Excretion|Decreased Thromboxane Production
32613	oxaprozin	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|O [Preparations]	Decreased Prostaglandin Production
33787	piroxicam cinnamate	Cyclooxygenase Inhibitors	P [Preparations]	Decreased Prostaglandin Production
16689	aceclofenac	Cyclooxygenase Inhibitors|Tumor Necrosis Factor Receptor Blocking Activity	A [Preparations]	Glycosaminoglycan Metabolism Increase|Decreased Prostaglandin Production
9524	sulfasalazine	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	Aminosalicylate|S [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
7258	naproxen	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|N [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Activating Factor Production|Decreased Thromboxane Production
10237	sulindac	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|S [Preparations]	Decreased Prostaglandin Production
7975	penicillamine	Chelating Activity	Antirheumatic Agent|P [Preparations]	Decreased Immunologically Active Molecule Activity
2640849	adalimumab-aacf	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
8356	piroxicam	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|P [Preparations]	Decreased Prostaglandin Production
2273510	rituximab-pvvr	CD20-directed Antibody Interactions|Antibody-Receptor Interactions	R [Preparations]	Increased Cellular Death
2612153	adalimumab-bwwd	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
2639649	adalimumab-aaty	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
2472325	rituximab-arrx	CD20-directed Antibody Interactions|Antibody-Receptor Interactions	R [Preparations]	Increased Cellular Death
2619155	adalimumab-afzb	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]|Tumor Necrosis Factor Blocker	Immunologic Activity Alteration
2266523	infliximab-axxq	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	I [Preparations]	Decreased Vascular Permeability|Increased Adhesion Factor Production
2640387	adalimumab-aqvh	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
2196092	upadacitinib	Janus Kinase Inhibitors	U [Preparations]|Janus Kinase Inhibitor	Increased Extracellular Communication
2640402	adalimumab-fkjp	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
6851	methotrexate	Thymidylate Synthetase Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	Folate Analog Metabolic Inhibitor|M [Preparations]	Decreased Epithelial Proliferation|Decreased DNA Integrity|Decreased Immunologic Activity
2641642	adalimumab-adaz	Biological Response Modifiers|Tumor Necrosis Factor Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
2105824	rituximab-abbs	CD20-directed Antibody Interactions	R [Preparations]	Increased Cellular Death
2103480	etanercept-szzs	Biological Response Modifiers|Tumor Necrosis Factor beta Receptor Blocking Activity|Tumor Necrosis Factor alpha Receptor Blocking Activity	E [Preparations]	Immunologic Activity Alteration
2103477	adalimumab-adbm	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
2047232	baricitinib	Janus Kinase Inhibitors	B [Preparations]|Janus Kinase Inhibitor	Increased Extracellular Communication
2103479	adalimumab-atto	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	A [Preparations]	Immunologic Activity Alteration
2103476	infliximab-qbtx	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	I [Preparations]	Decreased Vascular Permeability|Increased Adhesion Factor Production
1790539	infliximab-dyyb	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	I [Preparations]	Decreased Vascular Permeability|Decreased Cytokine Activity|Increased Adhesion Factor Production
1927283	infliximab-abda	Biological Response Modifiers|Tumor Necrosis Factor alpha Receptor Blocking Activity	I [Preparations]	Decreased Vascular Permeability|Increased Adhesion Factor Production
6142	ketoprofen	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|K [Preparations]	Decreased Prostaglandin Production
1923319	sarilumab	Interleukin 6 Receptor Antagonists	Interleukin-6 Receptor Antagonist|S [Preparations]	Decreased Cytokine Activity
1538097	vedolizumab	Integrin Receptor Antagonists	Integrin Receptor Antagonist|V [Preparations]	Decreased Adhesion Factor Activity
847083	ustekinumab	Interleukin-12 Antagonists|Interleukin-23 Antagonists	U [Preparations]|Interleukin-23 Antagonist|Interleukin-12 Antagonist	
354770	natalizumab	Integrin Receptor Antagonists	Integrin Receptor Antagonist|N [Preparations]	Decreased Adhesion Factor Activity
221134	opium tincture	Opioid Agonists	O [Preparations]	Decreased GI Motility|Digestive Alteration|Increased GI Smooth Muscle Tone
2418	cholecalciferol	Enzyme Interactions	Vitamin D|C [Preparations]	Decreased Renal Ca++ Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
7833	aminosalicylic acid	Cyclooxygenase Inhibitors|Para-Aminobenzoic Acid Inhibitors	A [Preparations]	Cellular Structure Alteration|Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
7676	opium	Opioid Agonists	O [Preparations]	Decreased GI Motility|Digestive Alteration|Increased GI Smooth Muscle Tone
1746906	obiltoxaximab	Anthrax Protective Antigen-directed Antibody Interactions	O [Preparations]|Anthrax Protective Antigen-directed Antibody	
237027	loteprednol	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|L [Preparations]	Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
221083	sulfur, colloidal		S [Preparations]	
103866	metronidazole benzoate	Unknown Cellular or Molecular Interaction	M [Preparations]	DNA Integrity Alteration|Decreased Protein Synthesis|Increased Cellular Death
1418	benzoyl peroxide	Free Radical Scavenging Activity	B [Preparations]	Decreased Sebaceous Gland Activity
82047	metronidazole hydrochloride	Unknown Cellular or Molecular Interaction	M [Preparations]	DNA Integrity Alteration|Decreased Protein Synthesis|Increased Cellular Death
89767	colloid sulfur		C [Preparations]	
52177	loteprednol etabonate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	L [Preparations]	Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
18602	azelaic acid	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased Sebaceous Gland Activity|Decreased Protein Synthesis
35382	resorcinol	Cellular or Molecular Interactions	R [Preparations]	Decreased Sebaceous Gland Activity
10223	sulfur		S [Preparations]	
6922	metronidazole	Unknown Cellular or Molecular Interaction	Nitroimidazole Antimicrobial|M [Preparations]	DNA Integrity Alteration|Decreased Protein Synthesis|Increased Cellular Death
1598641	finafloxacin	DNA Gyrase Inhibitors|Topoisomerase Inhibitors	F [Preparations]	Decreased DNA Replication
4458	flumethasone	Glucocorticoid Receptor Agonists	F [Preparations]	Increased Glucocorticoid Secretion|Decreased Immunologic Activity
1049105	benzocaine hydrochloride	Sodium Channel Interactions	B [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
235851	ciprofloxacin lactate	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	C [Preparations]	Decreased DNA Replication|Decreased DNA Integrity|Decreased Transcription to RNA|Increased Protein Breakdown
2348	chloramphenicol	Protein Synthesis Inhibitors	Amphenicol-class Antibacterial|C [Preparations]	Decreased Protein Synthesis
2551	ciprofloxacin	Cytochrome P450 1A2 Inhibitors|DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	C [Preparations]|Fluoroquinolone Antibacterial	Decreased DNA Replication|Decreased DNA Integrity|Decreased Transcription to RNA|Increased Protein Breakdown
1399	benzocaine	Sodium Channel Interactions	Standardized Chemical Allergen|B [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
81981	ciprofloxacin hydrochloride	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	C [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA|Increased Protein Breakdown
47998	chloramphenicol sodium succinate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
20767	chloramphenicol palmitate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
20768	chloramphenicol stearate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
20769	chloramphenicol succinate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
25113	flumethasone pivalate	Glucocorticoid Receptor Agonists	F [Preparations]	Increased Glucocorticoid Secretion|Decreased Immunologic Activity
17609	aluminum acetate		A [Preparations]	Astringent Activity
8536	polymyxin B	Acid-Base Activity	Polymyxin-class Antibacterial|P [Preparations]	Cellular Structure Alteration
7623	ofloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	Quinolone Antimicrobial|O [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA
168	acetic acid		A [Preparations]	
388	polymyxin B sulfate	Acid-Base Activity	P [Preparations]	Cellular Structure Alteration
4845	glucosamine	Unknown Cellular or Molecular Interaction	G [Preparations]	Analgesia|Bone Alteration
4847	glucosamine sulfate	Unknown Cellular or Molecular Interaction	G [Preparations]	Analgesia|Bone Alteration
236608	glucosamine hydrochloride	Unknown Cellular or Molecular Interaction	G [Preparations]	Analgesia|Bone Alteration
29787	methyl salicylate	Cyclooxygenase Inhibitors|Prostaglandin Receptor Antagonists	M [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production
1789517	glucosamine sulfate potassium chloride	Unknown Cellular or Molecular Interaction	G [Preparations]	Analgesia|Bone Alteration
1102287	rilpivirine hydrochloride	Non-Nucleoside Reverse Transcriptase Inhibitors	R [Preparations]	Decreased Reverse Transcription to DNA
2462459	nevirapine hemihydrate	Cytochrome P450 2B6 Inducers|Cytochrome P450 3A Inducers|Non-Nucleoside Reverse Transcriptase Inhibitors	N [Preparations]	Decreased Reverse Transcription to DNA
1433868	dolutegravir	Organic Cation Transporter 2 Inhibitors|HIV Integrase Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|D [Preparations]	Decreased DNA Integrity
1306284	cobicistat	P-Glycoprotein Inhibitors|Cytochrome P450 2D6 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	C [Preparations]|Cytochrome P450 3A Inhibitor	
N0000175520	Human Immunodeficiency Virus Protease Inhibitor			
1433867	dolutegravir sodium	HIV Integrase Inhibitors	D [Preparations]	Decreased DNA Integrity
N0000175887	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor			
1306286	elvitegravir	Cytochrome P450 2C9 Inducers|HIV Integrase Inhibitors	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|E [Preparations]	Decreased DNA Integrity
N0000175463	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor			
N0000175464	Human Immunodeficiency Virus 1 Non-Nucleoside and Nucleoside Analog Reverse Transcriptase Inhibitor			
N0000175462	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor			
N0000175616	Human Immunodeficiency Virus 1 Fusion Inhibitor			
1235585	raltegravir potassium	HIV Integrase Inhibitors	R [Preparations]	Decreased DNA Integrity
719872	raltegravir	HIV Integrase Inhibitors	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|R [Preparations]	Decreased DNA Integrity
1102270	rilpivirine	Non-Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|R [Preparations]	Decreased Reverse Transcription to DNA
620216	maraviroc	Chemokine Co-receptor 5 Antagonists	CCR5 Co-receptor Antagonist|M [Preparations]	
2043283	ibalizumab	CD4-directed Antibody Interactions|HIV 1 Post-attachment Fusion Inhibitors	I [Preparations]|CD4-directed Blocking Antibody|Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor	
475969	etravirine	Cytochrome P450 2C9 Inhibitors|P-Glycoprotein Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A Inducers|Non-Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|E [Preparations]	Decreased Reverse Transcription to DNA
322248	tenofovir disoproxil fumarate	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
276237	emtricitabine	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|E [Preparations]	Decreased Reverse Transcription to DNA
190521	abacavir	Nucleoside Reverse Transcriptase Inhibitors|Cytochrome P450 1A1 Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|A [Preparations]	Decreased Reverse Transcription to DNA
195085	efavirenz	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 2B6 Inducers|Cytochrome P450 3A Inducers|Non-Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|E [Preparations]	Decreased Reverse Transcription to DNA
221052	abacavir sulfate	Nucleoside Reverse Transcriptase Inhibitors	A [Preparations]	Decreased Reverse Transcription to DNA
3364	didanosine	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|D [Preparations]	Decreased Reverse Transcription to DNA
139896	enfuvirtide	HIV Fusion Protein Inhibitors|Fusion Protein Inhibitors	Human Immunodeficiency Virus 1 Fusion Inhibitor|E [Preparations]	Decreased Endocytosis|Increased Immunologically Active Molecule Activity
142152	delavirdine mesylate	Non-Nucleoside Reverse Transcriptase Inhibitors	D [Preparations]	Decreased Reverse Transcription to DNA
117466	tenofovir	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
83816	delavirdine	Non-Nucleoside Reverse Transcriptase Inhibitors	D [Preparations]	Decreased Reverse Transcription to DNA
68244	lamivudine	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|L [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
59763	stavudine	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|S [Preparations]	Decreased Reverse Transcription to DNA
53654	nevirapine	Cytochrome P450 2B6 Inducers|Cytochrome P450 3A Inducers|Non-Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|N [Preparations]	Decreased Reverse Transcription to DNA
11413	zidovudine	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Z [Preparations]	Decreased Reverse Transcription to DNA
2380374	fostemsavir tromethamine	HIV 1 Post-attachment Fusion Inhibitors	F [Preparations]	
2475076	cabotegravir sodium	HIV Integrase Inhibitors	C [Preparations]	Immunologic Activity Alteration
1999661	bictegravir sodium	Nucleoside Reverse Transcriptase Inhibitors	B [Preparations]	Decreased Reverse Transcription to DNA
1999660	bictegravir	Nucleoside Reverse Transcriptase Inhibitors	B [Preparations]	Decreased Reverse Transcription to DNA
2380373	fostemsavir	HIV 1 Post-attachment Fusion Inhibitors	F [Preparations]	
2043313	ibalizumab-uiyk	CD4-directed Antibody Interactions|HIV 1 Post-attachment Fusion Inhibitors	I [Preparations]	
2475077	cabotegravir	Organic Anion Transporter 1 Inhibitors|Organic Anion Transporter 3 Inhibitors|HIV Integrase Inhibitors	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|C [Preparations]	Immunologic Activity Alteration
1721604	tenofovir alafenamide fumarate	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
1010598	naloxone hydrochloride dihydrate	Opioid Antagonists	N [Preparations]	Central Nervous System Stimulation|Increased Blood Pressure|Increased Medullary Respiratory Drive
2378841	dexamethasone acetate anhydrous	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Histamine Activity|Decreased Leukotriene Activity|Decreased Intravascular Volume|Decreased Kinin Activity|Decreased Myeloid Cell Production|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
203192	naloxone hydrochloride	Opioid Antagonists	N [Preparations]	Central Nervous System Stimulation|Increased Blood Pressure|Increased Medullary Respiratory Drive
3264	dexamethasone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Intravascular Volume|Decreased Histamine Activity|Decreased Kinin Activity|Decreased Leukotriene Activity|Decreased Myeloid Cell Production|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
3265	dexamethasone isonicotinate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Histamine Activity|Decreased Intravascular Volume|Decreased Leukotriene Activity|Decreased Kinin Activity|Decreased Myeloid Cell Production|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
221139	phenylephrine tannate	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	P [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
235486	dexamethasone phosphate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Kinin Activity|Decreased Histamine Activity|Decreased Intravascular Volume|Decreased Leukotriene Activity|Decreased Myeloid Cell Production|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
82030	isoproterenol hydrochloride	Adrenergic beta-Agonists|Adrenergic beta1-Agonists|Adrenergic beta2-Agonists	I [Preparations]	Decreased Blood Pressure|Bronchodilation|Muscular Arterial Vasodilation|Positive Chronotropy|Positive Inotropy
82031	isoproterenol sulfate	Adrenergic beta-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	I [Preparations]	Decreased Blood Pressure|Bronchodilation|Positive Chronotropy|Muscular Arterial Vasodilation|Positive Inotropy
91167	phenylephrine bitartrate	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	P [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
48933	dexamethasone sodium phosphate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Histamine Activity|Decreased Kinin Activity|Decreased Leukotriene Activity|Decreased Intravascular Volume|Decreased Lysosomal Function|Decreased Myeloid Cell Production|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
22690	dexamethasone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Intravascular Volume|Decreased Kinin Activity|Decreased Histamine Activity|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Myeloid Cell Production|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
22694	dexamethasone trimethyl acetate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	D [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Adhesion Factor Activity|Decreased Complement Production|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Histamine Activity|Decreased Intravascular Volume|Decreased Leukotriene Activity|Decreased Kinin Activity|Decreased Lysosomal Function|Decreased Myeloid Cell Production|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
7242	naloxone	Opioid Antagonists	Opioid Antagonist|N [Preparations]	Central Nervous System Stimulation|Increased Blood Pressure|Increased Medullary Respiratory Drive
8163	phenylephrine	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	alpha-1 Adrenergic Agonist|P [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
8164	phenylephrine hydrochloride	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	P [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
6054	isoproterenol	Adrenergic beta-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	beta-Adrenergic Agonist|I [Preparations]	Decreased Blood Pressure|Bronchodilation|Muscular Arterial Vasodilation|Positive Chronotropy|Positive Inotropy
268872	prednisolone sodium metasulphobenzoate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
203189	methylprednisolone sodium succinate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	M [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
155323	methylprednisolone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	M [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
62136	methylprednisolone aceponate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	M [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
38546	triamcinolone hexacetonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	T [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Cytokine Activity|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
55062	prednisolone sodium phosphate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
55063	prednisolone sodium succinate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
10759	triamcinolone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|T [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Cytokine Activity|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
10761	triamcinolone acetonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|T [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Cytokine Activity|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
10762	triamcinolone diacetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	T [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Cytokine Activity|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
29917	methylprednisolone sodium phosphate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	M [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
34374	prednisolone phosphate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
34372	prednisolone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
34376	prednisolone tebutate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
8638	prednisolone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
8640	prednisone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|P [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
6902	methylprednisolone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|M [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lysosomal Function Alteration|Lipid Metabolism Alteration
5492	hydrocortisone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
5095	halothane	Unknown Cellular or Molecular Interaction	H [Preparations]	General Anesthesia|Decreased Central Nervous System Organized Electrical Activity
3920	enflurane	Glycine Agonists|GABA A Modulators	E [Preparations]	General Anesthesia|Cerebral Arterial Vasodilation|Decreased Central Nervous System Organized Electrical Activity|Decreased Medullary Respiratory Drive|Negative Chronotropy|Decreased Intraocular Fluid Pressure|Systemic Arterial Vasodilation
1363043	ethyl ether		E [Preparations]	Vasoconstriction
163524	hydrocortisone cypionate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
235483	hydrocortisone sodium succinate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
235482	hydrocortisone sodium phosphate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
103468	hydrocortisone butyrate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
21651	cortisol succinate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	C [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
41277	hydrocortisone aceponate	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
27196	hydrocortisone probutate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
27197	hydrocortisone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
27199	hydrocortisone valerate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Decreased Capillary Permeability|Carbohydrate Metabolism Alteration|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Lipid Metabolism Alteration
6026	isoflurane	GABA A Modulators|Glycine Agonists	General Anesthetic|I [Preparations]	Vasodilation|General Anesthesia|Cerebral Arterial Vasoconstriction|Decreased Organized Electrical Activity|Decreased Medullary Respiratory Drive
1545999	oxytetracycline anhydrous	Protein Synthesis Inhibitors	Tetracycline-class Antimicrobial|O [Preparations]	Decreased Mitosis|Decreased Protein Synthesis
2059173	tioxolone		T [Preparations]	
4780	oxytetracycline hydrochloride	Protein Synthesis Inhibitors	O [Preparations]	Decreased Mitosis|Decreased Protein Synthesis
5293	hexachlorophene	Unknown Cellular or Molecular Interaction	Antiseptic|H [Preparations]	Decreased Cell Membrane Integrity
236847	erythromycin stinoprate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
236873	tetracycline trihydrate	Protein Synthesis Inhibitors	T [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
253186	magnesium salicylate tetrahydrate	Unknown Cellular or Molecular Interaction	M [Preparations]	Increased Skin Keratinization
4053	erythromycin	Protein Synthesis Inhibitors	Macrolide|Macrolide Antimicrobial|E [Preparations]	Decreased Sebaceous Gland Activity|Decreased Protein Synthesis
4055	erythromycin estolate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
4056	erythromycin ethylsuccinate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
4058	erythromycin phosphate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
266974	oxytetracycline dihydrate	Protein Synthesis Inhibitors	O [Preparations]	Decreased Mitosis|Decreased Protein Synthesis
3154	demeclocycline	Protein Synthesis Inhibitors	Tetracycline-class Antimicrobial|D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
221175	tretinoin microsphere	Receptor Interactions|Unknown Cellular or Molecular Interaction	T [Preparations]	Decreased Sebaceous Gland Activity|Decreased Epithelial Proliferation|Decreased Sebaceous Gland Quantity
235418	potassium salicylate	Unknown Cellular or Molecular Interaction	P [Preparations]	Increased Skin Keratinization
2105975	tetracycline phosphate complex	Protein Synthesis Inhibitors	T [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
142446	tetracycline hydrochloride	Protein Synthesis Inhibitors	T [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
102758	clomocycline sodium	Protein Synthesis Inhibitors	C [Preparations]	Cell Membrane Alteration
2582	clindamycin	Protein Synthesis Inhibitors	Lincosamide Antibacterial|C [Preparations]	Decreased Sebaceous Gland Activity|Neuromuscular Blockade|Decreased Protein Synthesis
81982	clindamycin hydrochloride	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
81993	demeclocycline hydrochloride	Protein Synthesis Inhibitors	D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
82065	oxytetracycline calcium	Protein Synthesis Inhibitors	O [Preparations]	Decreased Mitosis|Decreased Protein Synthesis
83947	tazarotene	Immunologic and Biological Factor Interactions|Receptor Interactions	Retinoid|T [Preparations]	Cellular Growth Phase Arrest|Cellular Division Phase Alteration|Decreased Immunologically Active Molecule Activity|Decreased Transcription to RNA
91075	clindamycin palmitate hydrochloride	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
60223	adapalene	Transcription Factor Activity	Retinoid|A [Preparations]	Decreased Sebaceous Gland Activity|Decreased Epithelial Proliferation|Cellular Growth Phase Arrest|Cellular Division Phase Alteration|Decreased Immunologically Active Molecule Activity|Keratin Alteration
10395	tetracycline	Protein Synthesis Inhibitors	Tetracycline-class Antimicrobial|T [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
21235	clindamycin palmitate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
797272	clindamycin phosphate	Protein Synthesis Inhibitors	C [Preparations]	Decreased Protein Synthesis
21272	clomocycline	Protein Synthesis Inhibitors	C [Preparations]	Cell Membrane Alteration
22656	desogestrel	Progestational Hormone Receptor Agonists	Progestin|D [Preparations]	Hypothalamic Endocrine Activity Alteration
24346	erythromycin gluceptate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
24347	erythromycin lactobionate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
24351	erythromycin stearate	Protein Synthesis Inhibitors	E [Preparations]	Decreased Protein Synthesis
10753	tretinoin	Receptor Interactions|Unknown Cellular or Molecular Interaction	Retinoid|T [Preparations]	Decreased Sebaceous Gland Activity|Decreased Epithelial Proliferation|Decreased Sebaceous Gland Quantity
31983	norethindrone acetate	Progestational Hormone Receptor Agonists	N [Preparations]	Decreased Embryonic Implantation|Gonadotropin Releasing Hormone Alteration|Decreased Luteinizing Hormone Secretion|Inhibit Ovulation
31984	norethindrone enanthate	Progestational Hormone Receptor Agonists	N [Preparations]	Decreased Embryonic Implantation|Gonadotropin Releasing Hormone Alteration|Decreased Luteinizing Hormone Secretion|Inhibit Ovulation
9907	sodium salicylate	Unknown Cellular or Molecular Interaction	S [Preparations]	Increased Skin Keratinization
7821	oxytetracycline	Protein Synthesis Inhibitors	O [Preparations]	Decreased Mitosis|Decreased Protein Synthesis
9522	salicylate	Unknown Cellular or Molecular Interaction	S [Preparations]	Increased Skin Keratinization
9525	salicylic acid	Unknown Cellular or Molecular Interaction	S [Preparations]	Increased Skin Keratinization
7514	norethindrone	Progestational Hormone Receptor Agonists	Progestin|N [Preparations]	Decreased Embryonic Implantation|Gonadotropin Releasing Hormone Alteration|Decreased Luteinizing Hormone Secretion|Inhibit Ovulation
2059038	sarecycline hydrochloride	P-Glycoprotein Inhibitors|Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
2205637	trifarotene	Receptor Interactions|Unknown Cellular or Molecular Interaction	Retinoid|T [Preparations]	
6979	minocycline hydrochloride	Protein Synthesis Inhibitors	M [Preparations]	Decreased Mitosis|Decreased Protein Modification
2059018	sarecycline	P-Glycoprotein Inhibitors|Protein Synthesis Inhibitors	Tetracycline-class Drug|S [Preparations]	Decreased Protein Synthesis
6980	minocycline	Protein Synthesis Inhibitors	Tetracycline-class Drug|M [Preparations]	Decreased Mitosis|Decreased Protein Modification|Decreased Prothrombin Activity
6064	isotretinoin	Receptor Interactions|Unknown Cellular or Molecular Interaction	Retinoid|I [Preparations]	Decreased Sebaceous Gland Activity
2606543	silver	Membrane Transporter Interactions	S [Preparations]	DNA Replication Alteration
278739	pegvisomant	Growth Hormone Receptor Antagonists|Insulin-like Growth Factor-1 Receptor Interactions	Growth Hormone Receptor Antagonist|P [Preparations]	Bone Formation Stimulation|Decreased Erythroid Cell Production|Decreased Growth Factor Activity|Decreased Protein Synthesis
221130	octreotide acetate	Somatostatin Receptor Agonists	O [Preparations]	Decreased Gastrin Activity|Decreased Growth Hormone Secretion|Decreased Glucagon Secretion|Decreased Insulin Secretion|Decreased Thyroid Stimulating Hormone Secretion|Serotonin Activity Alteration
236167	lanreotide acetate	Somatostatin Receptor Agonists	L [Preparations]	Decreased Growth Hormone Secretion
142426	bromocriptine mesylate	Dopamine Agonists	B [Preparations]	Decreased Growth Hormone Secretion|Decreased Prolactin Secretion|Increased Dopamine Activity
1760	bromocriptine	Dopamine Agonists	B [Preparations]|Ergot Derivative	Decreased Growth Hormone Secretion|Decreased Prolactin Secretion|Increased Dopamine Activity
68092	lanreotide	Somatostatin Receptor Agonists	Somatostatin Analog|L [Preparations]	Decreased Growth Hormone Secretion
7617	octreotide	Somatostatin Receptor Agonists	Somatostatin Analog|O [Preparations]	Decreased Gastrin Activity|Decreased Growth Hormone Secretion|Decreased Glucagon Secretion|Decreased Insulin Secretion|Decreased Thyroid Stimulating Hormone Secretion|Serotonin Activity Alteration
1545988	cyclophosphamide anhydrous	Alkylating Activity	Alkylating Drug|C [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
203217	leuprolide acetate	Gonadotropin Releasing Hormone Receptor Agonists|Hormone Receptor Modulators	L [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased GnRH Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
3002	cyclophosphamide	Alkylating Activity	C [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
221085	cyclophosphamide lyophilized	Alkylating Activity	C [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
40048	carboplatin	Nucleic Acid Synthesis Inhibitors	Platinum-based Drug|C [Preparations]	Decreased DNA Integrity
42375	leuprolide	Gonadotropin Releasing Hormone Receptor Agonists|Hormone Receptor Modulators	Gonadotropin Releasing Hormone Receptor Agonist|L [Preparations]	Decreased GnRH Secretion|Decreased Follicle Stimulating Hormone Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
29451	megestrol acetate	Progestational Hormone Receptor Agonists|Estrogen Receptor Antagonists	M [Preparations]	Appetite Stimulation|Decreased Luteinizing Hormone Secretion
2595041	leuprolide mesylate	Gonadotropin Releasing Hormone Receptor Agonists|Hormone Receptor Modulators	L [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased GnRH Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
6703	megestrol	Progestational Hormone Receptor Agonists|Estrogen Receptor Antagonists	Progestin|M [Preparations]	Appetite Stimulation|Decreased Luteinizing Hormone Secretion
2539968	dostarlimab-gxly	Antibody-Receptor Interactions|Programmed Death Receptor-1-directed Antibody Interactions	D [Preparations]	
2539967	dostarlimab	Antibody-Receptor Interactions|Programmed Death Receptor-1-directed Antibody Interactions	D [Preparations]|Programmed Death Receptor-1 Blocking Antibody	
860189	onabotulinumtoxinA	Acetylcholine Release Inhibitors|Acetylcholine Transporter Interactions	O [Preparations]	Decreased Striated Muscle Tone|Decreased Muscular System Acetylcholine Activity|Decreased Striated Muscle Acetylcholine Activity|Decreased Striated Muscle Contraction
360288	eletriptan hydrobromide	Serotonin Agonists	E [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
322249	frovatriptan succinate	Serotonin Agonists	F [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
283792	almotriptan malate	Serotonin Agonists|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists	A [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
236680	dihydroergotamine tartrate	Cytochrome P450 3A Inhibitors|Adrenergic alpha-Antagonists|Serotonin Antagonists|Adrenergic alpha-Agonists	D [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction
236690	naratriptan hydrochloride	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	N [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
237082	rizatriptan benzoate	Serotonin Agonists|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists	R [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
4025	ergotamine	Cytochrome P450 3A Inhibitors|Serotonin Antagonists|Adrenergic alpha-Agonists|Dopamine Receptor Interactions	Ergotamine Derivative|E [Preparations]	Cerebral Arterial Vasoconstriction|Increased Uterine Smooth Muscle Contraction or Tone
279645	almotriptan	Serotonin Agonists|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|A [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
203176	dihydroergotamine mesylate	Cytochrome P450 3A Inhibitors|Adrenergic alpha-Antagonists|Adrenergic alpha-Agonists|Serotonin Antagonists	D [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction
228783	frovatriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|F [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
231049	eletriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|E [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
3418	dihydroergotamine	Cytochrome P450 3A Inhibitors|Adrenergic alpha-Antagonists|Adrenergic alpha-Agonists|Serotonin Antagonists	Ergotamine Derivative|D [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction
135775	zolmitriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|Z [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
141366	naratriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|N [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
88014	rizatriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|R [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
67158	sumatriptan succinate	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	S [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
37418	sumatriptan	Serotonin Agonists|Serotonin 1d Receptor Agonists|Serotonin 1b Receptor Agonists	Serotonin-1b and Serotonin-1d Receptor Agonist|S [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
42676	ergotamine tartrate	Cytochrome P450 3A Inhibitors|Adrenergic alpha-Agonists|Serotonin Antagonists|Dopamine Receptor Interactions	E [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction|Increased Uterine Smooth Muscle Contraction or Tone
2571813	atogepant	Calcitonin Gene-related Peptide Receptor Antagonists|Calcitonin Gene-related Peptide Antagonists	A [Preparations]|Calcitonin Gene-related Peptide Receptor Antagonist	
2198973	eletriptan hydrobromide monohydrate	Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists	E [Preparations]	Cerebral Arterial Vasoconstriction|Increased Central Nervous System Serotonin Activity
2282322	rimegepant sulfate	Receptor Interactions	R [Preparations]	
2268216	ubrogepant	Receptor Interactions|Calcitonin Gene-related Peptide Receptor Antagonists	U [Preparations]|Calcitonin Gene-related Peptide Receptor Antagonist	
2282307	rimegepant	Receptor Interactions|Calcitonin Gene-related Peptide Receptor Antagonists	R [Preparations]|Calcitonin Gene-related Peptide Receptor Antagonist	
402429	gemifloxacin mesylate	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	G [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
138099	gemifloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	Quinolone Antimicrobial|G [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA
1311626	paroxetine hydrochloride anhydrous	Serotonin Uptake Inhibitors	P [Preparations]	Increased Brain Stem Serotonin Activity
746070	lithium aspartate	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
436212	paroxetine mesylate	Serotonin Uptake Inhibitors	P [Preparations]	Increased Brain Stem Serotonin Activity
1298842	paroxetine hydrochloride, hemihydrate	Serotonin Uptake Inhibitors	P [Preparations]	Increased Brain Stem Serotonin Activity
1298832	lithium hydroxide monohydrate	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
155137	sertraline hydrochloride	Serotonin Uptake Inhibitors	S [Preparations]	Increased Central Nervous System Serotonin Activity
235830	paroxetine hydrochloride	Serotonin Uptake Inhibitors	P [Preparations]	Increased Brain Stem Serotonin Activity
236082	nefazodone hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors|Adrenergic alpha1-Antagonists	N [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
91119	tranylcypromine sulfate	Monoamine Oxidase Inhibitors	T [Preparations]	Increased Dopamine Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
2002	carbamazepine	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 2C19 Inducers|Cytochrome P450 2B6 Inducers|Sodium Channel Interactions|Unknown Cellular or Molecular Interaction|Cytochrome P450 1A2 Inducers	Mood Stabilizer|C [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
36437	sertraline	Cytochrome P450 2D6 Inhibitors|Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|S [Preparations]	Increased Central Nervous System Serotonin Activity
52105	lithium citrate	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
42351	lithium carbonate	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions|Unknown Cellular or Molecular Interaction	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
10734	tranylcypromine	Monoamine Oxidase Inhibitors	Monoamine Oxidase Inhibitor|T [Preparations]	Increased Dopamine Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
28815	lithium orotate	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
31565	nefazodone	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors|Adrenergic alpha1-Antagonists	Serotonin Reuptake Inhibitor|N [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
32937	paroxetine	Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|P [Preparations]	Increased Brain Stem Serotonin Activity
6448	lithium	Norepinephrine Transporter Interactions|Serotonin Transporter Interactions	L [Preparations]	Norepinephrine Activity Alteration|Serotonin Activity Alteration
1545653	empagliflozin	Sodium-Glucose Transporter 2 Inhibitors	Sodium-Glucose Cotransporter 2 Inhibitor|E [Preparations]	Increased Renal Organic Ion Excretion|Renal Ion Transport Alteration
1670007	insulin degludec	Insulin Receptor Agonists	Insulin Analog|I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
1486966	dapagliflozin propanediol	Sodium-Glucose Transporter 2 Inhibitors	D [Preparations]	Increased Renal Organic Ion Excretion|Renal Ion Transport Alteration
1440051	lixisenatide	Glucagon-like Peptide-1 (GLP-1) Agonists	GLP-1 Receptor Agonist|L [Preparations]	Decreased Glucagon Secretion|Decreased Gastric Motility|Increased Insulin Secretion
1373458	canagliflozin	Sodium-Glucose Transporter 2 Inhibitors	C [Preparations]	Increased Renal Organic Ion Excretion|Renal Ion Transport Alteration
1546031	canagliflozin anhydrous	P-Glycoprotein Inhibitors|Sodium-Glucose Transporter 2 Inhibitors	Sodium-Glucose Cotransporter 2 Inhibitor|C [Preparations]	Increased Renal Organic Ion Excretion|Renal Ion Transport Alteration
1551291	dulaglutide	Glucagon-like Peptide-1 (GLP-1) Agonists	GLP-1 Receptor Agonist|D [Preparations]	Decreased Gastric Motility|Decreased Glucagon Secretion
1368000	alogliptin benzoate	Dipeptidyl Peptidase 4 Inhibitors	A [Preparations]	Peptide Metabolism Alteration
1546030	saxagliptin anhydrous	Dipeptidyl Peptidase 4 Inhibitors	Dipeptidyl Peptidase 4 Inhibitor|S [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
1100699	linagliptin	Dipeptidyl Peptidase 4 Inhibitors	Dipeptidyl Peptidase 4 Inhibitor|L [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
1534763	albiglutide	Glucagon-like Peptide-1 (GLP-1) Agonists	A [Preparations]	Decreased Gastric Motility
1043560	saxagliptin hydrochloride	Dipeptidyl Peptidase 4 Inhibitors	S [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
1368001	alogliptin	Dipeptidyl Peptidase 4 Inhibitors	Dipeptidyl Peptidase 4 Inhibitor|A [Preparations]	Peptide Metabolism Alteration
1488564	dapagliflozin	Sodium-Glucose Transporter 2 Inhibitors	Sodium-Glucose Cotransporter 2 Inhibitor|D [Preparations]	Increased Renal Organic Ion Excretion|Renal Ion Transport Alteration
4815	glyburide	Potassium Channel Interactions|Insulin Receptor Agonists	Sulfonylurea|G [Preparations]	Increased Diuresis|Decreased Glycolysis|Increased Glucose Transport into Cells|Increased Insulin Secretion
4821	glipizide	Insulin Receptor Agonists	Sulfonylurea|G [Preparations]	Decreased Glycolysis|Increased Insulin Secretion|Increased Glucose Transport into Cells
593411	sitagliptin	Dipeptidyl Peptidase 4 Inhibitors	Dipeptidyl Peptidase 4 Inhibitor|S [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
621590	sitagliptin phosphate	Dipeptidyl Peptidase 4 Inhibitors	S [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
857974	saxagliptin	Dipeptidyl Peptidase 4 Inhibitors	S [Preparations]	Decreased Glucagon Secretion|Increased Insulin Secretion
400008	insulin glulisine, human	Insulin Receptor Agonists	Insulin Analog|I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
352385	insulin aspart protamine, human	Insulin Receptor Agonists|Hormone Receptor Agonists	I [Preparations]	Decreased Glucose Transport into Cells|Decreased Glycolysis|Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
356773	pramlintide acetate	Amylin Agonists	P [Preparations]	Appetite Suppression|Decreased Glucagon Secretion|Decreased Gastric Motility
317235	insulin isophane, beef	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
317598	insulin isophane, beef-pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
314682	lente insulin, beef-pork	Insulin Receptor Agonists	L [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
314683	lente insulin, human	Insulin Receptor Agonists	L [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
314686	insulin, regular, beef	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
314684	insulin lispro protamine, human	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
314685	insulin, protamine zinc, beef-pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
259319	pioglitazone hydrochloride	Peroxisome Proliferator-activated Receptor gamma Agonists|Peroxisome Proliferator-activated Receptor alpha Agonists|Insulin Receptor Agonists	P [Preparations]	Increased Glucose Transport into Cells|Increased Glycolysis
253181	insulin isophane, human	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
253182	insulin, regular, human	Insulin Receptor Agonists	I [Preparations]|Insulin	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
253198	rosiglitazone maleate	Peroxisome Proliferator-activated Receptor alpha Agonists|Peroxisome Proliferator-activated Receptor gamma Agonists|Insulin Receptor Agonists	R [Preparations]	Increased Glucose Transport into Cells|Increased Glycolysis
274332	nateglinide	Potassium Channel Antagonists|Insulin Receptor Agonists	Glinide|N [Preparations]	Increased Insulin Secretion
274783	insulin glargine	Insulin Receptor Agonists	Insulin Analog|I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
217364	glyburide, micronized	Potassium Channel Interactions|Insulin Receptor Agonists	G [Preparations]	Increased Diuresis|Decreased Glycolysis|Increased Insulin Secretion|Increased Glucose Transport into Cells
221108	insulin isophane, pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Gluconeogenesis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
221109	insulin, regular, pork	Insulin Receptor Agonists	I [Preparations]	Decreased Gluconeogenesis|Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
221110	ultralente insulin, human	Insulin Receptor Agonists	U [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
221173	tolbutamide sodium	Insulin Receptor Agonists	T [Preparations]	Decreased Glycolysis|Increased Glucose Transport into Cells|Increased Insulin Secretion
235280	lente insulin, beef	Insulin Receptor Agonists	L [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235279	insulin, protamine zinc, pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235275	insulin, regular, beef-pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235278	insulin, protamine zinc, beef	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235281	ultralente insulin, beef-pork	Insulin Receptor Agonists	U [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235283	insulin, prompt zinc, beef-pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
235282	ultralente insulin, beef	Insulin Receptor Agonists	U [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
235284	insulin, prompt zinc, beef	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
235286	insulin, prompt zinc, pork	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
235743	metformin hydrochloride	Insulin Receptor Agonists	M [Preparations]	Decreased Glycogenesis|Decreased Gluconeogenesis|Increased Glucose Transport into Cells
139953	pramlintide	Amylin Agonists	Amylin Analog|P [Preparations]	Appetite Suppression|Decreased Glucagon Secretion|Decreased Gastric Motility
141626	colesevelam	Bile-acid Binding Activity	Bile Acid Sequestrant|C [Preparations]	Decreased Cholesterol Absorption
141625	colesevelam hydrochloride	Bile-acid Binding Activity	C [Preparations]	Decreased Cholesterol Absorption
2404	chlorpropamide	Insulin Receptor Agonists	C [Preparations]	Decreased Glycolysis|Increased Glucose Transport into Cells|Increased Insulin Secretion
93108	lente insulin, pork	Insulin Receptor Agonists	L [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
84108	rosiglitazone	Peroxisome Proliferator-activated Receptor alpha Agonists|Peroxisome Proliferator-activated Receptor gamma Agonists|Insulin Receptor Agonists	Thiazolidinedione|Peroxisome Proliferator Receptor gamma Agonist|R [Preparations]	Increased Glucose Transport into Cells|Increased Glycolysis
86009	insulin lispro	Insulin Receptor Agonists	Insulin Analog|I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
72610	troglitazone	Peroxisome Proliferator-activated Receptor gamma Agonists|Peroxisome Proliferator-activated Receptor alpha Agonists	T [Preparations]	Decreased Gluconeogenesis|Increased Glucose Transport into Cells|Increased Glycolysis
73044	repaglinide	Potassium Channel Antagonists|Insulin Receptor Agonists	Glinide|R [Preparations]	Increased Insulin Secretion
60548	exenatide	Glucagon-like Peptide-1 (GLP-1) Agonists	GLP-1 Receptor Agonist|E [Preparations]	Decreased Glucagon Secretion|Decreased Gastric Motility|Increased Insulin Secretion
51428	insulin aspart, human	Insulin Receptor Agonists	Insulin Analog|I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glucose Transport into Cells|Increased Glycogenesis|Increased Lipogenesis|Increased Protein Synthesis
10633	tolazamide	Insulin Receptor Agonists	Sulfonylurea|T [Preparations]	Increased Diuresis|Decreased Glycolysis|Increased Insulin Secretion|Increased Glucose Transport into Cells
10635	tolbutamide	Insulin Receptor Agonists	T [Preparations]	Decreased Glycolysis|Increased Glucose Transport into Cells|Increased Insulin Secretion
25789	glimepiride	Insulin Receptor Agonists	Sulfonylurea|G [Preparations]	Decreased Glycolysis|Increased Insulin Secretion|Increased Glucose Transport into Cells
30009	miglitol	alpha Glucosidase Inhibitors	alpha-Glucosidase Inhibitor|M [Preparations]	Inhibition Carbohydrate Digestion
33738	pioglitazone	Peroxisome Proliferator-activated Receptor alpha Agonists|Peroxisome Proliferator-activated Receptor gamma Agonists|Insulin Receptor Agonists	Thiazolidinedione|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator Receptor gamma Agonist|P [Preparations]	Increased Glucose Transport into Cells|Increased Glycolysis
16681	acarbose	alpha Glucosidase Inhibitors|Amylase Inhibitors	alpha-Glucosidase Inhibitor|A [Preparations]	Inhibition Carbohydrate Digestion
2376838	insulin lispro-aabc	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
2601723	tirzepatide	Glucagon-like Peptide-1 (GLP-1) Agonists|G-Protein-linked Receptor Interactions|Glucagon-like Peptide-1 (GLP-1) Receptor Interactions	GLP-1 Receptor Agonist|T [Preparations]|Glucose-dependent Insulinotropic Polypeptide Receptor Agonist	
2589006	insulin glargine-aglr	Insulin Receptor Agonists	I [Preparations]	Decreased Glycogenolysis|Decreased Lipolysis|Increased Glycogenesis|Increased Glucose Transport into Cells|Increased Lipogenesis|Increased Protein Synthesis
6809	metformin	Insulin Receptor Agonists	Biguanide|M [Preparations]	Decreased Glycogenesis|Decreased Gluconeogenesis|Increased Glucose Transport into Cells
173	acetohexamide	Potassium Channel Interactions|Insulin Receptor Agonists	A [Preparations]	Decreased Glycolysis|Increased Glucose Transport into Cells|Increased Insulin Secretion
1599564	edoxaban tosylate		E [Preparations]	Decreased Coagulation Factor Activity
1599538	edoxaban	Factor Xa Inhibitors	Factor Xa Inhibitor|E [Preparations]	Decreased Coagulation Factor Activity
1364430	apixaban	Antithrombins|Factor Xa Inhibitors	Factor Xa Inhibitor|A [Preparations]	Decreased Coagulation Factor Activity
1037041	dabigatran etexilate mesylate	Thrombin Inhibitors	D [Preparations]	Decreased Coagulation Activity
1037042	dabigatran etexilate	Thrombin Inhibitors	D [Preparations]	Decreased Coagulation Activity
1114195	rivaroxaban	Factor Xa Inhibitors	Factor Xa Inhibitor|R [Preparations]	Decreased Coagulation Factor Activity
5224	heparin	Thrombin Inhibitors|Antithrombin Activators	H [Preparations]	Decreased Coagulation Factor Activity
236025	heparin sodium, bovine	Thrombin Inhibitors|Antithrombin Activators	H [Preparations]	Decreased Coagulation Factor Activity
436195	bemiparin sodium	Antithrombins|Serine Proteinase Inhibitors|Factor Xa Inhibitors	B [Preparations]	Decreased Coagulation Factor Activity
321208	fondaparinux	Antithrombins|Factor Xa Inhibitors	Factor Xa Inhibitor|F [Preparations]	Decreased Coagulation Factor Activity
322154	fondaparinux sodium	Antithrombins	F [Preparations]	Decreased Coagulation Factor Activity
314659	heparin sodium, porcine	Thrombin Inhibitors|Antithrombin Activators	H [Preparations]	Decreased Coagulation Factor Activity
280611	bemiparin	Antithrombins|Serine Proteinase Inhibitors|Factor Xa Inhibitors	B [Preparations]	Decreased Coagulation Factor Activity
221095	enoxaparin sodium	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	E [Preparations]	Decreased Coagulation Factor Activity
152612	certoparin sodium	Antithrombins|Factor Xa Inhibitors	C [Preparations]	Decreased Coagulation Factor Activity
152610	certoparin	Antithrombins|Factor Xa Inhibitors	C [Preparations]	Decreased Coagulation Factor Activity
235473	heparin, porcine	Antithrombin Activators|Thrombin Inhibitors	Anti-coagulant|Unfractionated Heparin|H [Preparations]	Decreased Coagulation Factor Activity
235995	tinzaparin sodium,porcine	Protease Inhibitors|Antithrombins	T [Preparations]	Decreased Coagulation Factor Activity
1856273	heparin, bovine	Thrombin Inhibitors|Antithrombin Activators	H [Preparations]	Decreased Coagulation Factor Activity
114194	warfarin sodium	Vitamin K Epoxide Reductase Inhibitors	W [Preparations]	Decreased Coagulation Factor Concentration|Decreased Coagulation Factor Activity
103843	danaparoid sodium	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	D [Preparations]	Decreased Coagulation Factor Activity
104466	tinzaparin sodium	Protease Inhibitors|Antithrombins	T [Preparations]	Decreased Coagulation Factor Activity
82118	warfarin potassium	Vitamin K Epoxide Reductase Inhibitors	W [Preparations]	Decreased Coagulation Factor Concentration|Decreased Coagulation Factor Activity
82137	dalteparin sodium	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	D [Preparations]	Decreased Coagulation Factor Activity
1598	dicumarol	Vitamin K Epoxide Reductase Inhibitors	D [Preparations]	Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
75960	reviparin	Antithrombins	R [Preparations]	Decreased Coagulation Factor Activity
75961	reviparin sodium	Antithrombins	R [Preparations]	Decreased Coagulation Factor Activity
78484	danaparoid	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	D [Preparations]	Decreased Coagulation Factor Activity
67031	nadroparin	Antithrombins|Serine Proteinase Inhibitors|Factor Xa Inhibitors	N [Preparations]	Decreased Coagulation Factor Activity
67109	dalteparin	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	Anti-coagulant|Low Molecular Weight Heparin|D [Preparations]	Decreased Coagulation Factor Activity
67108	enoxaparin	Antithrombins|Enzyme Activators|Serine Proteinase Inhibitors|Factor Xa Inhibitors	Low Molecular Weight Heparin|E [Preparations]	Decreased Coagulation Factor Activity
69528	parnaparin	Antithrombins	P [Preparations]	Decreased Coagulation Factor Activity
69646	tinzaparin	Protease Inhibitors|Antithrombins	Low Molecular Weight Heparin|T [Preparations]	Decreased Coagulation Factor Activity
40028	anistreplase	Tissue Plasminogen Activators	A [Preparations]	Increased Thrombolysis
20044	heparin calcium	Antithrombin Activators|Thrombin Inhibitors	H [Preparations]	Decreased Coagulation Factor Activity
11055	urokinase	Tissue Plasminogen Activators	Thrombolytic Agent|U [Preparations]	Increased Thrombolysis
11289	warfarin	Vitamin K Inhibitors|Vitamin K Epoxide Reductase Inhibitors	W [Preparations]|Vitamin K Antagonist	Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
9877	heparin sodium	Antithrombin Activators|Thrombin Inhibitors	H [Preparations]	Decreased Coagulation Factor Activity
8410	alteplase	Plasminogen Activators|Tissue Plasminogen Activators	A [Preparations]	Increased Thrombolysis
17941	anisindione	Vitamin K Epoxide Reductase Inhibitors	A [Preparations]	Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
10106	streptokinase	Tissue Plasminogen Activators	S [Preparations]	Increased Thrombolysis
8150	phenprocoumon	Vitamin K Epoxide Reductase Inhibitors	P [Preparations]	Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
1546009	levofloxacin anhydrous	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	L [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA|Increased Protein Breakdown
2878	cortisone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|C [Preparations]	Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
82122	levofloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	L [Preparations]|Fluoroquinolone Antibacterial	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA|Increased Protein Breakdown
55672	rifabutin	Nucleic Acid Synthesis Inhibitors	Rifamycin Antimycobacterial|R [Preparations]	Cellular Growth Phase Reduction|Decreased Protein Synthesis|Decreased Transcription to RNA
21655	cortisone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	C [Preparations]	Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
35617	rifapentine	Nucleic Acid Synthesis Inhibitors	Rifamycin Antimycobacterial|R [Preparations]	Cellular Growth Phase Reduction|Decreased Protein Synthesis|Decreased RNA Replication|Decreased Transcription to RNA
52582	mesalamine	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	Aminosalicylate|M [Preparations]	Decreased Leukotriene Activity|Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
237005	levomethadyl	Opioid Agonists	L [Preparations]	Decreased Organized Electrical Activity
218337	methadone hydrochloride	NMDA Receptor Antagonists|Full Opioid Agonists|Opioid Agonists	M [Preparations]	Analgesia|Decreased Organized Electrical Activity
236069	nalmefene hydrochloride	Opioid Antagonists	N [Preparations]	Central Nervous System Stimulation|Increased Blood Pressure|Increased Medullary Respiratory Drive
142432	clonidine hydrochloride	Adrenergic alpha2-Agonists	C [Preparations]	Analgesia|Decreased Blood Pressure|Decreased Sympathetic Organized Electrical Activity|Negative Chronotropy|Neurotransmitter & Neuromuscular Transmitter Activity Alteration|Systemic Arterial Vasodilation|Renal Arterial Vasodilation
105069	naltrexone hydrochloride	Opioid Antagonists	N [Preparations]	Pupillary Constriction|Central Nervous System Stimulation
82043	levomethadyl acetate hydrochloride	Opioid Agonists	L [Preparations]	Decreased Organized Electrical Activity
31479	nalmefene	Opioid Antagonists	Opioid Antagonist|N [Preparations]	Central Nervous System Stimulation|Increased Blood Pressure|Increased Medullary Respiratory Drive
7243	naltrexone	Opioid Antagonists	Opioid Antagonist|N [Preparations]	Pupillary Constriction|Central Nervous System Stimulation
6813	methadone	NMDA Receptor Antagonists|Full Opioid Agonists|Opioid Agonists	M [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
540810	amphetamine saccharate	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	A [Preparations]	Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
405812	amphetamine aspartate monohydrate	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	A [Preparations]	Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
203188	methylphenidate hydrochloride	Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	M [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
221057	amphetamine aspartate	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	A [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
3287	dextroamphetamine sulfate	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	D [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
3288	dextroamphetamine	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	Central Nervous System Stimulant|D [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
221088	dextroamphetamine saccharate	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	D [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
81952	amphetamine sulfate	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	A [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
82044	methamphetamine hydrochloride	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	M [Preparations]	Appetite Suppression|Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
30125	modafinil	Dopamine Uptake Inhibitors	Sympathomimetic-like Agent|M [Preparations]	Central Nervous System Stimulation|Increased Sympathetic Activity|Increased Central Nervous System Organized Electrical Activity
7966	pemoline	Dopamine Uptake Inhibitors	P [Preparations]	Increased Cerebral Cortex Organized Electrical Activity|Increased Cerebral Cortex Dopamine Activity|Increased Medullary Respiratory Drive
6816	methamphetamine	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	Central Nervous System Stimulant|Amphetamine Anorectic|M [Preparations]	Appetite Suppression|Central Nervous System Stimulation|Increased Sympathetic Activity|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
6901	methylphenidate	Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	Central Nervous System Stimulant|M [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
725	amphetamine	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	Central Nervous System Stimulant|A [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
1426886	cysteamine hydrochloride	Cystine Disulfide Reduction|Unknown Cellular or Molecular Interaction	C [Preparations]	Unknown Physiological Effect
3022	cysteamine	Cystine Disulfide Reduction|Unknown Cellular or Molecular Interaction	Cystine Depleting Agent|C [Preparations]	Unknown Physiological Effect
81990	cysteamine bitartrate	Cystine Disulfide Reduction|Unknown Cellular or Molecular Interaction	C [Preparations]	Unknown Physiological Effect
1309404	ipratropium bromide monohydrate	Cholinergic Muscarinic Antagonists	I [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
1445143	ipratropium bromide anhydrous	Cholinergic Muscarinic Antagonists	I [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
1367172	budesonide (11.beta.,16.alpha.(S))	Glucocorticoid Receptor Agonists	B [Preparations]	Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
705022	fluticasone furoate	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	F [Preparations]	Decreased Capillary Permeability|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis
1298840	flunisolide hemihydrate	Glucocorticoid Receptor Agonists	F [Preparations]	Decreased Capillary Permeability|Decreased Fibroblast Migration|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Protein Synthesis|Increased Lysosomal Function
686390	dexbrompheniramine tannate	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
1546428	flunisolide anhydrous	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Decreased Capillary Permeability|Decreased Polymorphonuclear Leukocyte Migration|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Protein Synthesis|Increased Lysosomal Function
5032	guaifenesin		G [Preparations]|Expectorant	Decreased Respiratory Secretion Viscosity|Increased Respiratory Secretions
405414	brompheniramine tannate	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity
405970	carbinoxamine tannate	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
407885	pseudoephedrine polistirex	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	P [Preparations]	Vasoconstriction|Bronchodilation
402349	levocetirizine dihydrochloride	Histamine H1 Receptor Antagonists	L [Preparations]	Decreased Histamine Activity
353104	dexchlorpheniramine tannate	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
356887	levocetirizine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|L [Preparations]	Decreased Histamine Activity
360283	diphenhydramine tannate	Histamine H1 Receptor Antagonists	D [Preparations]	
314786	phenyltoloxamine resin complex	Histamine H1 Receptor Antagonists	P [Preparations]	Analgesia|Decreased Histamine Activity
485608	promethazine hydrobromide	Dopamine Antagonists|Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Emesis Suppression
3642	doxylamine	Histamine H1 Receptor Antagonists|Histamine Receptor Antagonists	Antihistamine|D [Preparations]	Decreased Histamine Activity
236260	diphenhydramine diacefyllinate	Histamine H1 Receptor Antagonists	D [Preparations]	
236474	fexofenadine hydrochloride	Histamine H1 Receptor Antagonists	F [Preparations]	Decreased Histamine Activity
236525	cyproheptadine pyrid phos	Histamine H1 Receptor Antagonists|Serotonin Antagonists	C [Preparations]	Decreased Histamine Activity|Decreased Serotonin Activity
236792	phenyltoloxamine polistirex	Histamine H1 Receptor Antagonists	P [Preparations]	Analgesia|Decreased Histamine Activity
236815	promethazine dioxide	Dopamine Antagonists|Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Emesis Suppression
253156	beclomethasone dipropionate monohydrate	Glucocorticoid Receptor Agonists	B [Preparations]	Vasoconstriction|Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
266959	pheniramine maleate	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
274964	ciclesonide	Glucocorticoid Receptor Agonists	C [Preparations]	Decreased Vascular Permeability|Decreased Prostaglandin Production
275635	desloratadine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|D [Preparations]	Decreased Histamine Activity
203150	cetirizine hydrochloride	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
203212	ipratropium bromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	I [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
159340	pheniramine aminosalicylate	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
164308	trimeprazine tartrate	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
3013	cyproheptadine	Serotonin Antagonists|Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity|Decreased Serotonin Activity
3266	phenylpropanolamine hydrochloride	Adrenergic alpha-Agonists	P [Preparations]	Vasoconstriction|Increased Urethra Smooth Muscle Tone
221074	chlorpheniramine polistirex	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
221075	chlorpheniramine tannate	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
221137	phenindamine tartrate	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
221141	phenyltoloxamine citrate	Histamine H1 Receptor Antagonists	P [Preparations]	Analgesia|Decreased Histamine Activity
221151	pseudoephedrine tannate	Adrenergic beta-Agonists|Adrenergic alpha-Agonists	P [Preparations]	Vasoconstriction|Bronchodilation
221152	pyrilamine tannate	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
153374	mometasone furoate monohydrate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	M [Preparations]	Vasoconstriction|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity
3498	diphenhydramine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|D [Preparations]	
235721	methapyrilene hydrochloride	Histamine H1 Receptor Antagonists	M [Preparations]	Decreased Histamine Activity
235725	chlorcyclizine hydrochloride	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
235824	azelastine hydrochloride	Histamine H1 Receptor Antagonists	A [Preparations]	Decreased Histamine Activity
3538	cromolyn sodium	Biological Response Modifiers|Ion Exchange Activity	C [Preparations]	Decreased Histamine Release|Decreased Histamine Activity|Decreased Leukotriene Activity
142427	brompheniramine maleate	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity
142429	chlorpheniramine maleate	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
142430	clemastine fumarate	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
142445	promethazine hydrochloride	Dopamine Antagonists|Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Emesis Suppression
115713	montelukast sodium	Leukotriene Receptor Antagonists	M [Preparations]	Bronchodilation|Decreased Tracheo-Bronchial Mucosal Edema
104592	cyproheptadine hydrochloride	Serotonin Antagonists|Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity|Decreased Serotonin Activity
108118	mometasone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|M [Preparations]	Vasoconstriction|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity
2354	chlorcyclizine	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
2400	chlorpheniramine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|C [Preparations]	Decreased Histamine Activity
2578	clemastine	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
71533	tripelennamine citrate	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
82004	diphenhydramine citrate	Histamine H1 Receptor Antagonists	D [Preparations]	
82091	pyrilamine maleate	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
87636	fexofenadine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|F [Preparations]	Decreased Histamine Activity
88249	montelukast	Leukotriene Receptor Antagonists	Leukotriene Receptor Antagonist|M [Preparations]	Bronchodilation|Decreased Tracheo-Bronchial Mucosal Edema
91063	tripelennamine hydrochloride	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
91065	bromodiphenhydramine hydrochloride	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity|Emesis Suppression
91066	carbinoxamine maleate	Histamine H1 Receptor Antagonists	C [Preparations]	Decreased Histamine Activity
91121	methdilazine hydrochloride	Histamine H1 Receptor Antagonists	M [Preparations]	Decreased Histamine Activity
91168	pseudoephedrine hydrochloride	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	P [Preparations]	Vasoconstriction|Bronchodilation
91169	pseudoephedrine sulfate	Adrenergic beta-Agonists|Adrenergic alpha-Agonists	P [Preparations]	Vasoconstriction|Bronchodilation
1767	brompheniramine	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity
48936	dexbrompheniramine maleate	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
50121	fluticasone propionate	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	F [Preparations]	Decreased Capillary Permeability|Decreased Fibroblast Migration|Decreased Glucocorticoid Secretion|Decreased Polymorphonuclear Leukocyte Migration|Decreased Lysosomal Function|Decreased Protein Synthesis
18600	azatadine	Calcium Channel Interactions	A [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
18603	azelastine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|A [Preparations]	Decreased Histamine Activity
19759	bromodiphenhydramine	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity|Emesis Suppression
19831	budesonide	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|B [Preparations]	Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
19959	acrivastine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|A [Preparations]	Decreased Histamine Activity
20220	carbinoxamine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|C [Preparations]	Decreased Histamine Activity
54828	dexchlorpheniramine maleate	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
20610	cetirizine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|C [Preparations]	Decreased Histamine Activity
58275	azatadine maleate	Calcium Channel Interactions	A [Preparations]	Decreased Acetylcholine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
22697	dexchlorpheniramine	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
22696	dexbrompheniramine	Histamine H1 Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
1546384	beclomethasone 17-monopropionate	Glucocorticoid Receptor Agonists	B [Preparations]	Vasoconstriction|Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
41126	fluticasone	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Decreased Capillary Permeability|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Lysosomal Function|Decreased Protein Synthesis
23665	doxylamine succinate	Histamine H1 Receptor Antagonists|Histamine Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
42328	astemizole	Histamine H1 Receptor Antagonists	A [Preparations]	Decreased Histamine Activity
25120	flunisolide	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	F [Preparations]	Decreased Capillary Permeability|Decreased Polymorphonuclear Leukocyte Migration|Decreased Glucocorticoid Secretion|Decreased Fibroblast Migration|Decreased Protein Synthesis|Increased Lysosomal Function
28889	loratadine	Histamine H1 Receptor Antagonists	L [Preparations]	Decreased Histamine Activity
29648	methdilazine	Histamine H1 Receptor Antagonists	M [Preparations]	Decreased Histamine Activity
42612	cromolyn	Biological Response Modifiers|Ion Exchange Activity	Mast Cell Stabilizer|C [Preparations]	Decreased Histamine Release|Decreased Leukotriene Activity|Decreased Histamine Activity
30145	mometasone furoate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	M [Preparations]	Vasoconstriction|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity
10825	trimeprazine	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
10847	tripelennamine	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
1347	beclomethasone	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|B [Preparations]	Vasoconstriction|Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
1348	beclomethasone dipropionate	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Vasoconstriction|Decreased Glucocorticoid Secretion|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Cellular Migration
33283	phenindamine	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
1362	diphenhydramine hydrochloride	Histamine H1 Receptor Antagonists	D [Preparations]	
33408	phenyltoloxamine	Histamine H1 Receptor Antagonists	P [Preparations]	Analgesia|Decreased Histamine Activity
7213	ipratropium	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|I [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
8745	promethazine	Dopamine Antagonists|Histamine H1 Receptor Antagonists	Phenothiazine|P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Emesis Suppression
2622915	doxylamine succinate, (R)-	Histamine H1 Receptor Antagonists|Histamine Receptor Antagonists	D [Preparations]	Decreased Histamine Activity
8896	pseudoephedrine	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	alpha-Adrenergic Agonist|P [Preparations]	Vasoconstriction|Bronchodilation
8132	pheniramine	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
9009	pyrilamine	Histamine H1 Receptor Antagonists	P [Preparations]	Decreased Histamine Activity
6822	methapyrilene	Histamine H1 Receptor Antagonists	M [Preparations]	Decreased Histamine Activity
1546373	ipratropium cation	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|I [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
1358172	chondroitin sulfate sodium (shark)	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
1299929	chondroitin sulfate sodium (bovine)	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
1306129	chondroitin sulfate, bovine	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
1306202	chondroitin sulfate, porcine	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
1366974	chondroitin sulfate sodium (porcine)	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
476847	chondroitin sulfate A sodium	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
588003	meclofenamate	Cyclooxygenase Inhibitors	M [Preparations]	Analgesia|Decreased Prostaglandin Production
232158	rofecoxib	Cyclooxygenase 2 Inhibitors	R [Preparations]	Decreased Prostaglandin Production
2473	chondroitin sulfates	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
1605114	chondroitin sulfate sodium	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
20343	carprofen	Cyclooxygenase Inhibitors	C [Preparations]	Decreased Prostaglandin Production
6677	meclofenamate sodium	Cyclooxygenase Inhibitors	M [Preparations]	Analgesia|Decreased Prostaglandin Production
1789516	chondroitin sulfate (shark)	Biological Macromolecular Activity	C [Preparations]	Collagen Formation Promotion|Decreased Prostaglandin Production
10691	tranexamic acid	Plasmin Inhibitors	Antifibrinolytic Agent|T [Preparations]	Decreased Fibrinolysis
7426	nimodipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|N [Preparations]	Cerebral Arterial Vasodilation|Coronary Arterial Vasodilation
1362139	ziprasidone hydrochloride anhydrous	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists	Z [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
885604	olanzapine pamoate monohydrate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists|Adrenergic beta-Antagonists|GABA A Antagonists|Cholinergic Muscarinic Antagonists	O [Preparations]	Decreased Norepinephrine Activity|Decreased Acetylcholine Activity|Decreased Enteric Nervous System GABA Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
1040027	lurasidone hydrochloride	Unknown Cellular or Molecular Interaction	L [Preparations]	
1294588	olanzapine pamoate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists|Adrenergic beta-Antagonists|GABA A Antagonists|Cholinergic Muscarinic Antagonists	O [Preparations]	Decreased Norepinephrine Activity|Decreased Acetylcholine Activity|Decreased Enteric Nervous System GABA Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
1667655	cariprazine	Dopamine Agonists|Serotonin Receptor Interactions	Atypical Antipsychotic|C [Preparations]	
860647	asenapine maleate	Unknown Cellular or Molecular Interaction	A [Preparations]	
858045	paliperidone palmitate	Unknown Cellular or Molecular Interaction	P [Preparations]	
784649	asenapine	Unknown Cellular or Molecular Interaction	Atypical Antipsychotic|A [Preparations]	
1040028	lurasidone	Unknown Cellular or Molecular Interaction	Atypical Antipsychotic|L [Preparations]	
5093	haloperidol	Dopamine Antagonists	Typical Antipsychotic|H [Preparations]	Decreased Brain Stem Organized Electrical Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
4495	flupenthixol	Dopamine Antagonists|Dopamine D2 Antagonists|Adrenergic alpha1-Antagonists	F [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
4496	fluphenazine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	Phenothiazine|F [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
4507	fluspirilene	Dopamine D2 Antagonists	F [Preparations]	
353116	ziprasidone mesylate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists	Z [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
289159	pipamperone dihydrochloride	Serotonin Agonists|Dopamine D2 Antagonists|Adrenergic alpha1-Antagonists	P [Preparations]	Increased Central Nervous System Serotonin Activity
284925	ziprasidone hydrochloride, monohydrate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists	Z [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
236771	perazine dimalonate	Dopamine Antagonists	P [Preparations]	Decreased Dopamine Activity
203137	selegiline hydrochloride	Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors	S [Preparations]	Increased Central Nervous System Dopamine Activity
203165	thioridazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists	T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
203186	mesoridazine besylate	Dopamine Antagonists	M [Preparations]	Decreased Dopamine Activity
203207	fluphenazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	F [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
160372	levomepromazine maleate	Cytochrome P450 2D6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Histamine H1 Receptor Antagonists|Dopamine D2 Antagonists	L [Preparations]	Decreased Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Decreased Brain Stem Organized Electrical Activity|Decreased Histamine Activity|Hypothalamic Endocrine Activity Alteration
217483	haloperidol lactate	Dopamine Antagonists	H [Preparations]	Decreased Brain Stem Organized Electrical Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
221153	quetiapine fumarate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists	Q [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
679314	paliperidone	Unknown Cellular or Molecular Interaction	Atypical Antipsychotic|P [Preparations]	
235739	prochlorperazine mesylate	Dopamine Antagonists	P [Preparations]	Decreased Central Nervous System Norepinephrine Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Emesis Suppression
235742	flupentixol hydrochloride	Dopamine Antagonists|Dopamine D2 Antagonists|Adrenergic alpha1-Antagonists	F [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
235745	pipotiazine palmitate	Dopamine Antagonists|Histamine H1 Receptor Antagonists|Cholinergic Muscarinic Antagonists	P [Preparations]	Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
142444	promazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
1294533	ziprasidone hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists	Z [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
115698	ziprasidone	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists	Atypical Antipsychotic|Z [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
104728	chlorpromazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
2403	chlorpromazine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	Phenothiazine|C [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
2598	clonazepam	GABA A Modulators|GABA A Agonists	Benzodiazepine|C [Preparations]	Increased GABA Activity
2626	clozapine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists|Cholinergic Muscarinic Antagonists	Atypical Antipsychotic|C [Preparations]	Decreased Norepinephrine Activity|Decreased Acetylcholine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
82051	molindone hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists	M [Preparations]	Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
89013	aripiprazole	Serotonin Receptor Interactions|Dopamine Receptor Interactions	Atypical Antipsychotic|A [Preparations]	Decreased Dopamine Activity|Decreased Serotonin Activity
73178	iloperidone	Unknown Cellular or Molecular Interaction	Atypical Antipsychotic|I [Preparations]	
91124	methotrimeprazine hydrochloride	Cytochrome P450 2D6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Histamine H1 Receptor Antagonists|Dopamine D2 Antagonists	M [Preparations]	Decreased Acetylcholine Activity|Decreased Brain Stem Organized Electrical Activity|Decreased Brain Stem Dopamine Activity|Decreased Histamine Activity|Hypothalamic Endocrine Activity Alteration
91127	acetophenazine maleate	Adrenergic alpha-Antagonists|Dopamine Antagonists	A [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
91130	trifluoperazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists	T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
91135	thiothixene hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists	T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity
91138	loxapine hydrochloride	Dopamine Antagonists|Serotonin Antagonists	L [Preparations]	Decreased Serotonin Activity|Increased Dopamine Activity
61381	olanzapine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists|Histamine H1 Receptor Antagonists|Adrenergic beta-Antagonists|GABA A Antagonists|Cholinergic Muscarinic Antagonists	Atypical Antipsychotic|O [Preparations]	Decreased Norepinephrine Activity|Decreased Acetylcholine Activity|Decreased Dopamine Activity|Decreased Enteric Nervous System GABA Activity|Decreased Histamine Activity|Decreased Serotonin Activity
62174	deserpidine	Norepinephrine Uptake Inhibitors|Vesicular Monoamine Transporter Antagonists	D [Preparations]	Decreased Blood Pressure|Decreased Sympathetic Activity|Decreased Sympathetic Norepinephrine Activity
51272	quetiapine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists	Atypical Antipsychotic|Q [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
10502	thioridazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	Phenothiazine|T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
10510	thiothixene	Adrenergic alpha-Antagonists|Dopamine Antagonists	Typical Antipsychotic|T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity
41996	sertindole	Serotonin Agonists|Dopamine D2 Antagonists	S [Preparations]	Decreased Dopamine Activity|Decreased Serotonin Activity
25188	flupenthixol decanoate	Dopamine Antagonists|Dopamine D2 Antagonists|Adrenergic alpha1-Antagonists	F [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
25190	fluphenazine decanoate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	F [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
26420	haloperidol decanoate	Dopamine Antagonists	H [Preparations]	Decreased Brain Stem Organized Electrical Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
10800	trifluoperazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	Phenothiazine|T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
30129	fluphenazine enanthate	Adrenergic alpha-Antagonists|Dopamine Antagonists|Unknown Cellular or Molecular Interaction	F [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity|Hypothalamic Endocrine Activity Alteration
33212	perphenazine enanthate	Adrenergic alpha-Antagonists|Dopamine Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
1373	benperidol	Dopamine Antagonists	B [Preparations]	Decreased Dopamine Activity
33739	pipamperone	Serotonin Agonists|Dopamine D2 Antagonists|Adrenergic alpha1-Antagonists	P [Preparations]	Increased Central Nervous System Serotonin Activity
16735	acetophenazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	A [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
9260	reserpine	Norepinephrine Uptake Inhibitors|Vesicular Monoamine Transporter Antagonists	Catecholamine-depleting Sympatholytic|R [Preparations]	Decreased Blood Pressure|Decreased Sympathetic Activity|Decreased Sympathetic Norepinephrine Activity
35636	risperidone	Adrenergic alpha-Antagonists|Dopamine Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists	Atypical Antipsychotic|R [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
8704	prochlorperazine	Dopamine Antagonists	Phenothiazine|P [Preparations]	Decreased Central Nervous System Norepinephrine Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Emesis Suppression
8705	prochlorperazine edisylate	Dopamine Antagonists	P [Preparations]	Decreased Central Nervous System Norepinephrine Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Emesis Suppression
8706	prochlorperazine maleate	Dopamine Antagonists	P [Preparations]	Decreased Central Nervous System Norepinephrine Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Emesis Suppression
8742	promazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
9639	selegiline	Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors	Monoamine Oxidase Inhibitor|Monoamine Oxidase Type B Inhibitor|S [Preparations]	Increased Central Nervous System Dopamine Activity
8042	perazine	Dopamine Antagonists	P [Preparations]	Decreased Dopamine Activity
8076	perphenazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	Phenothiazine|P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
8338	piperacetazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	P [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity
8348	pipothiazine	Dopamine Antagonists|Histamine H1 Receptor Antagonists|Cholinergic Muscarinic Antagonists	P [Preparations]	Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
2570387	samidorphan L-malate	Opioid Antagonists	S [Preparations]	
6475	loxapine	Dopamine Antagonists|Serotonin Antagonists	L [Preparations]	Decreased Serotonin Activity|Increased Dopamine Activity
6476	loxapine succinate	Dopamine Antagonists|Serotonin Antagonists	L [Preparations]	Decreased Serotonin Activity|Increased Dopamine Activity
2275731	lumateperone tosylate	Unknown Cellular or Molecular Interaction	L [Preparations]	Dopamine Activity Alteration|Serotonin Activity Alteration
6779	mesoridazine	Dopamine Antagonists	M [Preparations]	Decreased Dopamine Activity
6852	methotrimeprazine	Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2D6 Inhibitors|Histamine H1 Receptor Antagonists|Dopamine D2 Antagonists	M [Preparations]	Decreased Acetylcholine Activity|Decreased Brain Stem Dopamine Activity|Decreased Brain Stem Organized Electrical Activity|Decreased Histamine Activity|Hypothalamic Endocrine Activity Alteration
2559612	samidorphan	Opioid Antagonists	Opioid Antagonist|S [Preparations]	
7019	molindone	Adrenergic alpha-Antagonists|Dopamine Antagonists	Typical Antipsychotic|M [Preparations]	Decreased Dopamine Activity|Hypothalamic Endocrine Activity Alteration
2275602	lumateperone	Unknown Cellular or Molecular Interaction	Atypical Antipsychotic|L [Preparations]	Dopamine Activity Alteration|Serotonin Activity Alteration
1673265	aripiprazole lauroxil	Dopamine Receptor Interactions|Serotonin Receptor Interactions	A [Preparations]	Decreased Dopamine Activity|Decreased Serotonin Activity
1721073	cariprazine hydrochloride	Dopamine Agonists|Serotonin Receptor Interactions	C [Preparations]	
1658314	brexpiprazole	Dopamine Agonists|Serotonin Receptor Interactions	Atypical Antipsychotic|B [Preparations]	
47686	carbamide peroxide	Physiochemical Activity	C [Preparations]	Increased Protein Breakdown|Decreased Skin Keratinization|Decreased Intraocular Fluid Pressure
59308	chromium picolinate	Immunologic Factor Interactions|Iron Chelating Activity|Biological Macromolecular Activity	C [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Cellular Activity Alteration
1356552	perampanel	Cytochrome P450 3A4 Inhibitors|Cytochrome P450 2C8 Inhibitors|AMPA Receptor Antagonists|UGT2B7 Inhibitors|UGT1A9 Inhibitors	Noncompetitive AMPA Glutamate Receptor Antagonist|P [Preparations]	Decreased Central Nervous System Glutamate Activity
1101333	gabapentin enacarbil	Unknown Cellular or Molecular Interaction	G [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
236875	tiagabine hydrochloride	GABA A Agonists|GABA B Agonists	T [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
623400	lacosamide	Sodium Channel Interactions	L [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity
235408	clorazepic acid	GABA A Modulators	Benzodiazepine|C [Preparations]	Increased Central Nervous System GABA Activity
1112990	ezogabine	Potassium Channel Openers	E [Preparations]	
114477	levetiracetam	Unknown Cellular or Molecular Interaction	L [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Unknown Physiological Effect
2353	clorazepate	GABA A Modulators|GABA A Agonists	C [Preparations]	Increased Central Nervous System GABA Activity
2607	clorazepate dipotassium	GABA A Modulators|GABA A Agonists	C [Preparations]	Increased Central Nervous System GABA Activity
82077	phenobarbital sodium	Neurotransmitter Transporter Interactions	P [Preparations]	Electrical Activity Alteration
38404	topiramate	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C19 Inhibitors|Sodium Channel Interactions	T [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Glutamate Activity|Increased GABA Activity
39998	zonisamide	P-Glycoprotein Inhibitors|Carbonic Anhydrase Inhibitors|Unknown Cellular or Molecular Interaction	Anti-epileptic Agent|Z [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Neurotransmitter & Neuromuscular Transmitter Activity Alteration
25480	gabapentin	Unknown Cellular or Molecular Interaction	G [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
28439	lamotrigine	Organic Cation Transporter 2 Inhibitors|Sodium Channel Antagonists|Dihydrofolate Reductase Inhibitors	Anti-epileptic Agent|Mood Stabilizer|L [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Glutamate Activity
31914	tiagabine	GABA B Agonists|GABA A Agonists	Anti-epileptic Agent|T [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
32624	oxcarbazepine	Sodium Channel Interactions	Anti-epileptic Agent|O [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
7781	oxazepam	GABA A Modulators|GABA A Agonists	Benzodiazepine|O [Preparations]	Increased Central Nervous System GABA Activity
8691	primidone	Neurotransmitter Transporter Interactions	Anti-epileptic Agent|P [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Neurotransmitter & Neuromuscular Transmitter Activity Alteration
8134	phenobarbital	Neurotransmitter Transporter Interactions	P [Preparations]	Electrical Activity Alteration
6470	lorazepam	GABA A Modulators|GABA A Agonists	Benzodiazepine|L [Preparations]	Increased Central Nervous System GABA Activity
2265690	cenobamate	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 2C8 Inducers|Cytochrome P450 2B6 Inducers|Cytochrome P450 3A Inhibitors|Sodium Channel Antagonists|GABA A Modulators|GABA A Receptor Positive Modulators	C [Preparations]	Increased Central Nervous System GABA Activity
2054068	mogamulizumab	Antibody-Receptor Interactions|Chemokine Receptor Type 4 Interactions	M [Preparations]|Chemokine Receptor Type 4 Interaction|Monoclonal Antibody	Increased Cellular Death
4179	etoposide	Topoisomerase Inhibitors	Topoisomerase Inhibitor|E [Preparations]	Cellular Proliferation Alteration|Decreased DNA Integrity|Increased Cellular Death
155036	mechlorethamine hydrochloride	Alkylating Activity	M [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
24614	etoposide phosphate	Topoisomerase Inhibitors	E [Preparations]	Cellular Proliferation Alteration|Decreased DNA Integrity|Increased Cellular Death
11198	vinblastine	Tubulin Interactions	Vinca Alkaloid|V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
11199	vinblastine sulfate	Tubulin Interactions	V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
10996	uracil mustard	Alkylating Activity	U [Preparations]	Cellular Activity Alteration
6674	mechlorethamine	Alkylating Activity	Alkylating Drug|M [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
6854	methoxsalen	Nucleic Acid Synthesis Inhibitors|Photoabsorption	Photoactivated Radical Generator|Psoralen|M [Preparations]	Decreased DNA Integrity|Photosensitizing Activity
2121085	siponimod	Sphingosine 1-Phosphate Receptor Modulators	Sphingosine 1-phosphate Receptor Modulator|S [Preparations]	Lymphocyte Activity Modulation
2626348	ublituximab-xiiy	B Lymphocyte Stimulator-directed Antibody Interactions|CD20-directed Antibody Interactions|Antibody-Receptor Interactions	U [Preparations]	Increased Cellular Death
2261783	diroximel fumarate	Unknown Cellular or Molecular Interaction	D [Preparations]	
2626349	ublituximab	B Lymphocyte Stimulator-directed Antibody Interactions|CD20-directed Antibody Interactions|Antibody-Receptor Interactions	U [Preparations]	Increased Cellular Death
1811461	hydroxypropyl cellulose (type H)	Demulcent Activity	Demulcent|H [Preparations]	
616739	rotigotine	Dopamine Agonists	Nonergot Dopamine Agonist|R [Preparations]	Increased Central Nervous System Dopamine Activity
262150	iron carbonyl	Electrolyte Activity	I [Preparations]	Increased Erythroid Cell Production
1922449	safinamide mesylate	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 3A5 Inhibitors|Potassium Channel Antagonists|Monoamine Oxidase-A Inhibitors|Monoamine Oxidase-B Inhibitors|Chloride Channel Antagonists	S [Preparations]	Decreased Glutamate Activity
2362167	opicapone	Catechol O-Methyltransferase Inhibitors	Catechol-O-Methyltransferase Inhibitor|O [Preparations]	Increased Central Nervous System Dopamine Activity
1791686	pimavanserin tartrate	Serotonin Receptor Interactions	P [Preparations]	
1545982	carbidopa anhydrous	Enzyme Inhibitors|Dopamine Receptor Interactions	C [Preparations]	Increased Central Nervous System Dopamine Activity
1791685	pimavanserin	Serotonin Receptor Interactions	Atypical Antipsychotic|P [Preparations]	
577300	rasagiline mesylate	Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors	R [Preparations]	Increased Dopamine Activity|Increased Serotonin Activity
1922448	safinamide	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2C19 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 3A5 Inhibitors|Potassium Channel Antagonists|Monoamine Oxidase-B Inhibitors|Monoamine Oxidase-A Inhibitors|Chloride Channel Antagonists	Monoamine Oxidase Type B Inhibitor|S [Preparations]	Decreased Glutamate Activity
282415	amantadine hydrochloride	M2 Protein Inhibitors|Ion Channel Interactions|Dopamine Receptor Interactions	A [Preparations]	Decreased RNA Replication|Increased Central Nervous System Dopamine Activity
236380	piribedil mesylate	Dopamine Agonists	P [Preparations]	Increased Dopamine Activity
236553	ropinirole hydrochloride	Dopamine Agonists	R [Preparations]	Increased Central Nervous System Dopamine Activity
236747	pramipexole dihydrochloride	Dopamine Agonists	P [Preparations]	Increased Central Nervous System Dopamine Activity
236892	budipine hydrochloride		B [Preparations]	Increased Dopamine Activity
4134	profenamine	Cholinergic Antagonists	P [Preparations]	Decreased Central Nervous System Organized Electrical Activity
2199015	istradefylline	Adenosine Receptor Antagonists	I [Preparations]	
3417	dihydroergocryptine	Dopamine Agonists|Adrenergic alpha-Agonists|Serotonin Antagonists	D [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction
236190	tropatepine hydrochloride	Cholinergic Muscarinic Antagonists	T [Preparations]	Decreased Acetylcholine Activity
134748	rasagiline	Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors	Monoamine Oxidase Inhibitor|R [Preparations]	Increased Dopamine Activity|Increased Serotonin Activity
2372	chlormethiazole	GABA A Modulators	C [Preparations]	Gamma Amino Butyric Acid (GABA) Activity Alteration
1424	benztropine	Cholinergic Antagonists|Histamine Receptor Antagonists|Dopamine Receptor Interactions|Cholinergic Muscarinic Antagonists	Antihistamine|Anticholinergic|B [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Dopamine Activity Alteration|Positive Chronotropy|Salivation Inhibition
1589	biperiden	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	B [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions
72302	ropinirole	Dopamine Agonists	Nonergot Dopamine Agonist|R [Preparations]	Increased Central Nervous System Dopamine Activity
72937	tolcapone	Catechol O-Methyltransferase Inhibitors	Catechol-O-Methyltransferase Inhibitor|T [Preparations]	Increased Central Nervous System Dopamine Activity
91154	biperiden hydrochloride	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	B [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions
71225	apomorphine hydrochloride	Dopamine Agonists	A [Preparations]	
2019	carbidopa	Enzyme Inhibitors|DOPA Decarboxylase Inhibitors|Dopamine Receptor Interactions	Aromatic Amino Acid Decarboxylation Inhibitor|C [Preparations]	Increased Central Nervous System Dopamine Activity
746741	pramipexole	Dopamine Agonists	Nonergot Dopamine Agonist|P [Preparations]	Increased Central Nervous System Dopamine Activity
60307	entacapone	Catechol O-Methyltransferase Inhibitors	Catechol-O-Methyltransferase Inhibitor|E [Preparations]	Increased Central Nervous System Dopamine Activity
47579	cabergoline	Dopamine Agonists	C [Preparations]|Ergot Derivative	Decreased Prolactin Secretion|Increased Dopamine Activity
38876	tropatepine	Cholinergic Muscarinic Antagonists	T [Preparations]	Decreased Acetylcholine Activity
18927	benztropine mesylate	Cholinergic Antagonists|Histamine Receptor Antagonists|Dopamine Receptor Interactions|Cholinergic Muscarinic Antagonists	B [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Dopamine Activity Alteration|Positive Chronotropy|Salivation Inhibition
19377	biperiden lactate	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	B [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions
19832	budipine		B [Preparations]	Increased Dopamine Activity
20802	clomethiazole edisylate	GABA A Modulators	C [Preparations]	Gamma Amino Butyric Acid (GABA) Activity Alteration
1043	apomorphine	Dopamine Agonists	Dopaminergic Agonist|A [Preparations]	
1115	trihexyphenidyl hydrochloride	Unknown Cellular or Molecular Interaction	T [Preparations]	Smooth Muscle Tone Alteration|Decreased Parasympathetic Acetylcholine Activity|Decreased Striated Muscle Contraction
2562549	magnolol		M [Preparations]	
10811	trihexyphenidyl	Unknown Cellular or Molecular Interaction	T [Preparations]	Smooth Muscle Tone Alteration|Decreased Parasympathetic Acetylcholine Activity|Decreased Striated Muscle Contraction
42646	dihydroergocryptine mesylate	Dopamine Agonists|Serotonin Antagonists|Adrenergic alpha-Agonists	D [Preparations]	Cerebral Arterial Vasoconstriction|Cutaneous Arterial Vasoconstriction
8047	pergolide	Dopamine Agonists	Ergot-derived Dopamine Receptor Agonist|P [Preparations]	Decreased Prolactin Secretion|Increased Central Nervous System Dopamine Activity|Increased Growth Hormone Secretion|Decreased Luteinizing Hormone Secretion
8048	pergolide mesylate	Dopamine Agonists	P [Preparations]	Decreased Prolactin Secretion|Increased Central Nervous System Dopamine Activity|Increased Growth Hormone Secretion|Decreased Luteinizing Hormone Secretion
8353	piribedil	Dopamine Agonists	P [Preparations]	Increased Dopamine Activity
6541	ethopropazine hydrochloride	Cholinergic Antagonists	E [Preparations]	Decreased Central Nervous System Organized Electrical Activity
620	amantadine	M2 Protein Inhibitors|Ion Channel Interactions|Dopamine Receptor Interactions	Influenza A M2 Protein Inhibitor|A [Preparations]	Decreased RNA Replication|Increased Central Nervous System Dopamine Activity
621	amantadine sulfate	M2 Protein Inhibitors|Dopamine Receptor Interactions|Ion Channel Interactions	A [Preparations]	Decreased RNA Replication|Increased Central Nervous System Dopamine Activity
6375	levodopa	Dopamine Receptor Interactions	L [Preparations]|Aromatic Amino Acid	Increased Central Nervous System Dopamine Activity
187832	pregabalin	Unknown Cellular or Molecular Interaction	P [Preparations]	
314809	psyllium hydrocolloid	Stool Bulking Activity	P [Preparations]	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption
314812	psyllium seed coatings,blond	Stool Bulking Activity	P [Preparations]	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption
153718	balsalazide disodium	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	B [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
104123	olsalazine sodium	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	O [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
18747	balsalazide	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	Aminosalicylate|B [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
31765	nicotine polacrilex	Cholinergic Nicotinic Agonists|Full Cholinergic Nicotinic Agonists	N [Preparations]	Increased Central Nervous System Acetylcholine Activity|Increased Muscular System Acetylcholine Activity|Increased Medullary Respiratory Drive|Increased Peripheral Nervous System Acetylcholine Activity
32385	olsalazine	Cyclooxygenase Inhibitors|Lipoxygenase Inhibitors	Aminosalicylate|O [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
8928	psyllium	Stool Bulking Activity	P [Preparations]	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption
7407	nicotine	Cholinergic Nicotinic Agonists|Full Cholinergic Nicotinic Agonists	Cholinergic Nicotinic Agonist|N [Preparations]	Increased Central Nervous System Acetylcholine Activity|Increased Medullary Respiratory Drive|Increased Muscular System Acetylcholine Activity|Increased Peripheral Nervous System Acetylcholine Activity
1546022	lisinopril anhydrous	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|L [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1600711	perindopril arginine	Angiotensin-converting Enzyme Inhibitors	P [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
321064	olmesartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|O [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
236878	eprosartan mesylate	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	E [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
203160	losartan potassium	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	L [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
227278	fosinopril sodium	Angiotensin-converting Enzyme Inhibitors	F [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
214354	candesartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|C [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
235758	benazepril hydrochloride	Angiotensin-converting Enzyme Inhibitors	B [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
235759	quinapril hydrochloride	Angiotensin-converting Enzyme Inhibitors	Q [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
236066	moexipril hydrochloride	Angiotensin-converting Enzyme Inhibitors	M [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
135481	candesartan cilexetil	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	C [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
118463	olmesartan medoxomil	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	O [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
83515	eprosartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|E [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
83818	irbesartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|I [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
72260	perindopril erbumine	Angiotensin-converting Enzyme Inhibitors	P [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
73494	telmisartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|T [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
69749	valsartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|V [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1546196	benazeprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|B [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
38454	trandolapril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|T [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
50166	fosinopril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|F [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
52175	losartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|L [Preparations]	Decreased Blood Pressure|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
18867	benazepril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|B [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
54552	perindopril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|P [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
29046	lisinopril	Angiotensin-converting Enzyme Inhibitors	L [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
30131	moexipril	Angiotensin-converting Enzyme Inhibitors	M [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
35208	quinapril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|Q [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
35296	ramipril	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|R [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1193325	ruxolitinib phosphate	Janus Kinase Inhibitors	R [Preparations]	Decreased Hematopoiesis|Cellular Proliferation Alteration
1193326	ruxolitinib	Protein Kinase Inhibitors|Janus Kinase Inhibitors	R [Preparations]|Kinase Inhibitor|Janus Kinase Inhibitor	Decreased Hematopoiesis|Cellular Proliferation Alteration
236612	anagrelide hydrochloride	Phosphodiesterase Inhibitors	A [Preparations]	Decreased Platelet Production|Decreased Megakaryocyte Maturation
1828	busulfan	Alkylating Activity	Alkylating Drug|B [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
596724	anagrelide	Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors	Platelet-reducing Agent|A [Preparations]	Decreased Platelet Production|Decreased Megakaryocyte Maturation
8347	pipobroman	Alkylating Activity	P [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA
2587060	ropeginterferon alfa-2b-njft	Interferon Receptor Interactions	R [Preparations]	Hemic/Lymphatic Activity Alteration
2587059	ropeginterferon alfa-2b	Interferon Receptor Interactions	R [Preparations]|Interferon alfa-2b	Hemic/Lymphatic Activity Alteration
1535213	corticotropin, human	Pituitary Hormone Receptor Agonists	C [Preparations]	Increased Glucocorticoid Secretion|Increased Mineralocorticoid Secretion
376	corticotropin	Pituitary Hormone Receptor Agonists	Adrenocorticotropic Hormone|C [Preparations]	Increased Glucocorticoid Secretion|Increased Mineralocorticoid Secretion
N0000175753	Anti-epileptic Agent			
266856	divalproex sodium	GABA A Receptor Interactions|GABA B Receptor Interactions	D [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
4135	ethosuximide	Enzyme Inhibitors|Unknown Cellular or Molecular Interaction	Anti-epileptic Agent|E [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Neurotransmitter & Neuromuscular Transmitter Activity Alteration
4136	ethotoin	Sodium Channel Interactions	E [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
134422	magnesium valproate		M [Preparations]	Increased GABA Activity
82806	fosphenytoin sodium	Sodium Channel Interactions	F [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
72236	fosphenytoin	Sodium Channel Interactions	F [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
71227	phenytoin sodium	Sodium Channel Interactions	P [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
1927	calcium valproate		C [Preparations]	Increased GABA Activity
47858	methsuximide	Unknown Cellular or Molecular Interaction	Anti-epileptic Agent|M [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Neurotransmitter & Neuromuscular Transmitter Activity Alteration
11118	valproic acid	GABA A Receptor Interactions|GABA B Receptor Interactions	Anti-epileptic Agent|Mood Stabilizer|V [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
40254	valproate		V [Preparations]	Increased GABA Activity
24812	felbamate	Unknown Cellular or Molecular Interaction	Anti-epileptic Agent|F [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
10827	trimethadione	Neurotransmitter Transporter Interactions	T [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Neurotransmitter & Neuromuscular Transmitter Activity Alteration
9919	sodium valproate	GABA B Receptor Interactions|GABA A Receptor Interactions	S [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
14851	vigabatrin	Enzyme Inhibitors	Anti-epileptic Agent|V [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Increased GABA Activity
8183	phenytoin	Cytochrome P450 2C9 Inducers|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C8 Inducers|Cytochrome P450 2B6 Inducers|Cytochrome P450 3A Inducers|Sodium Channel Interactions|Cytochrome P450 2D6 Inducers|Cytochrome P450 1A2 Inducers	Anti-epileptic Agent|P [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
6757	mephenytoin	Sodium Channel Interactions	M [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity
6825	metharbital	GABA A Modulators	M [Preparations]	
1547220	eliglustat	P-Glycoprotein Inhibitors|Cytochrome P450 2D6 Inhibitors|Glucosylceramide Synthase Inhibitors	Glucosylceramide Synthase Inhibitor|E [Preparations]	
1547219	eliglustat tartrate	P-Glycoprotein Inhibitors|Cytochrome P450 2D6 Inhibitors|Glucosylceramide Synthase Inhibitors	E [Preparations]	
1291609	taliglucerase alfa	Enzymatic Activity	Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|T [Preparations]	Lipid Metabolism Alteration
901805	velaglucerase alfa	Enzymatic Activity	Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|V [Preparations]	Lipid Metabolism Alteration
402316	miglustat	Glucosylceramide Synthase Inhibitors	Glucosylceramide Synthase Inhibitor|M [Preparations]	Glycosphingolipid Synthesis Decrease
3007	cycloserine	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
84959	imiglucerase	Enzymatic Activity	Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|I [Preparations]	Lipid Metabolism Alteration
46049	alglucerase	Enzymatic Activity	A [Preparations]	Generalized Systemic Effects
4177	etomidate	GABA A Modulators|Adrenergic alpha2-Agonists	General Anesthetic|E [Preparations]	General Anesthesia|Decreased Central Nervous System Organized Electrical Activity
203085	pentobarbital sodium	Neurotransmitter Transporter Interactions	P [Preparations]	General Anesthesia|Decreased Organized Electrical Activity
203128	midazolam hydrochloride	GABA A Modulators|GABA A Agonists	M [Preparations]	Increased Central Nervous System GABA Activity
3322	diazepam	GABA A Modulators|GABA A Agonists	Benzodiazepine|D [Preparations]	Increased GABA Activity
142441	midazolam maleate	GABA A Modulators	M [Preparations]	Increased Central Nervous System GABA Activity
1314242	amobarbital sodium	Neurotransmitter Transporter Interactions	A [Preparations]	General Anesthesia|Electrical Activity Alteration|Respiratory/Pulmonary Activity Alteration
8782	propofol	GABA A Modulators	General Anesthetic|P [Preparations]	General Anesthesia|Decreased Central Nervous System Disorganized Electrical Activity|Decreased Central Nervous System Organized Electrical Activity|Decreased Peripheral Nervous System Organized Electrical Activity
8004	pentobarbital	Neurotransmitter Transporter Interactions	P [Preparations]	General Anesthesia|Decreased Organized Electrical Activity
2559907	propofol lipid emulsion	GABA A Modulators	P [Preparations]	General Anesthesia|Decreased Central Nervous System Disorganized Electrical Activity|Decreased Central Nervous System Organized Electrical Activity|Decreased Peripheral Nervous System Organized Electrical Activity
6960	midazolam	GABA A Modulators|GABA A Agonists	Benzodiazepine|M [Preparations]	Increased Central Nervous System GABA Activity
719	amobarbital	Neurotransmitter Transporter Interactions	A [Preparations]	General Anesthesia|Electrical Activity Alteration|Respiratory/Pulmonary Activity Alteration
598	alprostadil	Prostaglandin Receptor Agonists	Prostaglandin Analog|Prostaglandin E1 Agonist|A [Preparations]	Decreased Blood Pressure|Genitourinary Arterial Vasodilation|Venous Vasodilation|Decreased Platelet Aggregation
342992	piperazine citrate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
271743	piperazine hexahydrate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
1549138	piperazine sulfate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
67518	piperazine hydrate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
54749	piperazine phosphate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
33746	piperazine adipate	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
8984	pyrantel	Cholinesterase Inhibitors	P [Preparations]	Increased Acetylcholine Activity
8985	pyrantel pamoate	Cholinesterase Inhibitors	P [Preparations]	Increased Acetylcholine Activity
2197593	pyrantel tartrate	Cholinesterase Inhibitors	P [Preparations]	Increased Acetylcholine Activity
8340	piperazine	GABA A Agonists	P [Preparations]	Increased Muscular System GABA Activity
6672	mebendazole	Receptor Interactions|Tubulin Interactions	Anthelmintic|M [Preparations]	Decreased Glucose Transport into Cells
6069	ivermectin	Chloride Channel Interactions	Pediculicide|Antiparasitic|I [Preparations]	Nervous System Activity Alteration
430	albendazole	beta Tubulin Interactions|Cytochrome P450 1A Inducers	Anthelmintic|A [Preparations]	Decreased Cytoskeleton Integrity|Decreased Glucose Transport into Cells|Decreased Metabolic Rate|Digestive Alteration
7982	penicillin G benzathine	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
1723735	ixazomib	Proteasome Inhibitors	Proteasome Inhibitor|I [Preparations]	Increased Cellular Death
1723734	ixazomib citrate	Proteasome Inhibitors	I [Preparations]	Increased Cellular Death
1546014	zoledronic acid anhydrous	Bone Surface Interactions	Bisphosphonate|Z [Preparations]	Bone Resorption Inhibition
733003	plerixafor	Unknown Cellular or Molecular Interaction	Hematopoietic Stem Cell Mobilizer|P [Preparations]	Increased Hematopoietic Stem Cell Mobilization
1726104	elotuzumab	SLAMF7-directed Antibody Interactions	E [Preparations]|SLAMF7-directed Immunostimulatory Antibody	Increased Lymphocyte Activation|Increased Immunologic Activity
1603350	panobinostat	Cytochrome P450 2D6 Inhibitors|Histone Deacetylase Inhibitors	Histone Deacetylase Inhibitor|P [Preparations]	Decreased Reverse Transcription to DNA
1302966	carfilzomib	Proteasome Inhibitors	Proteasome Inhibitor|C [Preparations]	Increased Cellular Death
1721947	daratumumab	CD38-directed Antibody Interactions	D [Preparations]|CD38-directed Cytolytic Antibody	
1369713	pomalidomide	E3 Ubiquitin Ligase Inhibitors	Thalidomide Analog|P [Preparations]	Cellular Proliferation Alteration|Vascular Growth Decrease|Cellular Growth Phase Reduction|Increased Cellular Death
2531369	melphalan flufenamide	Alkylating Activity	M [Preparations]	
358258	bortezomib	Proteasome Inhibitors|Ubiquitin Ligase Inhibitors	Proteasome Inhibitor|B [Preparations]	Increased Cellular Death
342369	lenalidomide	E3 Ubiquitin Ligase Inhibitors	Thalidomide Analog|L [Preparations]	Cellular Proliferation Alteration|Vascular Growth Decrease|Cellular Growth Phase Reduction|Increased Cellular Death
235857	melphalan hydrochloride	Alkylating Activity	M [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA
142433	doxorubicin hydrochloride	Topoisomerase 2 Inhibitors|Topoisomerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
2105	carmustine	Alkylating Activity	Alkylating Drug|C [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
2555	cisplatin	Nucleic Acid Synthesis Inhibitors	Platinum-based Drug|C [Preparations]	Decreased DNA Integrity
77655	zoledronic acid	Bone Surface Interactions	Z [Preparations]	Bone Resorption Inhibition
66925	procarbazine hydrochloride	Alkylating Activity|Nucleic Acid Synthesis Inhibitors	P [Preparations]	Decreased DNA Replication|Decreased Mitosis|Decreased RNA Replication|Decreased Protein Synthesis
2619425	teclistamab-cqyv	CD3-directed Antibody Interactions|Antibody-Receptor Interactions|Antibody-Surface Antigen Interactions	T [Preparations]	
8702	procarbazine	Alkylating Activity|Nucleic Acid Synthesis Inhibitors	Alkylating Drug|P [Preparations]	Decreased DNA Replication|Decreased Mitosis|Decreased Protein Synthesis|Decreased RNA Replication
2619426	teclistamab	CD3-directed Antibody Interactions|Antibody-Receptor Interactions|Antibody-Surface Antigen Interactions	T [Preparations]	
2282019	isatuximab-irfc	CD38-directed Antibody Interactions	I [Preparations]	
2375130	daratumumab-fihj	CD38-directed Antibody Interactions	D [Preparations]	
6718	melphalan	Alkylating Activity	Alkylating Drug|M [Preparations]	Decreased DNA Replication|Decreased DNA Integrity|Decreased Transcription to RNA
2594775	ciltacabtagene autoleucel	Biological Response Modifiers	C [Preparations]	Cell-mediated Immunity
2531370	melphalan flufenamide hydrochloride	Alkylating Activity	M [Preparations]	
2387844	belantamab	Antibody Interactions	B [Preparations]	Passively Acquired Immunity|Microtubule Inhibition|Increased Cellular Death
2387833	belantamab mafodotin-blmf	Antibody Interactions	B [Preparations]	Passively Acquired Immunity|Microtubule Inhibition|Increased Cellular Death
2387834	belantamab mafodotin	Antibody Interactions	B [Preparations]	Passively Acquired Immunity|Microtubule Inhibition|Increased Cellular Death
2282018	isatuximab	CD38-directed Antibody Interactions	I [Preparations]|CD38-directed Cytolytic Antibody	Increased Cellular Death
1603349	panobinostat lactate	Histone Deacetylase Inhibitors	P [Preparations]	Decreased Reverse Transcription to DNA
2536430	idecabtagene vicleucel	Antibody-Surface Antigen Interactions	I [Preparations]	Immunologic Activity Alteration
2178390	selinexor	Membrane Transporter Interactions|Nuclear Export Inhibitors	S [Preparations]|Nuclear Export Inhibitor	Cellular Transport Alteration|Cellular Cycle Alteration|Increased Cellular Death
1721603	tenofovir alafenamide	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA
1546027	entecavir anhydrous	Nucleoside Reverse Transcriptase Inhibitors	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|E [Preparations]	
474128	telbivudine	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
300195	tenofovir disoproxil	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA
306266	entecavir	Nucleoside Reverse Transcriptase Inhibitors	E [Preparations]	
141400	adefovir dipivoxil	Nucleoside Reverse Transcriptase Inhibitors	A [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
16521	adefovir	Nucleoside Reverse Transcriptase Inhibitors	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|A [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
1928942	tenofovir disoproxil succinate	Nucleoside Reverse Transcriptase Inhibitors	T [Preparations]	Decreased Reverse Transcription to DNA
1546017	tenofovir anhydrous	Nucleoside Reverse Transcriptase Inhibitors	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|T [Preparations]	Decreased Reverse Transcription to DNA|Increased Immunologically Active Molecule Activity
1667640	calcium chloride anhydrous	Phosphate Chelating Activity	C [Preparations]	Increased Cardiac Muscle Organized Electrical Activity
1298846	calcium gluconate monohydrate	Phosphate Chelating Activity	C [Preparations]	Bone Resorption Alteration
221068	calcium chloride dihydrate	Phosphate Chelating Activity	C [Preparations]	Increased Cardiac Muscle Organized Electrical Activity
1901	calcium chloride	Phosphate Chelating Activity	C [Preparations]	Increased Cardiac Muscle Organized Electrical Activity
1908	calcium gluconate	Phosphate Chelating Activity	C [Preparations]	Bone Resorption Alteration
36676	sodium bicarbonate	Acid-Base Activity|Electrolyte Activity	S [Preparations]	Gastric Acid Alteration|Increased Renal HCO3- Excretion
56512	sodium polystyrene sulfonate	Potassium Ion Binding Activity|Potassium Ion Exchange Activity|Sodium-Potassium Exchanging ATPase Interactions	Potassium Binder|S [Preparations]	Increased Renal K+ Excretion
1716203	patiromer	Potassium Ion Binding Activity	Potassium Binder|P [Preparations]	
2047628	sodium zirconium cyclosilicate	Acidifying Activity|Electrolyte Activity	S [Preparations]	Digestive/GI System Activity Alteration
2204723	patiromer sorbitex calcium	Potassium Ion Binding Activity	P [Preparations]	
1545996	methyldopa anhydrous	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	Central alpha-2 Adrenergic Agonist|M [Preparations]	Decreased Blood Pressure|Decreased Central Nervous System Norepinephrine Activity
1546004	timolol anhydrous	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	beta-Adrenergic Blocker|T [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy|Decreased Intraocular Fluid Pressure
862004	guafacine hydrochloride	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
5487	hydrochlorothiazide	Sodium Chloride Symporter Inhibitors	Thiazide Diuretic|H [Preparations]	Vasodilation|Decreased Blood Pressure|Increased Diuresis|Decreased Distal Tubule Ca++ Excretion|Decreased Intravascular Volume|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion
5495	hydroflumethiazide	Sodium Chloride Symporter Inhibitors	Thiazide Diuretic|H [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion
1091642	azilsartan medoxomil	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	A [Preparations]	Decreased Blood Pressure|Arterial Vasodilation
1294597	azilsartan kamedoxomil	Angiotensin 2 Receptor Antagonists	A [Preparations]	Decreased Blood Pressure|Arterial Vasodilation
5764	indapamide	Sodium Chloride Symporter Inhibitors|Potassium Channel Interactions	Thiazide-like Diuretic|I [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion
2376944	levamlodipine	Calcium Channel Antagonists	L [Preparations]	Arterial Vasodilation
732498	aliskiren hemifumarate	Angiotensin-converting Enzyme Inhibitors|Renin Inhibitors	A [Preparations]	Decreased Blood Pressure
1091643	azilsartan	Angiotensin 2 Receptor Antagonists|Angiotensin 2 Type 1 Receptor Antagonists	Angiotensin 2 Receptor Blocker|A [Preparations]	Decreased Blood Pressure|Arterial Vasodilation
977863	clevidipine butyrate	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	C [Preparations]	Decreased Blood Pressure|Arterial Vasodilation
1299927	terazosin hydrochloride anhydrous	Adrenergic alpha-Antagonists	T [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
5033	guanabenz	Adrenergic alpha2-Agonists	Central alpha-2 Adrenergic Agonist|G [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
5036	guanethidine	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Decreased Sympathetic Norepinephrine Activity|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
1309210	oil of garlic	Unknown Cellular or Molecular Interaction	O [Preparations]	Decreased Platelet Aggregation
668310	carvedilol phosphate	Adrenergic alpha-Antagonists|Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	C [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Inotropy|Negative Chronotropy
4316	felodipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|F [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
4603	furosemide	Sodium Potassium Chloride Symporter Inhibitors	Loop Diuretic|F [Preparations]	Decreased Blood Pressure|Increased Diuresis at Loop of Henle|Decreased Intravascular Volume|Increased Loop of Henle Mg++ Excretion|Increased Loop of Henle Na+ Excretion|Increased Loop of Henle K+ Excretion|Increased Loop of Henle Ca++ Excretion|Increased Loop of Henle Cl- Excretion
1298837	amiloride hydrochloride, anhydrous	Sodium-Potassium Exchanging ATPase Interactions	A [Preparations]	Decreased Blood Pressure|Decreased Collecting Duct K+ Excretion|Decreased Distal Tubule K+ Excretion|Decreased Renal Ca++ Excretion|Increased Collecting Duct Na+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Renal Mg++ Excretion
298869	eplerenone	Aldosterone Antagonists	Aldosterone Antagonist|E [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Distal Tubule H+ Excretion|Decreased Distal Tubule K+ Excretion|Increased Distal Tubule Na+ Excretion
325646	aliskiren	Angiotensin-converting Enzyme Inhibitors|Renin Inhibitors	Renin Inhibitor|A [Preparations]	Decreased Blood Pressure
328141	Angelica sinensis preparation	Unknown Cellular or Molecular Interaction	A [Preparations]	Unknown Physiological Effect
283819	barnidipine hydrochloride	L-Calcium Channel Receptor Antagonists	B [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
314592	diltiazem maleate	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	D [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
236374	tertatolol hydrochloride	Adrenergic beta-Antagonists	T [Preparations]	Decreased Blood Pressure
259335	imidapril hydrochloride	Angiotensin-converting Enzyme Inhibitors	I [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
259379	dihydralazine sul hemipenthy	Unknown Cellular or Molecular Interaction	D [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation|Arterial Vasodilation
259493	zofenopril calcium	Angiotensin-converting Enzyme Inhibitors	Z [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
259487	manidipine hydrochloride	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A4 Inhibitors|L-Calcium Channel Receptor Antagonists|T-Calcium Channel Receptor Antagonists	M [Preparations]	Vasodilation|Decreased Blood Pressure
236806	bupranolol hydrochloride	Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Chronotropy
236904	mepindolol sulfate	Adrenergic beta-Antagonists	M [Preparations]	Decreased Blood Pressure
236948	phenylalanine,DL-		P [Preparations]	
4109	ethacrynic acid	Sodium Potassium Chloride Symporter Inhibitors	Loop Diuretic|E [Preparations]	Decreased Blood Pressure|Increased Diuresis at Loop of Henle|Decreased Intravascular Volume|Increased Loop of Henle Mg++ Excretion|Increased Loop of Henle Cl- Excretion|Increased Loop of Henle Na+ Excretion|Increased Loop of Henle Ca++ Excretion|Increased Loop of Henle K+ Excretion
4108	ethacrynate sodium	Sodium Potassium Chloride Symporter Inhibitors	E [Preparations]	Decreased Blood Pressure|Increased Diuresis at Loop of Henle|Decreased Intravascular Volume|Increased Loop of Henle Mg++ Excretion|Increased Loop of Henle Ca++ Excretion|Increased Loop of Henle Cl- Excretion|Increased Loop of Henle K+ Excretion|Increased Loop of Henle Na+ Excretion
203131	oxprenolol hydrochloride	Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	O [Preparations]	Decreased Blood Pressure|Negative Chronotropy
203138	verapamil hydrochloride	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	V [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
203142	guanfacine hydrochloride	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
203145	celiprolol hydrochloride	Adrenergic beta2-Agonists|Adrenergic alpha2-Antagonists|Adrenergic beta1-Antagonists	C [Preparations]	Vasodilation|Decreased Blood Pressure|Increased Sympathetic Activity|Negative Chronotropy|Negative Inotropy
203181	guanethidine sulfate	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Decreased Sympathetic Norepinephrine Activity|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
203211	diltiazem hydrochloride	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	D [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
227225	guanabenz acetate	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
221172	timolol hemihydrate	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	T [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy|Decreased Intraocular Fluid Pressure
3409	dihydralazine	Unknown Cellular or Molecular Interaction	D [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation|Arterial Vasodilation
233603	clevidipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|C [Preparations]	Decreased Blood Pressure|Arterial Vasodilation
3443	diltiazem	Cytochrome P450 3A4 Inhibitors|Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Calcium Channel Blocker|D [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
235230	nicardipine hydrochloride	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
235224	terazosin hydrochloride	Adrenergic alpha-Antagonists	T [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
235752	bepridil hydrochloride	Calcium Channel Antagonists|Sodium Channel Interactions	B [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
235959	dihydralazine sulfate	Unknown Cellular or Molecular Interaction	D [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation|Arterial Vasodilation
236178	nadoxolol hydrochloride	Adrenergic beta-Antagonists	N [Preparations]	Decreased Blood Pressure
142132	carteolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	C [Preparations]	Cardiac Rhythm Alteration|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy|Decreased Intraocular Aqueous Secretion
142146	bisoprolol fumarate	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy
142144	betaxolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy|Decreased Intraocular Aqueous Secretion
142424	amiloride hydrochloride	Sodium Channel Antagonists|Sodium-Potassium Exchanging ATPase Interactions	A [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Distal Tubule K+ Excretion|Decreased Collecting Duct K+ Excretion|Decreased Renal K+ Excretion|Decreased Renal Ca++ Excretion|Increased Collecting Duct Na+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Renal Mg++ Excretion
2116	carteolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	beta-Adrenergic Blocker|C [Preparations]	Arterial Vasodilation|Negative Inotropy|Negative Chronotropy|Decreased Intraocular Aqueous Secretion
104416	amlodipine besylate	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	A [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
2396	chlorothiazide	Sodium Chloride Symporter Inhibitors	Thiazide Diuretic|C [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule HCO3- Excretion|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Na+ Excretion
2409	chlorthalidone	Sodium Chloride Symporter Inhibitors	Thiazide-like Diuretic|C [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule Cl- Excretion
2599	clonidine	Adrenergic alpha2-Agonists	Central alpha-2 Adrenergic Agonist|C [Preparations]	Analgesia|Decreased Blood Pressure|Negative Chronotropy|Neurotransmitter & Neuromuscular Transmitter Activity Alteration|Systemic Arterial Vasodilation|Renal Arterial Vasodilation
81947	alprenolol hydrochloride	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	A [Preparations]	Decreased Blood Pressure|Negative Chronotropy
1436	bepridil	Calcium Channel Antagonists|Sodium Channel Interactions	B [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
81999	diltiazem malate	L-Calcium Channel Receptor Antagonists	D [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
82023	guanethidine monosulfate	Adrenergic alpha2-Agonists	G [Preparations]	Decreased Blood Pressure|Decreased Sympathetic Norepinephrine Activity|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
1520	betaxolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|B [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy|Decreased Intraocular Aqueous Secretion
82070	penbutolol sulfate	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
83213	mibefradil	T-Calcium Channel Receptor Antagonists|L-Calcium Channel Receptor Antagonists	M [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
83214	mibefradil dihydrochloride	L-Calcium Channel Receptor Antagonists|T-Calcium Channel Receptor Antagonists	M [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
89911	flumethiazide	Sodium Chloride Symporter Inhibitors	F [Preparations]	Decreased Blood Pressure|Increased Diuresis|Increased Renal K+ Excretion|Increased Renal Cl- Excretion|Increased Renal Na+ Excretion
91217	chlorothiazide sodium	Sodium Chloride Symporter Inhibitors	C [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule K+ Excretion|Increased Distal Tubule HCO3- Excretion|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule H+ Excretion
91239	guanadrel sulfate	Adrenergic alpha-Agonists	G [Preparations]	Decreased Blood Pressure|Decreased Autonomic Ganglionic Activity|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
91241	methyldopate hydrochloride	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	M [Preparations]	Decreased Blood Pressure|Decreased Central Nervous System Norepinephrine Activity
1808	bumetanide	Sodium Potassium Chloride Symporter Inhibitors	Loop Diuretic|B [Preparations]	Decreased Blood Pressure|Increased Diuresis at Loop of Henle|Decreased Intravascular Volume|Increased Loop of Henle Na+ Excretion|Increased Loop of Henle K+ Excretion|Increased Loop of Henle Mg++ Excretion|Increased Loop of Henle Ca++ Excretion|Increased Loop of Henle Cl- Excretion
1817	bupranolol	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	B [Preparations]	Decreased Blood Pressure|Negative Chronotropy
1546358	moexiprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|M [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
36908	spirapril	Angiotensin-converting Enzyme Inhibitors	S [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1546393	fosinoprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|F [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
59743	quinethazone	Sodium Chloride Symporter Inhibitors	Q [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion
42933	timolol maleate	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	T [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy|Decreased Intraocular Fluid Pressure
1546379	trandolaprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|T [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
37798	terazosin	Adrenergic alpha-Antagonists	alpha-Adrenergic Blocker|T [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
60245	imidapril	Angiotensin-converting Enzyme Inhibitors	I [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
37840	tertatolol	Adrenergic beta-Antagonists	T [Preparations]	Decreased Blood Pressure
38413	torsemide	Sodium Potassium Chloride Symporter Inhibitors	Loop Diuretic|T [Preparations]	Decreased Blood Pressure|Increased Diuresis at Loop of Henle|Decreased Intravascular Volume|Increased Loop of Henle K+ Excretion|Increased Loop of Henle Ca++ Excretion|Increased Loop of Henle Cl- Excretion|Increased Loop of Henle Mg++ Excretion|Increased Loop of Henle Na+ Excretion
49276	doxazosin	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	alpha-Adrenergic Blocker|D [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
39173	doxazosin mesylate	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	D [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Bladder Sphincter Tone|Venous Vasodilation
39879	mepirodipine	L-Calcium Channel Receptor Antagonists	M [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
39990	zofenopril	Angiotensin-converting Enzyme Inhibitors	Z [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
19008	benzthiazide	Carbonic Anhydrase Inhibitors|Sodium Chloride Symporter Inhibitors	B [Preparations]	Vasodilation|Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Cl- Excretion
19484	bisoprolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|B [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy
53692	nilvadipine	Calcium Channel Antagonists	N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
20192	carazolol	Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	C [Preparations]	Decreased Blood Pressure|Negative Chronotropy
40114	guanfacine	Adrenergic alpha2-Agonists	Central alpha-2 Adrenergic Agonist|G [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
20352	carvedilol	Adrenergic alpha-Antagonists|Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	alpha-Adrenergic Blocker|beta-Adrenergic Blocker|C [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
20498	celiprolol	Adrenergic beta2-Agonists|Adrenergic alpha2-Antagonists|Adrenergic beta1-Antagonists	C [Preparations]	Vasodilation|Decreased Blood Pressure|Increased Sympathetic Activity|Negative Chronotropy|Negative Inotropy
21102	cilazapril	Angiotensin-converting Enzyme Inhibitors	C [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
22033	cyclothiazide	Carbonic Anhydrase Inhibitors|Sodium Chloride Symporter Inhibitors	C [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule K+ Excretion|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule H+ Excretion
11170	verapamil	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A Inhibitors|Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Calcium Channel Blocker|V [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation|Negative Chronotropy
10600	timolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	T [Preparations]	Decreased Blood Pressure|Negative Chronotropy|Negative Inotropy|Decreased Intraocular Fluid Pressure
26296	guanadrel	Adrenergic alpha-Agonists	G [Preparations]	Decreased Blood Pressure|Decreased Autonomic Ganglionic Activity|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
28382	lacidipine	L-Calcium Channel Receptor Antagonists	L [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
29275	manidipine	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 3A4 Inhibitors|T-Calcium Channel Receptor Antagonists|L-Calcium Channel Receptor Antagonists	M [Preparations]	Vasodilation|Decreased Blood Pressure
29518	mepindolol	Adrenergic beta-Antagonists	M [Preparations]	Decreased Blood Pressure
10763	triamterene	Sodium Channel Antagonists|Sodium-Potassium Exchanging ATPase Interactions	Potassium-sparing Diuretic|T [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Distal Tubule K+ Excretion|Decreased Collecting Duct K+ Excretion|Decreased Renal Ca++ Excretion|Decreased Renal K+ Excretion|Increased Collecting Duct Na+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Renal Mg++ Excretion
10772	trichlormethiazide	Carbonic Anhydrase Inhibitors|Sodium Chloride Symporter Inhibitors	T [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion
31462	nadoxolol	Adrenergic beta-Antagonists	N [Preparations]	Decreased Blood Pressure
11371	xipamide		X [Preparations]	Increased Diuresis
1546400	perindoprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|P [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Mineralocorticoid Secretion|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1369	bendroflumethiazide	Sodium Chloride Symporter Inhibitors	Thiazide Diuretic|B [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule HCO3- Excretion|Increased Distal Tubule K+ Excretion
33717	pinacidil	Potassium Channel Openers	P [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation
21406	ubidecarenone	Enzyme Interactions	U [Preparations]	Unknown Physiological Effect
33910	isradipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|I [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
9259	rescinnamine	Angiotensin-converting Enzyme Inhibitors	R [Preparations]	Decreased Blood Pressure
1546359	quinaprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|Q [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1546377	ramiprilat	Angiotensin-converting Enzyme Inhibitors	Angiotensin Converting Enzyme Inhibitor|R [Preparations]	Decreased Blood Pressure|Decreased Bradykinin Degradation|Decreased Intravascular Volume|Decreased Renal K+ Excretion|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
17767	amlodipine	Cytochrome P450 3A Inhibitors|Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|Calcium Channel Blocker|A [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
9997	spironolactone	Aldosterone Antagonists	Aldosterone Antagonist|S [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Decreased Distal Tubule H+ Excretion|Decreased Distal Tubule K+ Excretion|Increased Distal Tubule Na+ Excretion
7801	oxprenolol	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	O [Preparations]	Decreased Blood Pressure|Negative Chronotropy
8565	polythiazide	Sodium Chloride Symporter Inhibitors	Thiazide Diuretic|P [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule H+ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule Na+ Excretion
7226	nadolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	beta-Adrenergic Blocker|N [Preparations]	Decreased Blood Pressure|Negative Inotropy|Negative Chronotropy
7973	penbutolol	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Inotropy|Negative Chronotropy
7396	nicardipine	Cytochrome P450 2D6 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 2C8 Inhibitors|Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
7417	nifedipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
7435	nisoldipine	Calcium Channel Antagonists|L-Calcium Channel Receptor Antagonists	Dihydropyridine Calcium Channel Blocker|N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
7441	nitrendipine	L-Calcium Channel Receptor Antagonists	N [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
8156	phenylalanine		P [Preparations]	
8332	pindolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists|Adrenergic beta2-Antagonists	beta-Adrenergic Blocker|P [Preparations]	Decreased Blood Pressure
2377031	levamlodipine maleate	Calcium Channel Antagonists	L [Preparations]	Arterial Vasodilation
2184116	amlodipine benzoate	L-Calcium Channel Receptor Antagonists	A [Preparations]	Decreased Blood Pressure|Coronary Arterial Vasodilation
6860	methyclothiazide	Sodium Chloride Symporter Inhibitors	M [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Cl- Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule Na+ Excretion
6876	methyldopa	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	M [Preparations]	Decreased Blood Pressure|Decreased Central Nervous System Norepinephrine Activity
6916	metolazone	Sodium Chloride Symporter Inhibitors	Thiazide-like Diuretic|M [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Intravascular Volume|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule H+ Excretion|Increased Distal Tubule Cl- Excretion
597	alprenolol	Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists	A [Preparations]	Decreased Blood Pressure|Negative Chronotropy
644	amiloride	Sodium Channel Antagonists|Sodium-Potassium Exchanging ATPase Interactions	Potassium-sparing Diuretic|A [Preparations]	Decreased Blood Pressure|Increased Diuresis|Decreased Distal Tubule K+ Excretion|Decreased Collecting Duct K+ Excretion|Decreased Renal Ca++ Excretion|Decreased Renal K+ Excretion|Increased Collecting Duct Na+ Excretion|Increased Distal Tubule Na+ Excretion|Increased Renal Mg++ Excretion
5691	imipramine	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|I [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
993548	bupropion hydrobromide	Cytochrome P450 2D6 Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	B [Preparations]	Increased Dopamine Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
700810	lisdexamfetamine		Central Nervous System Stimulant|L [Preparations]	Central Nervous System Stimulation
673579	lisdexamfetamine dimesylate		L [Preparations]	Central Nervous System Stimulation
352372	dexmethylphenidate	Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	Central Nervous System Stimulant|D [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
353103	atomoxetine hydrochloride	Norepinephrine Uptake Inhibitors	A [Preparations]	Increased Cerebral Cortex Norepinephrine Activity
353105	dexmethylphenidate hydrochloride	Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	D [Preparations]	Central Nervous System Stimulation|Bronchodilation|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
1099738	desipramine dibudinate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
203130	nortriptyline hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	N [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
203174	desipramine hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
203204	bupropion hydrochloride	Cytochrome P450 2D6 Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	B [Preparations]	Increased Dopamine Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
3247	desipramine	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|D [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
150816	imipramine hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	I [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
235988	venlafaxine hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
91118	imipramine pamoate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	I [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
60841	reboxetine mesylate	Neurotransmitter Transporter Interactions	R [Preparations]	Neurotransmitter & Neuromuscular Transmitter Activity Alteration
60842	reboxetine	Neurotransmitter Transporter Interactions	R [Preparations]	Neurotransmitter & Neuromuscular Transmitter Activity Alteration
38400	atomoxetine	Norepinephrine Uptake Inhibitors	Norepinephrine Reuptake Inhibitor|A [Preparations]	Increased Cerebral Cortex Norepinephrine Activity
39786	venlafaxine	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Serotonin and Norepinephrine Reuptake Inhibitor|V [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
42347	bupropion	Cytochrome P450 2D6 Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Aminoketone|B [Preparations]	Increased Dopamine Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
7531	nortriptyline	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|N [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
2562176	serdexmethylphenidate		S [Preparations]	Central Nervous System Stimulation
2607741	venlafaxine besylate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
2605948	venlafaxine besylate monohydrate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
2562177	serdexmethylphenidate chloride		S [Preparations]	Central Nervous System Stimulation
121070	chromic phosphate P32	Radiopharmaceutical Activity	C [Preparations]	
214837	sodium phenylbutyrate		S [Preparations]	
2265678	voxelotor	Cytochrome P450 3A4 Inhibitors|Hemoglobin S Polymerization Inhibitors	V [Preparations]|Hemoglobin S Polymerization Inhibitor	Decreased Blood Viscosity|Increased Oxygen Carrying Capacity
1720882	isavuconazole	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Organic Cation Transporter 2 Inhibitors	Azole Antifungal|I [Preparations]	Decreased Cell Wall Synthesis & Repair
1244607	tafluprost	Prostaglandin Receptor Agonists	Prostaglandin Analog|T [Preparations]	Increased Prostaglandin Activity|Decreased Intraocular Fluid Pressure
353497	levobetaxolol	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	L [Preparations]	Vasoconstriction|Decreased Intraocular Fluid Pressure
283809	travoprost	Prostaglandin Receptor Agonists	Prostaglandin Analog|T [Preparations]	Decreased Intraocular Fluid Pressure
283810	bimatoprost	Prostaglandin Receptor Agonists	Prostaglandin Analog|B [Preparations]	Increased Prostaglandin Activity|Decreased Intraocular Fluid Pressure
314731	metipranolol hydrochloride	Adrenergic beta-Antagonists	M [Preparations]	Decreased Intraocular Aqueous Secretion
3740	echothiophate iodide	Cholinesterase Inhibitors	E [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity|Decreased Intraocular Fluid Pressure
1546408	unoprostone	Prostaglandin Receptor Agonists	U [Preparations]	Decreased Intraocular Fluid Pressure
261718	levobetaxolol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta1-Antagonists	L [Preparations]	Vasoconstriction|Decreased Intraocular Fluid Pressure
203156	dipivefrin hydrochloride	Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	D [Preparations]	Pupillary Dilation|Decreased Intraocular Aqueous Secretion
227212	levobunolol hydrochloride	Adrenergic beta-Antagonists	L [Preparations]	Decreased Intraocular Aqueous Secretion
194881	brinzolamide	Carbonic Anhydrase Inhibitors	Carbonic Anhydrase Inhibitor|B [Preparations]	Decreased Intraocular Fluid Pressure
236065	dorzolamide hydrochloride	Carbonic Anhydrase Inhibitors	D [Preparations]	Decreased Intraocular Fluid Pressure
134615	brimonidine	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	alpha-Adrenergic Agonist|B [Preparations]	Decreased Intraocular Fluid Pressure
135313	isopropyl unoprostone	Prostaglandin Receptor Agonists	I [Preparations]	Decreased Intraocular Fluid Pressure
1813	levobunolol	Adrenergic beta-Antagonists	beta-Adrenergic Blocker|L [Preparations]	Decreased Intraocular Aqueous Secretion
60207	dorzolamide	Carbonic Anhydrase Inhibitors	Carbonic Anhydrase Inhibitor|D [Preparations]	Decreased Intraocular Fluid Pressure
43611	latanoprost	Prostaglandin Receptor Agonists	Prostaglandin Analog|L [Preparations]	Decreased Intraocular Fluid Pressure
39171	brimonidine tartrate	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	B [Preparations]	Decreased Intraocular Fluid Pressure
23410	dipivefrin	Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic beta2-Agonists|Adrenergic beta1-Agonists	D [Preparations]	Pupillary Dilation|Decreased Intraocular Aqueous Secretion
10824	metipranolol	Adrenergic beta-Antagonists	M [Preparations]	Decreased Intraocular Aqueous Secretion
6826	methazolamide	Carbonic Anhydrase Inhibitors	M [Preparations]	Increased Proximal Tubule K+ Excretion|Increased Proximal Tubule Cl- Excretion|Increased Proximal Tubule HCO3- Excretion|Increased Proximal Tubule Na+ Excretion|Decreased Intraocular Fluid Pressure
1992863	netarsudil mesylate	Norepinephrine Uptake Inhibitors|Rho Kinase Inhibitors	N [Preparations]	Decreased Intraocular Fluid Pressure
1992864	netarsudil	Norepinephrine Uptake Inhibitors|Rho Kinase Inhibitors	N [Preparations]|Rho Kinase Inhibitor	Decreased Intraocular Fluid Pressure
1372638	levothyroxine sodium anhydrous	Thyroid Hormone Receptor Agonists	L [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
325521	thyroid (beef)	Thyroid Hormone Receptor Agonists	T [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
142448	liothyronine sodium	Thyroid Hormone Receptor Agonists	L [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
40144	levothyroxine sodium	Thyroid Hormone Receptor Agonists	L [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
10565	thyroglobulin	Thyroid Hormone Receptor Agonists	T [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
10572	thyroid (USP)	Thyroid Hormone Receptor Agonists	T [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
10582	levothyroxine	Thyroid Hormone Receptor Agonists	l-Thyroxine|L [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
10814	liothyronine	Thyroid Hormone Receptor Agonists	l-Triiodothyronine|L [Preparations]	Cellular Synthetic Activity Alteration|Increased Gluconeogenesis|Increased Metabolic Rate
1439834	vortioxetine hydrobromide	Serotonin 5HT-3 Antagonists|Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Serotonin Activity
1487366	desvenlafaxine fumarate monohydrate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
1086768	vilazodone hydrochloride	Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Serotonin Activity
1455099	vortioxetine	Serotonin 5HT-3 Antagonists|Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Serotonin Activity
1433211	levomilnacipran hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	L [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
1433212	levomilnacipran	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Serotonin and Norepinephrine Reuptake Inhibitor|L [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
734064	desvenlafaxine	Cytochrome P450 2D6 Inhibitors|Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Serotonin and Norepinephrine Reuptake Inhibitor|D [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
476250	duloxetine hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
1086769	vilazodone	Serotonin Uptake Inhibitors	V [Preparations]	Increased Central Nervous System Serotonin Activity
588250	milnacipran	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Serotonin and Norepinephrine Reuptake Inhibitor|M [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
683693	desvenlafaxine succinate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Increased Central Nervous System Serotonin Activity|Increased Central Nervous System Norepinephrine Activity
4493	fluoxetine	Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|F [Preparations]	Increased Central Nervous System Serotonin Activity
353108	escitalopram oxalate	Serotonin Uptake Inhibitors	E [Preparations]	Increased Central Nervous System Serotonin Activity
321988	escitalopram	Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|E [Preparations]	Increased Central Nervous System Serotonin Activity
227224	fluoxetine hydrochloride	Serotonin Uptake Inhibitors	F [Preparations]	Increased Central Nervous System Serotonin Activity
72625	duloxetine	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Serotonin and Norepinephrine Reuptake Inhibitor|D [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
30003	milnacipran hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	M [Preparations]	Increased Central Nervous System Norepinephrine Activity|Increased Central Nervous System Serotonin Activity
2613950	taurursodiol		T [Preparations]	
1921877	edaravone	Unknown Cellular or Molecular Interaction	E [Preparations]	
35623	riluzole	Sodium Channel Antagonists	Benzothiazole|R [Preparations]	Decreased Central Nervous System Glutamate Activity
4186	eugenol	Immunologic Factor Interactions|Unknown Cellular or Molecular Interaction	Standardized Chemical Allergen|E [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Unknown Physiological Effect
237162	dexketoprofen	Cyclooxygenase Inhibitors	D [Preparations]	Decreased Prostaglandin Production
233386	dexketoprofen trometamol	Cyclooxygenase Inhibitors	D [Preparations]	Decreased Prostaglandin Production
132889	levonordefrin	Sodium Channel Interactions	L [Preparations]	Vasoconstriction|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
3648	droperidol	Dopamine Antagonists|Dopamine D2 Antagonists	Dopamine-2 Receptor Antagonist|D [Preparations]	Decreased Norepinephrine Activity|Decreased Epinephrine Activity|Pulmonary Arterial Vasodilation|Systemic Venous Vasodilation
186024	bromperidol decanoate		B [Preparations]	
236140	trifluperidol hydrochloride	Dopamine Antagonists	T [Preparations]	Decreased Dopamine Activity
2406	chlorprothixene	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists	C [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity
91125	triflupromazine hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists	T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Serotonin Activity
91133	chlorprothixene hydrochloride	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists	C [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity
19777	bromperidol		B [Preparations]	
10805	triflupromazine	Adrenergic alpha-Antagonists|Dopamine Antagonists|Serotonin Antagonists	T [Preparations]	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Serotonin Activity
10804	trifluperidol	Dopamine Antagonists	T [Preparations]	Decreased Dopamine Activity
8766	periciazine	Adrenergic alpha-Antagonists|Dopamine Antagonists	P [Preparations]	Decreased Dopamine Activity
7974	penfluridol	Dopamine Antagonists	P [Preparations]	Decreased Dopamine Activity
8331	pimozide	Dopamine Antagonists	Typical Antipsychotic|P [Preparations]	Decreased Dopamine Activity|Increased Central Nervous System Dopamine Activity
4778	gentian violet	Unknown Cellular or Molecular Interaction	G [Preparations]	Unknown Physiological Effect
236594	amphotericin B liposomal	Ergosterol Synthesis Inhibitors	A [Preparations]	Decreased Cell Wall Integrity
3743	econazole	14-alpha Demethylase Inhibitors	Azole Antifungal|E [Preparations]	Decreased Cell Wall Integrity
142434	econazole nitrate	14-alpha Demethylase Inhibitors	E [Preparations]	Decreased Cell Wall Integrity
101299	amphotericin B colloidal dispersion	Ergosterol Synthesis Inhibitors	A [Preparations]	Decreased Cell Wall Integrity
2623	clotrimazole	Squalene Monooxygenase Inhibitors	Azole Antifungal|C [Preparations]	Decreased Cell Wall Integrity
42790	miconazole nitrate	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	M [Preparations]	Decreased Cell Wall Integrity|Decreased Cell Membrane Integrity
37319	sulconazole	14-alpha Demethylase Inhibitors	Azole Antifungal|S [Preparations]	Decreased Cell Wall Integrity
52172	ciclopirox olamine	Protein Synthesis Inhibitors	C [Preparations]	Decreased DNA Replication|Decreased RNA Replication|Decreased Protein Synthesis
56226	oxiconazole nitrate	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	O [Preparations]	Decreased Cell Wall Integrity
21090	ciclopirox	Protein Synthesis Inhibitors	C [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis|Decreased RNA Replication
56798	sulconazole nitrate	14-alpha Demethylase Inhibitors	S [Preparations]	Decreased Cell Wall Integrity
32638	oxiconazole	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|O [Preparations]	Decreased Cell Wall Integrity
7597	nystatin	Ergosterol Synthesis Inhibitors	N [Preparations]|Polyene Antifungal	Decreased Cell Wall Integrity
2588846	levoketoconazole	Cytochrome P450 17A1 Inhibitors|P-Glycoprotein Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 2C8 Inhibitors|Organic Cation Transporter 2 Inhibitors|Cytochrome P450 3A5 Inhibitors|14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors|Cytochrome P450 11A1 Inhibitors|Cytochrome P450 11B1 Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	L [Preparations]|Cortisol Synthesis Inhibitor	Decreased Cell Wall Integrity|Decreased Cell Membrane Integrity
6932	miconazole	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|M [Preparations]	Decreased Cell Wall Integrity|Decreased Cell Membrane Integrity
1546369	gentian violet cation	Unknown Cellular or Molecular Interaction	G [Preparations]	Unknown Physiological Effect
6135	ketoconazole	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A5 Inhibitors|14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|K [Preparations]	Decreased Cell Wall Integrity|Decreased Cell Membrane Integrity
732	amphotericin B	Ergosterol Synthesis Inhibitors	Lipid-based Polyene Antifungal|A [Preparations]|Polyene Antifungal	Decreased Cell Wall Integrity
2054252	migalastat	Enzyme Interactions	M [Preparations]	Lipid Metabolism Alteration
2054264	migalastat hydrochloride	Enzyme Interactions	M [Preparations]	Lipid Metabolism Alteration
338817	agalsidase beta	Cellular or Molecular Interactions	Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme|A [Preparations]	Lipid Metabolism Alteration
2637445	pegunigalsidase alfa-iwxj		P [Preparations]	Glycosphingolipid Synthesis Increase
2637446	pegunigalsidase alfa		P [Preparations]	Glycosphingolipid Synthesis Increase
282388	imatinib	Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A4 Inhibitors|Protein Kinase Inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors	I [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration|Increased T Lymphocyte Destruction
284924	imatinib mesylate	Protein Kinase Inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors	I [Preparations]	Cellular Proliferation Alteration|Connective Tissue Alteration|Increased T Lymphocyte Destruction
1919083	midostaurin	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	M [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration|Increased Cellular Death
4885	glutamine	Biological Macromolecular Activity	Amino Acid|G [Preparations]	Metabolic Activity Alteration
1364468	teduglutide	Glucagon-like Peptide-2 (GLP-2) Agonists	T [Preparations]|GLP-2 Analog	
25916	glutamic acid	Biological Macromolecular Activity	G [Preparations]	Metabolic Activity Alteration
5463	hyaluronic acid	Biological Macromolecular Activity	H [Preparations]	Connective Tissue Alteration|Generalized Systemic Effects
1299928	zinc sulfate anhydrous	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	Z [Preparations]	Astringent Activity
1440975	zinc gluconate trihydrate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	Z [Preparations]	
1309410	zinc sulfate monohydrate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	Z [Preparations]	Astringent Activity
1311282	zinc sulfate, heptahydrate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	Z [Preparations]	Astringent Activity
1299637	anhydrous zinc acetate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	A [Preparations]	
898492	collagenase Clostridium histolyticum	Enzyme Activators	Collagen-specific Enzyme|C [Preparations]	Dermatologic Activity Alteration
62372	hyaluronate		H [Preparations]	
58939	collagenase	Enzyme Activators	Collagen-specific Enzyme|C [Preparations]	Dermatologic Activity Alteration
42892	sodium hyaluronate	Biological Macromolecular Activity	S [Preparations]	Connective Tissue Alteration|Generalized Systemic Effects
39937	zinc chloride	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	Z [Preparations]	Astringent Activity
39954	zinc sulfate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	Z [Preparations]	Astringent Activity
58295	zinc acetate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	Z [Preparations]	
58300	zinc gluconate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	Z [Preparations]	
2198976	sodium acetylated hyaluronate		S [Preparations]	
1597876	nivolumab	Programmed Death Receptor-1-directed Antibody Interactions	N [Preparations]|Programmed Death Receptor-1 Blocking Antibody	Increased Lymphocyte Cell Production
1547545	pembrolizumab	Programmed Death Receptor-1-directed Antibody Interactions	P [Preparations]|Programmed Death Receptor-1 Blocking Antibody	
466523	doxorubicin hydrochloride liposome	Topoisomerase 2 Inhibitors|Topoisomerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
314513	BCG, live, Montreal strain	Immunologic Adjuvants	B [Preparations]	Actively Acquired Immunity|Increased Antibody Production|Increased Antibody Activity
3639	doxorubicin	Topoisomerase 2 Inhibitors|Topoisomerase Inhibitors	Anthracycline Topoisomerase Inhibitor|D [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
221050	BCG, live, Tice strain	Immunologic Adjuvants	Live Attenuated Bacillus Calmette-Guerin Immunotherapy|Live Attenuated Bacillus Calmette-Guerin Vaccine|B [Preparations]	Increased Macrophage Proliferation|Actively Acquired Immunity|Increased Antibody Activity|Increased Antibody Production|Increased Immunologically Active Molecule Activity
10473	thiotepa	Alkylating Activity	Alkylating Drug|T [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
31435	valrubicin	Topoisomerase Inhibitors	V [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
32592	oxaliplatin	Nucleic Acid Synthesis Inhibitors|Physiochemical Activity	Platinum-based Drug|O [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
2596770	nivolumab-rmbw	Programmed Death Receptor-1-directed Antibody Interactions	N [Preparations]	Increased Lymphocyte Cell Production
2268306	enfortumab vedotin-ejfv	Antibody-Soluble Protein Interactions	E [Preparations]	Microtubule Inhibition|Increased Cellular Death
2268307	enfortumab	Antibody-Soluble Protein Interactions	E [Preparations]	Microtubule Inhibition|Increased Cellular Death
2277607	enfortumab vedotin	Antibody-Soluble Protein Interactions	E [Preparations]	Microtubule Inhibition|Increased Cellular Death
1792776	atezolizumab	Programmed Death Receptor-1-directed Antibody Interactions	A [Preparations]|Programmed Death Receptor-1 Blocking Antibody	Increased Immunologic Activity
632	mitomycin	Alkylating Activity|Nucleic Acid Synthesis Inhibitors	Alkylating Drug|M [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
236081	valacyclovir hydrochloride	DNA Polymerase Inhibitors	V [Preparations]	Decreased DNA Replication
81944	acyclovir sodium	DNA Polymerase Inhibitors	A [Preparations]	Decreased DNA Replication
1426	benzyl alcohol		Pediculicide|B [Preparations]	
73645	valacyclovir	DNA Polymerase Inhibitors	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|V [Preparations]	Decreased DNA Replication
68099	famciclovir	DNA Polymerase Inhibitors	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|F [Preparations]	Decreased DNA Replication
59839	penciclovir	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|P [Preparations]	Decreased DNA Replication
1000492	resveratrol	Enzyme Inhibitors	R [Preparations]	Vasodilation
281	acyclovir	DNA Polymerase Inhibitors	Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|A [Preparations]	Decreased DNA Replication
3435	iodoquinol	Unknown Cellular or Molecular Interaction	I [Preparations]	
52071	linolenic acid	Unknown Cellular or Molecular Interaction	L [Preparations]	Unknown Physiological Effect
1426444	calcium phosphate, monobasic, anhydrous	Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
1356127	risedronate sodium hemi-pentahydrate	Bone Surface Interactions	R [Preparations]	Bone Resorption Inhibition
1356128	risedronate sodium monohydrate	Bone Surface Interactions	R [Preparations]	Bone Resorption Inhibition
1546406	pamidronic acid	Bone Surface Interactions	Bisphosphonate|P [Preparations]	Bone Resorption Inhibition
2123126	romosozumab	Antibody-Receptor Interactions	R [Preparations]	Bone Resorption Inhibition|Bone Formation Stimulation
993449	denosumab	RANK Ligand Blocking Activity	RANK Ligand Inhibitor|D [Preparations]	Bone Resorption Inhibition
236560	calcium dihydrogen phosphate	Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
236916	ibandronate sodium	Bone Surface Interactions	I [Preparations]	Bone Resorption Inhibition
203152	alendronate sodium	Bone Surface Interactions	A [Preparations]	Bone Resorption Inhibition
166551	raloxifene hydrochloride	Selective Estrogen Receptor Modulators	R [Preparations]	Bone Resorption Inhibition|Cholesterol Metabolism Alteration
214342	calcium acetate	Phosphate Chelating Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
236083	alendronic acid	Bone Surface Interactions	Bisphosphonate|A [Preparations]	Bone Resorption Inhibition
114260	teriparatide acetate	Hormone Receptor Agonists	T [Preparations]	Bone Formation Stimulation|Decreased Renal Ca++ Excretion|Decreased Renal PO4-- Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
115265	ibandronic acid	Bone Surface Interactions	Bisphosphonate|I [Preparations]	Bone Resorption Inhibition
115264	ibandronate	Bone Surface Interactions	I [Preparations]	Bone Resorption Inhibition
105443	pamidronate disodium	Bone Surface Interactions	P [Preparations]	Bone Resorption Inhibition
72143	raloxifene	Selective Estrogen Receptor Modulators	Estrogen Agonist/Antagonist|R [Preparations]	Bone Resorption Inhibition|Cholesterol Metabolism Alteration
73056	risedronate	Bone Surface Interactions	R [Preparations]	Bone Resorption Inhibition
1311287	calcitonin	Structural Macromolecules	C [Preparations]	Bone Resorption Inhibition|Increased Distal Tubule K+ Excretion|Increased Distal Tubule PO4-- Excretion|Increased Distal Tubule Na+ Excretion|Increased Distal Tubule Mg++ Excretion|Increased Distal Tubule Ca++ Excretion|Stimulation Small Intestine Fluid/Electrolyte Secretion
1909	calcium glycerophosphate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
1918	calcium pantothenate	Phosphate Chelating Activity|Electrolyte Activity|Enzyme Interactions	C [Preparations]	Bone Resorption Alteration|Cellular Activity Alteration|Increased Renal PO4-- Excretion
1919	calcium phosphate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
1310463	calcium phosphate, dihydrate	Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
36118	salmon calcitonin	Structural Macromolecules	Calcitonin|S [Preparations]	Bone Resorption Inhibition|Increased Distal Tubule Ca++ Excretion|Increased Distal Tubule Mg++ Excretion|Increased Distal Tubule K+ Excretion|Increased Distal Tubule PO4-- Excretion|Increased Distal Tubule Na+ Excretion|Stimulation Small Intestine Fluid/Electrolyte Secretion
60334	risedronate sodium	Bone Surface Interactions	R [Preparations]	Bone Resorption Inhibition
46041	alendronate	Bone Surface Interactions	A [Preparations]	Bone Resorption Inhibition
47613	calcium citrate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
47622	calcium lactate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
47624	calcium levulinate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
25806	calcium glubionate	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
32915	teriparatide	Hormone Receptor Agonists	Parathyroid Hormone Analog|T [Preparations]	Bone Formation Stimulation|Decreased Renal PO4-- Excretion|Decreased Renal Ca++ Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
11473	pamidronate	Bone Surface Interactions	P [Preparations]	Bone Resorption Inhibition
2123180	romosozumab-aqqg	Antibody-Receptor Interactions	R [Preparations]	Bone Resorption Inhibition|Bone Formation Stimulation
2106283	calcium citrate anhydrous	Phosphate Chelating Activity|Electrolyte Activity	C [Preparations]	Bone Resorption Alteration|Increased Renal PO4-- Excretion
1921069	abaloparatide	Parathormone Receptor Agonists	A [Preparations]|Parathyroid Hormone-Related Peptide Analog	Bone Formation Stimulation|Bone Resorption Stimulation
1926958	risedronate sodium anhydrous	Bone Surface Interactions	R [Preparations]	Bone Resorption Inhibition
1545992	doxycycline anhydrous	Protein Synthesis Inhibitors	Tetracycline-class Drug|D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
3640	doxycycline	Protein Synthesis Inhibitors	Tetracycline-class Drug|D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
236647	doxycycline hydrochloride	Protein Synthesis Inhibitors	D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
203122	doxycycline monohydrate	Protein Synthesis Inhibitors	D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
82012	doxycycline calcium	Protein Synthesis Inhibitors	D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
23663	doxycycline hyclate	Protein Synthesis Inhibitors	D [Preparations]	Cell Membrane Alteration|Decreased Mitosis|Decreased Protein Synthesis
5175	hemin	Enzyme Inhibitors	H [Preparations]	Cellular Activity Alteration
267366	sodium ascorbate	Free Radical Scavenging Activity|Enzyme Interactions	S [Preparations]	Cellular Activity Alteration
61805	nitisinone	Cytochrome P450 2C9 Inhibitors|Organic Anion Transporter 1 Inhibitors|Organic Anion Transporter 3 Inhibitors|Hydroxyphenylpyruvate Dioxygenase Inhibitors|Cytochrome P450 2E1 Inducers	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor|N [Preparations]	Decreased Amino Acid Synthesis
1151	ascorbic acid	Free Radical Scavenging Activity|Enzyme Interactions	A [Preparations]|Vitamin C	Cellular Activity Alteration
735651	eltrombopag olamine	Organic Anion Transporting Polypeptide 1B1 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Thrombopoietin Receptor Agonists|UGT1A4 Inhibitors|UGT2B15 Inhibitors|UGT1A6 Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors|UGT1A3 Inhibitors|UGT2B7 Inhibitors	E [Preparations]	
711942	eltrombopag	Organic Anion Transporting Polypeptide 1B1 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Thrombopoietin Receptor Agonists|UGT2B7 Inhibitors|UGT1A3 Inhibitors|UGT1A1 Inhibitors|UGT2B15 Inhibitors|UGT1A4 Inhibitors|UGT1A9 Inhibitors|UGT1A6 Inhibitors	Thrombopoietin Receptor Agonist|E [Preparations]	Increased Platelet Production|Increased Megakaryocyte Maturation
203148	ondansetron hydrochloride	Serotonin 5HT-3 Antagonists|Serotonin 3 Receptor Antagonists	O [Preparations]	Decreased Central Nervous System Serotonin Activity|Decreased Peripheral Nervous System Serotonin Activity|Emesis Suppression
221078	citalopram hydrobromide	Serotonin Uptake Inhibitors	C [Preparations]	Increased Central Nervous System Serotonin Activity
152761	acamprosate calcium	NMDA Receptor Antagonists|GABA A Modulators	A [Preparations]	Increased GABA Activity
3554	disulfiram	Acetyl Aldehyde Dehydrogenase Inhibitors	Aldehyde Dehydrogenase Inhibitor|D [Preparations]	Emesis|Positive Chronotropy
2556	citalopram	Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|C [Preparations]	Increased Central Nervous System Serotonin Activity
82819	acamprosate	NMDA Receptor Antagonists|GABA A Modulators	A [Preparations]	Increased GABA Activity
26225	ondansetron	Serotonin 5HT-3 Antagonists|Serotonin 3 Receptor Antagonists	Serotonin-3 Receptor Antagonist|O [Preparations]	Decreased Central Nervous System Serotonin Activity|Decreased Peripheral Nervous System Serotonin Activity|Emesis Suppression
2119176	ondansetron hydrochloride anhydrous	Serotonin 5HT-3 Antagonists	O [Preparations]	Decreased Central Nervous System Serotonin Activity|Decreased Peripheral Nervous System Serotonin Activity|Emesis Suppression
203143	fluvoxamine maleate	Serotonin Uptake Inhibitors	F [Preparations]	Increased Central Nervous System Serotonin Activity
2597	clomipramine	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|C [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
81984	clomipramine hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	C [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
42355	fluvoxamine	Serotonin Uptake Inhibitors	Serotonin Reuptake Inhibitor|F [Preparations]	Increased Central Nervous System Serotonin Activity
1305760	povidone (K-30) simethicone emulsion	Unknown Cellular or Molecular Interaction	P [Preparations]	Unknown Physiological Effect
1310497	povidone K90	Unknown Cellular or Molecular Interaction	P [Preparations]	Unknown Physiological Effect
1305759	povidone K12	Unknown Cellular or Molecular Interaction	P [Preparations]	Unknown Physiological Effect
1297406	povidone K30	Unknown Cellular or Molecular Interaction	P [Preparations]	Unknown Physiological Effect
61773	flutrimazole	Ergosterol Synthesis Inhibitors	F [Preparations]	Decreased Cell Wall Integrity
8610	povidone	Unknown Cellular or Molecular Interaction	P [Preparations]	Unknown Physiological Effect
203220	betamethasone sodium phosphate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
215664	betamethasone dipropionate, augmented	Lipoxygenase Inhibitors|Glucocorticoid Receptor Agonists	B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
227897	betamethasone valerate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
2635	coal tar	Unknown Cellular or Molecular Interaction	C [Preparations]	Antipruritic Activity
1514	betamethasone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Prostaglandin Activity|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
1516	betamethasone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Protein Synthesis|Decreased Prostaglandin Activity|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
1517	betamethasone benzoate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Antipruritic Activity|Carbohydrate Metabolism Alteration|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
82101	sulfacetamide sodium	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Cellular Growth Phase Arrest|Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
90732	coal tar pitch volatiles	Unknown Cellular or Molecular Interaction	C [Preparations]	Antipruritic Activity
90735	coal tar extract	Unknown Cellular or Molecular Interaction	C [Preparations]	Antipruritic Activity
36345	selenium sulfide	Physiochemical Activity|Unknown Cellular or Molecular Interaction	S [Preparations]	Increased Glutathione Concentration|Cellular Degradation/Digestion Alteration
39952	zinc pyrithione	Proton Pump Inhibitors|Unknown Cellular or Molecular Interaction	Z [Preparations]	Decreased Cell Membrane Integrity|Decreased Mitosis
19254	betamethasone dipropionate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	B [Preparations]	Carbohydrate Metabolism Alteration|Antipruritic Activity|Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Lysosomal Function|Decreased Prostaglandin Activity|Decreased Protein Synthesis|Decreased Thromboxane Activity|Decreased Cellular Migration|Lipid Metabolism Alteration
20875	chloroxine	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Mitosis
10169	sulfacetamide	Para-Aminobenzoic Acid Inhibitors	Sulfonamide Antibacterial|S [Preparations]	Cellular Growth Phase Arrest|Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
28031	itraconazole	P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Breast Cancer Resistance Protein Inhibitors|14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|I [Preparations]	Decreased Cell Wall Integrity
235370	trientine hydrochloride	Metal Chelating Activity	T [Preparations]	Increased Renal Ion Excretion
10798	trientine	Metal Chelating Activity|Copper Chelating Activity	T [Preparations]|Copper Chelator	Increased Renal Ion Excretion
2611541	trientine tetrahydrochloride	Metal Chelating Activity	T [Preparations]	Increased Renal Ion Excretion
1298838	gonadorelin diacetate tetrahydrate	Gonadotropin Releasing Hormone Receptor Agonists	G [Preparations]	Increased Follicle Stimulating Hormone Secretion|Increased Luteinizing Hormone Secretion
203147	nafarelin acetate	Gonadotropin Releasing Hormone Receptor Agonists|Hormone Receptor Agonists	N [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
204194	gonadorelin hydrochloride	Gonadotropin Releasing Hormone Receptor Agonists	G [Preparations]	Increased Follicle Stimulating Hormone Secretion|Increased Luteinizing Hormone Secretion
204193	gonadorelin acetate	Gonadotropin Releasing Hormone Receptor Agonists	G [Preparations]	Increased Follicle Stimulating Hormone Secretion|Increased Luteinizing Hormone Secretion
1294622	histrelin acetate	Gonadotropin Releasing Hormone Receptor Agonists	H [Preparations]	Decreased GnRH Secretion|Decreased Follicle Stimulating Hormone Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Decreased Luteinizing Hormone Secretion
50975	histrelin	Gonadotropin Releasing Hormone Receptor Agonists	H [Preparations]|Gonadotropin Releasing Hormone Receptor Agonist	Decreased GnRH Secretion|Decreased Follicle Stimulating Hormone Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
40137	tamoxifen citrate	Selective Estrogen Receptor Modulators	T [Preparations]	Decreased DNA Replication|Decreased Ovarian Estrogen Secretion|Stimulate Ovulation
28656	nafarelin	Gonadotropin Releasing Hormone Receptor Agonists|Hormone Receptor Agonists	Gonadotropin Releasing Hormone Receptor Agonist|N [Preparations]	Decreased Follicle Stimulating Hormone Secretion|Decreased Ovarian Estrogen Secretion|Decreased Testosterone Secretion|Increased GnRH Secretion|Decreased Luteinizing Hormone Secretion
10324	tamoxifen	Selective Estrogen Receptor Modulators	Estrogen Agonist/Antagonist|T [Preparations]	Decreased DNA Replication|Decreased Ovarian Estrogen Secretion|Stimulate Ovulation
6384	gonadorelin	Gonadotropin Releasing Hormone Receptor Agonists	G [Preparations]	Increased Follicle Stimulating Hormone Secretion|Increased Luteinizing Hormone Secretion
4325	fenbendazole		F [Preparations]	Decreased Cell Wall Integrity
4450	fluconazole	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|14-alpha Demethylase Inhibitors	Azole Antifungal|F [Preparations]	Decreased Cell Wall Integrity
37806	terconazole	14-alpha Demethylase Inhibitors	Azole Antifungal|T [Preparations]	Decreased Cell Membrane Integrity
38298	tioconazole	14-alpha Demethylase Inhibitors	Azole Antifungal|T [Preparations]	Decreased Cell Membrane Integrity
47464	butoconazole nitrate	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	B [Preparations]	Decreased Cell Membrane Integrity
19884	butoconazole	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|B [Preparations]	Decreased Cell Membrane Integrity
10184	sulfanilamide	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Decreased Folic Acid Modification
2560215	ibrexafungerp citrate	Glucan Synthase Inhibitors	I [Preparations]	
2560213	ibrexafungerp	Glucan Synthase Inhibitors	I [Preparations]|Triterpenoid Antifungal	
2602577	oteseconazole	Breast Cancer Resistance Protein Inhibitors|14-alpha Demethylase Inhibitors	Azole Antifungal|O [Preparations]	
2589225	tralokinumab	Interleukin-13 Antagonists	T [Preparations]|Interleukin-13 Antagonist	
1876376	dupilumab	Interleukin 4 Receptor alpha Antagonists	D [Preparations]|Interleukin-4 Receptor alpha Antagonist	Decreased Immunologic Activity
1099727	triprolidine tannate	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
484288	tacrolimus monohydrate	Enzyme Inhibitors	T [Preparations]	Cellular Growth Phase Arrest|Decreased Cytokine Production|Decreased T Lymphocyte Production
4461	fluocinolone acetonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
321952	pimecrolimus	Enzyme Inhibitors|Calcineurin Inhibitors	Calcineurin Inhibitor Immunosuppressant|P [Preparations]	Decreased Cytokine Activity|Decreased Cytokine Production|Increased Cytokine Degradation
3638	doxepin	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|D [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
203179	doxepin hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
235991	anhydrous tacrolimus	Enzyme Inhibitors|Calcineurin Inhibitors	Calcineurin Inhibitor Immunosuppressant|A [Preparations]	Cellular Growth Phase Arrest|Decreased Cytokine Production|Decreased T Lymphocyte Production
71534	triprolidine hydrochloride	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
46307	amlexanox	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased Immunologically Active Molecule Activity
42316	tacrolimus	Enzyme Inhibitors|Calcineurin Inhibitors	T [Preparations]	Cellular Growth Phase Arrest|Decreased Cytokine Production|Decreased T Lymphocyte Production
25126	fluocinolone	Lipoxygenase Inhibitors	F [Preparations]	Vasoconstriction|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
10849	triprolidine	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
11423	zinc oxide	Physiochemical Activity	Z [Preparations]	Sunscreening Activity
2591476	abrocitinib	P-Glycoprotein Inhibitors|Janus Kinase Inhibitors	A [Preparations]|Janus Kinase Inhibitor	
2589374	tralokinumab-ldrm	Interleukin-13 Antagonists	T [Preparations]	
1865953	crisaborole	Phosphodiesterase 4 Inhibitors	Phosphodiesterase 4 Inhibitor|C [Preparations]	Unknown Physiological Effect
644101	idursulfase		Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme|I [Preparations]	Glycosaminoglycan Metabolism Increase|Increased Lysosomal Function
82055	neostigmine bromide	Cholinesterase Inhibitors	N [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity|Increased GI Smooth Muscle Tone|Increased Striated Muscle Contraction|Salivation Stimulation
47088	bethanechol chloride	Cholinergic Muscarinic Agonists	B [Preparations]	Increased Bladder Contractility|Increased GI Smooth Muscle Tone|Stimulation Gastric Mucous Secretion|Stimulation Pancreatic Fluid/Electrolyte Secretion|Stimulation Pancreatic Enzymatic Secretion
19257	bethanechol	Cholinergic Muscarinic Agonists	Cholinergic Muscarinic Agonist|B [Preparations]	Increased Bladder Contractility|Increased GI Smooth Muscle Tone|Stimulation Gastric Mucous Secretion|Stimulation Pancreatic Enzymatic Secretion|Stimulation Pancreatic Fluid/Electrolyte Secretion
28981	loracarbef	Transpeptidase Inhibitors	L [Preparations]	Decreased Cell Wall Synthesis & Repair
7315	neostigmine	Cholinesterase Inhibitors	Cholinesterase Inhibitor|N [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity|Increased GI Smooth Muscle Tone|Increased Striated Muscle Contraction|Salivation Stimulation
7316	neostigmine methylsulfate	Cholinesterase Inhibitors	N [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity|Increased GI Smooth Muscle Tone|Increased Striated Muscle Contraction|Salivation Stimulation
392509	laronidase		Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme|L [Preparations]	Glycosaminoglycan Metabolism Increase|Increased Lysosomal Function
863035	bepotastine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|B [Preparations]	Decreased Histamine Activity
1000082	alcaftadine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|A [Preparations]	Antipruritic Activity
658552	bepotastine besilate	Histamine H1 Receptor Antagonists	B [Preparations]	Decreased Histamine Activity
236599	olopatadine hydrochloride	Histamine H1 Receptor Antagonists	O [Preparations]	Decreased Histamine Activity
259318	pemirolast potassium	Calcium Channel Antagonists	P [Preparations]	Decreased Histamine Release|Decreased Cellular Locomotion|Decreased Exocytosis|Decreased Histamine Activity|Decreased Histamine Production|Increased Histamine Degradation|Decreased Cellular Migration
236961	epinastine hydrochloride	Adrenergic alpha-Agonists|Histamine H1 Receptor Antagonists	E [Preparations]	Decreased Histamine Activity
266663	nedocromil sodium	Biological Response Modifiers	N [Preparations]	Decreased Histamine Release
221094	emedastine difumarate	Histamine H1 Receptor Antagonists	E [Preparations]	Decreased Histamine Activity
1294532	levocabastine hydrochloride	Histamine H1 Receptor Antagonists	L [Preparations]	Decreased Histamine Activity
135391	olopatadine	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Antagonist|Mast Cell Stabilizer|Histamine-1 Receptor Inhibitor|O [Preparations]	Decreased Histamine Release|Decreased Histamine Activity
81954	antazoline hydrochloride	Histamine H1 Receptor Antagonists	A [Preparations]	Decreased Histamine Activity
39684	epinastine	Adrenergic Agonists|Adrenergic alpha-Agonists|Histamine H1 Receptor Antagonists	Adrenergic Receptor Agonist|Histamine-1 Receptor Inhibitor|E [Preparations]	Decreased Histamine Release|Decreased Histamine Activity
19551	pemirolast	Calcium Channel Antagonists	P [Preparations]	Decreased Histamine Release|Decreased Cellular Locomotion|Decreased Exocytosis|Decreased Histamine Production|Decreased Histamine Activity|Increased Histamine Degradation|Decreased Cellular Migration
866	antazoline phosphate	Histamine H1 Receptor Antagonists	A [Preparations]	Decreased Histamine Activity
865	antazoline	Histamine H1 Receptor Antagonists	A [Preparations]	Decreased Histamine Activity
28144	emedastine	Histamine H1 Receptor Antagonists	E [Preparations]	Decreased Histamine Activity
28200	ketorolac tromethamine	Cyclooxygenase Inhibitors	K [Preparations]	Decreased Prostaglandin Production
28627	levocabastine	Histamine H1 Receptor Antagonists	L [Preparations]	Decreased Histamine Activity
29439	medrysone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|M [Preparations]	Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
31563	nedocromil	Biological Response Modifiers	Mast Cell Stabilizer|N [Preparations]	Decreased Histamine Release
11404	ketotifen fumarate	Histamine H1 Receptor Antagonists	K [Preparations]	Decreased Histamine Activity
6146	ketotifen	Histamine H1 Receptor Antagonists	Histamine-1 Receptor Inhibitor|K [Preparations]	Decreased Histamine Activity
1862579	rucaparib	Poly(ADP-Ribose) Polymerase Inhibitors	R [Preparations]|Poly(ADP-Ribose) Polymerase Inhibitor	Cellular Growth Phase Reduction|Decreased DNA Integrity|Decreased Reverse Transcription to DNA
5657	ifosfamide	Alkylating Activity	Alkylating Drug|I [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
1918231	niraparib	Poly(ADP-Ribose) Polymerase Inhibitors	N [Preparations]|Poly(ADP-Ribose) Polymerase Inhibitor	DNA Alteration|Increased Cellular Death
1597582	olaparib	Poly(ADP-Ribose) Polymerase Inhibitors	O [Preparations]|Poly(ADP-Ribose) Polymerase Inhibitor	Cellular Growth Phase Reduction|Decreased DNA Integrity|Decreased Reverse Transcription to DNA
486610	paclitaxel protein-bound	Immunologic Adjuvants|beta Tubulin Interactions	P [Preparations]	Decreased Mitosis
5296	altretamine	Alkylating Activity|Nucleic Acid Synthesis Inhibitors	A [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
253337	bevacizumab	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	B [Preparations]|Vascular Endothelial Growth Factor Inhibitor	Vascular Growth Decrease
1299922	docetaxel anhydrous	Protein Synthesis Inhibitors|Tubulin Interactions	Microtubule Inhibitor|D [Preparations]	Microtubule Inhibition|Decreased DNA Integrity|Decreased Mitosis|Decreased Meiosis|Decreased Protein Synthesis|Decreased RNA Integrity
236234	gemcitabine hydrochloride	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	G [Preparations]	Decreased DNA Integrity|Increased Cellular Death
114527	vinorelbine tartrate	Nucleic Acid Synthesis Inhibitors|Tubulin Interactions	V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
2346	chlorambucil	Alkylating Activity	Alkylating Drug|C [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
72962	docetaxel	Protein Synthesis Inhibitors|Tubulin Interactions	D [Preparations]	Microtubule Inhibition|Decreased DNA Integrity|Decreased Mitosis|Decreased Meiosis|Decreased Protein Synthesis|Decreased RNA Integrity
39541	vinorelbine	Nucleic Acid Synthesis Inhibitors|Tubulin Interactions	Vinca Alkaloid|V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
56946	paclitaxel	Immunologic Adjuvants|beta Tubulin Interactions	Microtubule Inhibitor|P [Preparations]	Microtubule Inhibition|Decreased Mitosis
12574	gemcitabine	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	Nucleoside Metabolic Inhibitor|G [Preparations]	Decreased DNA Integrity|Increased Cellular Death
2627648	bevacizumab-adcd	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	B [Preparations]	Vascular Growth Decrease
2599041	bevacizumab-maly	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	B [Preparations]	Vascular Growth Decrease
2268037	bevacizumab-bvzr	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors	B [Preparations]	Vascular Growth Decrease
2640208	niraparib tosylate monohydrate	Poly(ADP-Ribose) Polymerase Inhibitors	N [Preparations]	DNA Alteration|Increased Cellular Death
1862578	rucaparib camsylate	Poly(ADP-Ribose) Polymerase Inhibitors	R [Preparations]	Cellular Growth Phase Reduction|Decreased DNA Integrity|Decreased Reverse Transcription to DNA
2046138	bevacizumab-awwb	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors	B [Preparations]	Vascular Growth Decrease
2637447	niraparib tosylate	Poly(ADP-Ribose) Polymerase Inhibitors	N [Preparations]	DNA Alteration|Increased Cellular Death
221165	standardized enzyme lactase	Unknown Cellular or Molecular Interaction	S [Preparations]	Unknown Physiological Effect
41397	lactase	Unknown Cellular or Molecular Interaction	L [Preparations]	Unknown Physiological Effect
618365	synthetic conjugated estrogens, B	Estrogen Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Pituitary Gland Activity Alteration|Vaginal Function Alteration
405416	estradiol acetate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
236859	estradiol hemihydrate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
253166	synthetic conjugated estrogens, A	Estrogen Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Pituitary Gland Activity Alteration|Vaginal Function Alteration
4083	estradiol	Estrogen Receptor Agonists	Estrogen|E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
4099	estrogens, conjugated (USP)	Estrogen Receptor Agonists	Estrogen|E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Pituitary Gland Activity Alteration|Vaginal Function Alteration
4100	estrogens	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Pituitary Gland Activity Alteration|Vaginal Function Alteration
4103	estrone	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Decreased Follicle Stimulating Hormone Secretion|Decreased Luteinizing Hormone Secretion|Vaginal Function Alteration
4124	ethinyl estradiol	Estrogen Receptor Agonists	Estrogen|E [Preparations]	Bone Formation Stimulation|Decreased Embryonic Implantation|Vaginal Function Alteration|Inhibit Ovulation
214549	estrogens, esterified (USP)	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Pituitary Gland Activity Alteration|Vaginal Function Alteration
91428	sodium estrone sulfate	Estrogen Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Decreased Follicle Stimulating Hormone Secretion|Decreased Luteinizing Hormone Secretion|Vaginal Function Alteration
60661	estradiol 3-benzoate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
1000146	estradiol cypionate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
24395	estradiol valerate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Gonadotropin Releasing Hormone Alteration|Vaginal Function Alteration
33747	estropipate	Estrogen Receptor Agonists	E [Preparations]	Bone Formation Stimulation|Pituitary Gland Activity Alteration|Vaginal Function Alteration
34119	polyestradiol	Estrogen Receptor Agonists	P [Preparations]	Bone Formation Stimulation|Vaginal Function Alteration
34120	polyestradiol phosphate	Estrogen Receptor Agonists	P [Preparations]	Bone Formation Stimulation|Vaginal Function Alteration
6693	mefenamic acid	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|M [Preparations]	Decreased Platelet Activating Factor Production|Decreased Prostaglandin Production|Decreased Thromboxane Production
N0000175795	Narcotic Antitussive			
N0000175796	Non-narcotic Antitussive			
539765	dextromethorphan hydroiodide	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Medullary Respiratory Drive
1115966	codeine hydrochloride	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
360375	fenugreek seed preparation	Unknown Cellular or Molecular Interaction	F [Preparations]	Increased GI Motility
282436	fenugreek seed meal	Unknown Cellular or Molecular Interaction	F [Preparations]	Increased GI Motility
2104181	cloperastine hydrochloride		C [Preparations]	
283547	carbetapentane citrate	Receptor Interactions	C [Preparations]	Medullary Respiratory Center Activity Alteration
236236	codeine camsyl	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
259262	dextromethorphan tannate	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Medullary Respiratory Drive
267251	dextromethorphan hydrochloride	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Medullary Respiratory Drive
221070	carbetapentane tannate	Receptor Interactions	C [Preparations]	Medullary Respiratory Center Activity Alteration
3289	dextromethorphan	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	Uncompetitive N-methyl-D-aspartate Receptor Antagonist|Sigma-1 Agonist|D [Preparations]	Decreased Medullary Respiratory Drive
235412	codeine polistirex	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
236131	codeine anhyd	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
236146	dextromethorphan polistirex	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Medullary Respiratory Drive
133053	caramiphen edisylate	Receptor Interactions	C [Preparations]	Medullary Respiratory Center Activity Alteration
102490	dextromethorphan hydrobromide	Uncompetitive NMDA Receptor Antagonists|Sigma-1 Receptor Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Decreased Medullary Respiratory Drive
104966	dihydrocodeine bitartrate	Full Opioid Agonists	D [Preparations]	Analgesia|Decreased Organized Electrical Activity
2653	cocaine	Dopamine Uptake Inhibitors|Sodium Channel Interactions	C [Preparations]	Decreased Sympathetic Norepinephrine Activity|Systemic Venous Vasoconstriction
2670	codeine	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
2672	codeine phosphate	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Organized Electrical Activity|Decreased Medullary Respiratory Drive
81985	cocaine hydrochloride	Dopamine Uptake Inhibitors|Sodium Channel Interactions	C [Preparations]	Decreased Sympathetic Norepinephrine Activity|Systemic Venous Vasoconstriction
91104	codeine sulfate	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
91275	potassium guaiacolsulfonate		P [Preparations]	Increased Respiratory Secretions
18993	benzonatate	Sodium-Potassium Exchanging ATPase Interactions	Non-narcotic Antitussive|B [Preparations]	Decreased Tracheobronchial Stretch Receptor Activity
20191	caramiphen	Receptor Interactions	C [Preparations]	Medullary Respiratory Center Activity Alteration
20217	carbetapentane	Receptor Interactions	C [Preparations]	Medullary Respiratory Center Activity Alteration
2104180	cloperastine		C [Preparations]	
23088	dihydrocodeine	Full Opioid Agonists	D [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
8597	potassium iodide	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Respiratory Secretion Viscosity|Decreased Thyroid Hormone Secretion|Increased Respiratory Secretions|Increased Thyroid Hormone Iodination|Unknown Physiological Effect
7533	noscapine	Sigma-1 Receptor Antagonists	N [Preparations]	
5975	ipecac	Receptor Interactions	I [Preparations]	
1545976	codeine anhydrous	Full Opioid Agonists	C [Preparations]|Opioid Agonist	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
1652891	codeine phosphate anhydrous	Full Opioid Agonists	C [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
1742407	hyoscyamine sulfate anhydrous	Serotonin Antagonists|Histamine Receptor Antagonists|Cholinergic Muscarinic Antagonists	H [Preparations]	Cardiovascular Activity Alteration|Decreased Respiratory Secretions
283561	ephedrine hydrate	Adrenergic beta-Agonists|Adrenergic alpha-Agonists	E [Preparations]	Bronchodilation|Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
3966	ephedrine	Adrenergic beta-Agonists|Adrenergic alpha-Agonists	alpha-Adrenergic Agonist|beta-Adrenergic Agonist|E [Preparations]|Norepinephrine Releasing Agent	Bronchodilation|Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions|Increased Norepinephrine Activity
221096	ephedrine tannate	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	E [Preparations]	Bronchodilation|Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions|Increased Norepinephrine Activity
221140	phenylpropanolamine bitartrate	Adrenergic alpha-Agonists	P [Preparations]	Increased Urethra Smooth Muscle Tone
153970	hyoscyamine	Serotonin Antagonists|Histamine Receptor Antagonists|Cholinergic Muscarinic Antagonists	H [Preparations]	Cardiovascular Activity Alteration|Decreased Respiratory Secretions
235810	naphazoline nitrate	Adrenergic alpha-Agonists	N [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
106101	oxymetazoline hydrochloride	Adrenergic alpha-Agonists	O [Preparations]	Vasoconstriction|Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
82054	naphazoline hydrochloride	Adrenergic alpha-Agonists	N [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
1047802	hyoscyamine hydrobromide	Serotonin Antagonists|Histamine Receptor Antagonists|Cholinergic Muscarinic Antagonists	H [Preparations]	Cardiovascular Activity Alteration|Decreased Respiratory Secretions
91165	ephedrine hydrochloride	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	E [Preparations]	Bronchodilation|Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions|Increased Norepinephrine Activity
91166	ephedrine sulfate	Adrenergic alpha-Agonists|Adrenergic beta-Agonists	E [Preparations]	Bronchodilation|Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions|Increased Norepinephrine Activity
1225	hyoscyamine sulfate	Serotonin Antagonists|Histamine Receptor Antagonists|Cholinergic Muscarinic Antagonists	H [Preparations]	Cardiovascular Activity Alteration|Decreased Respiratory Secretions
7812	oxymetazoline	Adrenergic alpha-Agonists	O [Preparations]|Vasoconstrictor	Vasoconstriction|Increased Sympathetic Activity|Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
7247	naphazoline	Adrenergic alpha-Agonists	N [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
8175	phenylpropanolamine	Adrenergic alpha-Agonists	P [Preparations]	Increased Urethra Smooth Muscle Tone
1364104	pasireotide diaspartate	Somatostatin Receptor Agonists	P [Preparations]	Decreased Adrenocorticotropic Hormone Secretion|Decreased Glucocorticoid Secretion
1364105	pasireotide	Somatostatin Receptor Agonists	Somatostatin Analog|P [Preparations]	Decreased Adrenocorticotropic Hormone Secretion|Decreased Glucocorticoid Secretion
2286253	osilodrostat phosphate	Cytochrome P450 Inhibitors|Adrenal Steroid Synthesis Inhibitors	O [Preparations]	Adrenal Cortical Activity Alteration
7004	mitotane	Cytochrome P450 3A4 Inducers|Unknown Cellular or Molecular Interaction	M [Preparations]	Decreased Glucocorticoid Secretion
2286252	osilodrostat	Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A5 Inhibitors|Adrenal Steroid Synthesis Inhibitors|Cytochrome P450 11B1 Inhibitors	O [Preparations]|Cortisol Synthesis Inhibitor	Adrenal Cortical Activity Alteration
1597818	pasireotide pamoate	Somatostatin Receptor Agonists	P [Preparations]	Decreased Adrenocorticotropic Hormone Secretion|Decreased Glucocorticoid Secretion
677	aminoglutethimide	Aromatase Inhibitors|Adrenal Steroid Synthesis Inhibitors|Steroid Receptor Antagonists	A [Preparations]	Decreased Glucocorticoid Secretion|Decreased Mineralocorticoid Secretion
N0000175623	Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody			
194279	palivizumab	Fusion Protein Inhibitors	Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody|P [Preparations]	Decreased Cell Wall Synthesis & Repair
42386	immunoglobulins, intravenous	Antigen Neutralization|Antibody-Receptor Interactions	I [Preparations]	Passively Acquired Immunity|Immunologic Activity Alteration
9344	ribavirin	Enzyme Inhibitors	R [Preparations]|Nucleoside Analog Antiviral	Decreased DNA Replication|Decreased RNA Replication
1599788	secukinumab	Interleukin-17A Antagonists	S [Preparations]|Interleukin-17A Antagonist	
1492727	apremilast	Phosphodiesterase 4 Inhibitors	Phosphodiesterase 4 Inhibitor|A [Preparations]	Decreased Leukotriene Production
1543543	belinostat	Histone Deacetylase Inhibitors	Histone Deacetylase Inhibitor|B [Preparations]	Increased Cellular Death
877510	romidepsin	Organic Cation Transporter 2 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporter 1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Histone Deacetylase Inhibitors|Bile Salt Export Pump Inhibitors	Histone Deacetylase Inhibitor|R [Preparations]	Increased Cellular Death
662019	pralatrexate	Protein Synthesis Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	Folate Analog Metabolic Inhibitor|P [Preparations]	Decreased Protein Synthesis
6466	lomustine	Alkylating Activity	Alkylating Drug|L [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Transcription to RNA
6964	mifepristone	Progestational Hormone Receptor Antagonists|Glucocorticoid Receptor Antagonists	Progestin Antagonist|M [Preparations]	Decreased Ovarian Progesterone Secretion
1653781	eluxadoline	Opioid Antagonists|Opioid mu-Receptor Agonists	E [Preparations]|mu-Opioid Receptor Agonist	Decreased Large Intestinal Motility
1307404	linaclotide	Guanylate Cyclase Activators|Chloride Channel Activators	Guanylate Cyclase-C Agonist|L [Preparations]	Increased Gastric Motility|Stimulation Small Intestine Fluid/Electrolyte Secretion|Stimulation Large Intestine Fluid/Electrolyte Secretion
623033	lubiprostone	Chloride Channel Activators	Chloride Channel Activator|L [Preparations]	Stimulation Large Intestine Fluid/Electrolyte Secretion
339270	tegaserod maleate	Serotonin Agonists|Serotonin 4 Receptor Antagonists	T [Preparations]	Decreased Enteric Nervous System Serotonin Activity|Increased Large Intestinal Motility|Stimulation Large Intestine Fluid/Electrolyte Secretion
3361	dicyclomine	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|D [Preparations]	GI Motility Alteration
152021	dicyclomine hydrochloride	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	D [Preparations]	GI Motility Alteration
139778	tegaserod	Serotonin Agonists|Serotonin 4 Receptor Antagonists|Serotonin 4 Receptor Agonists	T [Preparations]|Serotonin-4 Receptor Agonist	Decreased Enteric Nervous System Serotonin Activity|Increased Large Intestinal Motility|Stimulation Large Intestine Fluid/Electrolyte Secretion
85248	alosetron	Serotonin 3 Receptor Antagonists	Serotonin-3 Receptor Antagonist|A [Preparations]	Decreased Enteric Nervous System Serotonin Activity
85247	alosetron hydrochloride	Serotonin 3 Receptor Antagonists	A [Preparations]	Decreased Enteric Nervous System Serotonin Activity
89784	isopropamide	Cholinergic Muscarinic Antagonists	I [Preparations]	Decreased Parasympathetic Activity|Decreased GI Motility
91163	methantheline bromide	Histamine H2 Receptor Antagonists|Cholinergic Muscarinic Antagonists	M [Preparations]	Decreased Gastric Motility|Gastric Mucous Secretion Alteration
20063	calcium polycarbophil	Stool Bulking Activity	C [Preparations]	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption
35619	rifaximin	Nucleic Acid Synthesis Inhibitors	Rifamycin Antibacterial|R [Preparations]	Cellular Growth Phase Reduction|Decreased Protein Synthesis|Decreased RNA Replication|Decreased Transcription to RNA
8761	propantheline	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|P [Preparations]	Decreased GI Motility|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Inhibition Gastric Acid Secretion
8762	propantheline bromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	P [Preparations]	Decreased GI Motility|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Inhibition Gastric Acid Secretion
2199673	tenapanor hydrochloride	Antiporter Interactions	T [Preparations]	Decreased Inorganic Ion Absorption|Digestive/GI System Activity Alteration
6821	methantheline	Histamine H2 Receptor Antagonists|Cholinergic Muscarinic Antagonists	M [Preparations]	Decreased Gastric Motility|Gastric Mucous Secretion Alteration
2199674	tenapanor	Antiporter Interactions	T [Preparations]	Decreased Inorganic Ion Absorption|Digestive/GI System Activity Alteration
6051	isopropamide iodide	Cholinergic Muscarinic Antagonists	I [Preparations]	Decreased Parasympathetic Activity|Decreased GI Motility
91350	apraclonidine hydrochloride	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	A [Preparations]	Decreased Intraocular Fluid Pressure
89792	mannitol hexanitrate	Osmotic Activity	M [Preparations]	Increased Diuresis|Increased Glomerular Filtration Pressure|Increased Renal Organic Ion Excretion|Increased Renal Ion Excretion
14845	apraclonidine	Adrenergic alpha-Agonists|Adrenergic alpha2-Agonists	alpha-Adrenergic Agonist|A [Preparations]	Decreased Intraocular Fluid Pressure
11002	urea	Physiochemical Activity	U [Preparations]	Increased Renal Urea Excretion|Emollient Activity
6628	mannitol	Osmotic Activity	Osmotic Diuretic|M [Preparations]	Increased Diuresis|Increased Glomerular Filtration Pressure|Increased Renal Ion Excretion
1862866	urea hydrochloride	Physiochemical Activity	U [Preparations]	Increased Renal Urea Excretion|Emollient Activity
203114	amiodarone hydrochloride	Calcium Channel Antagonists|Adrenergic beta-Antagonists|Sodium Channel Antagonists|Potassium Channel Interactions	A [Preparations]	Atrial Repolarization|Negative Chronotropy|Ventricular Repolarization
203135	propafenone hydrochloride	Adrenergic beta-Antagonists|Sodium Channel Interactions	P [Preparations]	Local Anesthesia|Decreased Cardiac Muscle Organized Electrical Activity|Negative Chronotropy
3248	deslanoside	Sodium-Potassium Exchanging ATPase Interactions	D [Preparations]	Conduction System Depolarization|Positive Inotropy|Nodal Depolarization|Negative Chronotropy
3403	digitoxin	Enzyme Inhibitors|Sodium-Potassium Exchanging ATPase Interactions	D [Preparations]	Conduction System Depolarization|Negative Chronotropy|Nodal Depolarization|Positive Inotropy
3407	digoxin	Enzyme Inhibitors|Sodium-Potassium Exchanging ATPase Interactions	Cardiac Glycoside|D [Preparations]	Conduction System Depolarization|Negative Chronotropy|Nodal Depolarization|Positive Inotropy
91235	Digitalis preparation	Sodium-Potassium Exchanging ATPase Interactions	D [Preparations]	Conduction System Depolarization|Nodal Depolarization|Negative Chronotropy|Positive Inotropy
8754	propafenone	Adrenergic beta-Antagonists|Sodium Channel Interactions	Antiarrhythmic|P [Preparations]	Local Anesthesia|Decreased Cardiac Muscle Organized Electrical Activity|Negative Chronotropy
703	amiodarone	P-Glycoprotein Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A Inhibitors|Calcium Channel Antagonists|Adrenergic beta-Antagonists|Sodium Channel Antagonists|Potassium Channel Interactions	Antiarrhythmic|A [Preparations]	Atrial Repolarization|Negative Chronotropy|Ventricular Repolarization
33309	phensuximide	Unknown Cellular or Molecular Interaction	P [Preparations]	Neurotransmitter & Neuromuscular Transmitter Activity Alteration
6758	mephobarbital	Cytochrome P450 2C19 Inhibitors|Neurotransmitter Transporter Interactions	M [Preparations]	Decreased Disorganized Electrical Activity|Decreased Organized Electrical Activity|Gamma Amino Butyric Acid (GABA) Activity Alteration
4492	fluorouracil	Thymidylate Synthetase Inhibitors|Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	Nucleoside Metabolic Inhibitor|F [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
59943	imiquimod	Interferon Inducers	I [Preparations]	Increased Cytokine Activity|Increased Cytokine Production
1306064	cefdinir monohydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
1743286	ceftaroline fosamil acetate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
1546021	cefixime anhydrous	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1545984	ceftazidime anhydrous	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1927663	delafloxacin		D [Preparations]|Fluoroquinolone Antibacterial	
864624	telavancin hydrochloride		T [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Membrane Integrity
1299904	azithromycin anhydrous	Protein Synthesis Inhibitors	Macrolide Antimicrobial|A [Preparations]	Decreased Protein Synthesis
1450910	cefaclor anhydrous	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1546020	cefprozil anhydrous	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
1299782	cephalexin anhydrous	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1540825	tedizolid	Breast Cancer Resistance Protein Inhibitors|Protein Synthesis Inhibitors	Oxazolidinone Antibacterial|T [Preparations]	Decreased Protein Synthesis
1540824	tedizolid phosphate	Protein Synthesis Inhibitors	T [Preparations]	Decreased Protein Synthesis
5690	imipenem	Transpeptidase Inhibitors	I [Preparations]	Decreased Cell Wall Synthesis & Repair
1546000	piperacillin anhydrous	Transpeptidase Inhibitors	Penicillin-class Antibacterial|P [Preparations]	Decreased Cell Wall Synthesis & Repair
1040004	ceftaroline fosamil	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
1040005	ceftaroline	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
473837	telavancin		T [Preparations]|Lipoglycopeptide Antibacterial	Decreased Cell Wall Synthesis & Repair|Decreased Cell Membrane Integrity
353107	ertapenem sodium	Enzyme Inhibitors	E [Preparations]	Decreased Cell Wall Synthesis & Repair|Post Translation Protein Modification Alteration
1539239	dalbavancin	Protein Synthesis Inhibitors	D [Preparations]|Lipoglycopeptide Antibacterial	Decreased Cell Wall Synthesis & Repair
1547611	oritavancin	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A4 Inducers|Cytochrome P450 2C19 Inhibitors|Protein Synthesis Inhibitors|Transpeptidase Inhibitors|Cytochrome P450 2D6 Inducers	O [Preparations]|Lipoglycopeptide Antibacterial	Decreased Cell Wall Synthesis & Repair|Decreased Cell Membrane Integrity|Increased Cellular Death
384455	tigecycline	Protein Synthesis Inhibitors	Tetracycline-class Antibacterial|T [Preparations]	Decreased Mitosis|Decreased Protein Synthesis|Increased Cellular Death
325642	ertapenem	Enzyme Inhibitors	Penem Antibacterial|E [Preparations]	Decreased Cell Wall Synthesis & Repair|Post Translation Protein Modification Alteration
327584	bacampicillin hydrochloride	Antibody-Receptor Interactions|Transpeptidase Inhibitors	B [Preparations]	Decreased Cell Wall Synthesis & Repair
1297879	ceftibuten dihydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
253155	azithromycin dihydrate	Protein Synthesis Inhibitors	A [Preparations]	Decreased Protein Synthesis
1298839	azithromycin monohydrate	Protein Synthesis Inhibitors	A [Preparations]	Decreased Protein Synthesis
1545986	imipenem anhydrous	Transpeptidase Inhibitors	Penem Antibacterial|I [Preparations]	Decreased Cell Wall Synthesis & Repair
281942	cephalexin hydrochloride	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203117	cefotaxime sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203118	cefoxitin sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203134	piperacillin sodium	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
203141	cefotetan disodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203171	cefazolin sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203172	ceftriaxone sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
227214	cefoperazone sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
190376	linezolid	Protein Synthesis Inhibitors	Oxazolidinone Antibacterial|L [Preparations]	Decreased Protein Synthesis
215948	cephalexin monohydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
221054	alatrofloxacin mesylate	Topoisomerase Inhibitors	A [Preparations]	Decreased Protein Synthesis
221071	ceftazidime sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
221177	trovafloxacin mesylate	DNA Gyrase Inhibitors	T [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
228476	gatifloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	G [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
228750	moxifloxacin hydrochloride	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	M [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
229369	dalfopristin	Protein Synthesis Inhibitors	D [Preparations]	Decreased Protein Synthesis
229367	quinupristin	Protein Synthesis Inhibitors	Q [Preparations]	Decreased Protein Synthesis
235552	ceftazidime pentahydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
235762	lomefloxacin hydrochloride	DNA Gyrase Inhibitors	L [Preparations]	Decreased DNA Replication|Decreased DNA Integrity|Increased Protein Breakdown
236058	cefepime hydrochloride	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
1294563	cephapirin benzathine	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
139462	moxifloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	M [Preparations]|Fluoroquinolone Antibacterial	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
141440	alatrofloxacin	Topoisomerase Inhibitors	A [Preparations]	Decreased Protein Synthesis
2176	cefaclor	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2178	cefamandole	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2180	cefazolin	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
2184	cefoperazone	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2186	cefotaxime	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
2187	cefotetan	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
115552	trovafloxacin	DNA Gyrase Inhibitors	T [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
2189	cefoxitin	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
2191	ceftazidime	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2192	ceftizoxime	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
2193	ceftriaxone	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
2231	cephalexin	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2236	cephalothin	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2238	cephapirin	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2239	cephradine	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
82048	mezlocillin sodium	Transpeptidase Inhibitors	M [Preparations]	Decreased Cell Wall Synthesis & Repair
82126	ceftizoxime sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
83682	cefditoren	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
72611	cefditoren pivoxil	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
47835	cefpodoxime proxetil	Enzyme Inhibitors|Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
18469	sparfloxacin	DNA Gyrase Inhibitors	S [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
18631	azithromycin	Protein Synthesis Inhibitors	Macrolide Antimicrobial|A [Preparations]	Decreased Protein Synthesis
18687	bacampicillin	Antibody-Receptor Interactions|Transpeptidase Inhibitors	B [Preparations]	Decreased Cell Wall Synthesis & Repair
1986366	bacitracin A	Enzyme Interactions|Cell Membrane Fusion Complex Interactions	B [Preparations]	Decreased Cell Wall Synthesis & Repair
19552	cefprozil	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
20473	cefamandole nafate	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
20481	cefepime	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
20489	cefpodoxime	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
20492	ceftibuten	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
23437	dirithromycin	Protein Synthesis Inhibitors	D [Preparations]	Decreased Protein Synthesis
25033	cefixime	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
25037	cefdinir	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
28872	lomefloxacin	DNA Gyrase Inhibitors	L [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Increased Protein Breakdown
1291	bacitracin	Enzyme Interactions|Cell Membrane Fusion Complex Interactions	B [Preparations]	Decreased Cell Wall Synthesis & Repair
42562	cephapirin sodium	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
10864	troleandomycin	Protein Synthesis Inhibitors	T [Preparations]	Decreased Protein Synthesis|Decreased Glucocorticoid Clearance
9860	cephalothin sodium	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
11417	bacitracin zinc	Enzyme Interactions|Cell Membrane Fusion Complex Interactions	B [Preparations]	Decreased Cell Wall Synthesis & Repair
10109	streptomycin	Protein Synthesis Inhibitors	Antimycobacterial|Aminoglycoside Antibacterial|S [Preparations]	Decreased Protein Synthesis
10110	streptomycin sulfate	Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
7455	nitrofurazone	Enzyme Inhibitors	N [Preparations]	
8339	piperacillin	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
1999763	gatifloxacin hemihydrate	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	G [Preparations]	Decreased DNA Replication|Decreased DNA Integrity|Decreased Protein Synthesis|Decreased Transcription to RNA
2184135	imipenem monohydrate	Transpeptidase Inhibitors	I [Preparations]	Decreased Cell Wall Synthesis & Repair
6927	mezlocillin	Transpeptidase Inhibitors	M [Preparations]	Decreased Cell Wall Synthesis & Repair
1926505	moxifloxacin hydrochloride monohydrate	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	M [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
1927662	delafloxacin meglumine		D [Preparations]	
1541465	dalbavancin hydrochloride	Protein Synthesis Inhibitors	D [Preparations]	Decreased Cell Wall Synthesis & Repair
1546025	gatifloxacin anhydrous	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	Quinolone Antimicrobial|G [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
1597609	ceftolozane	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1549827	oritavancin diphosphate	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Protein Synthesis Inhibitors|Transpeptidase Inhibitors|Cytochrome P450 2D6 Inducers	O [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Membrane Integrity|Increased Cellular Death
1597608	ceftolozane sulfate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
22396	deflazacort	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|D [Preparations]	Decreased Immunologic Activity
2641674	delandistrogene moxeparvovec-rokl	Gene Editing or Modification|Gene Alterations	D [Preparations]	Unknown Physiological Effect
2641675	delandistrogene moxeparvovec	Gene Editing or Modification|Gene Alterations	D [Preparations]	Unknown Physiological Effect
2267207	golodirsen		G [Preparations]|Antisense Oligonucleotide	Increased Protein Synthesis
6664	mazindol	Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	M [Preparations]	Bronchodilation|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
2389840	viltolarsen	Gene Alterations|Gene Transcription Modulation	V [Preparations]	Unknown Physiological Effect
2480096	casimersen	Gene Alterations	C [Preparations]|Antisense Oligonucleotide	Increased Protein Synthesis
1810569	eteplirsen	Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors	E [Preparations]|Antisense Oligonucleotide	Decreased RNA Integrity
1737557	turoctocog alfa	Enzyme Activators	T [Preparations]	Increased Coagulation Factor Concentration
1300488	nonacog alfa	Enzyme Activators	Human Blood Coagulation Factor|N [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor Activity|Increased Coagulation Factor Concentration
1426164	factor VII, human		Human Blood Coagulation Factor|F [Preparations]	Increased Coagulation Activity
1300486	antihemophilic factor, human recombinant	Enzyme Activators	Human Antihemophilic Factor|A [Preparations]	Increased Coagulation Factor VIII Concentration|Increased Coagulation Activity|Increased Coagulation Factor Concentration
4254	factor VII		F [Preparations]	Increased Coagulation Activity
4257	factor VIII	Enzyme Activators	F [Preparations]	Increased Coagulation Factor Concentration
826070	factor VIII, human	Enzyme Activators	F [Preparations]	Increased Coagulation Factor Concentration
1300485	antihemophilic factor, human recombinant residues 743-1636 deleted	Enzyme Activators	A [Preparations]	Increased Coagulation Factor Concentration
314504	anti-inhibitor coagulant complex	Enzyme Activators	Anti-inhibitor Coagulant Complex|A [Preparations]	Reversed Anticoagulation Activity|Increased Coagulation Activity|Increased Coagulation Factor Concentration
253151	recombinant antihemophilic factor VIII	Enzyme Activators	R [Preparations]	Increased Coagulation Factor Concentration
203083	antihemophilic factor, human	Enzyme Activators	Human Antihemophilic Factor|A [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor VIII Concentration|Increased Coagulation Factor Concentration
221060	antihemophilic factor, porcine	Enzyme Activators	A [Preparations]	Increased Coagulation Factor Concentration
2641609	valoctocogene roxaparvovec-rvox	Gene Transduction or Replacement	V [Preparations]	Increased Coagulation Factor VIII Activity|Increased Coagulation Factor VIII Concentration
2631083	antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl	Fusion Protein Interactions	A [Preparations]	
2275722	antihemophilic factor (recombinant) pegylated-exei	Enzyme Activators	A [Preparations]	Increased Coagulation Factor Concentration
2631084	antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein	Fusion Protein Interactions	A [Preparations]	
2055654	antihemophilic factor (recombinant), PEGylated-aucl		A [Preparations]	Increased Coagulation Factor VIII Concentration|Increased Coagulation Factor VIII Activity
2055655	damoctocog alfa pegol		D [Preparations]	Increased Coagulation Factor VIII Activity|Increased Coagulation Factor VIII Concentration
2641610	valoctocogene roxaparvovec	Gene Transduction or Replacement	V [Preparations]	Increased Coagulation Factor VIII Concentration|Increased Coagulation Factor VIII Activity
1989794	emicizumab		E [Preparations]	Increased Coagulation Factor VIII Activity
1741397	antihemophilic factor (recombinant) pegylated	Enzyme Activators	A [Preparations]	Increased Coagulation Factor Concentration
1989795	emicizumab-kxwh		E [Preparations]	Increased Coagulation Factor VIII Activity
1796377	lonoctocog alfa	Enzyme Activators	L [Preparations]	Increased Coagulation Factor Concentration
1729084	simoctocog alfa	Enzyme Activators	S [Preparations]	Increased Coagulation Factor Concentration
1592899	antihemophilic factor, porcine B-domain truncated recombinant	Enzyme Activators	A [Preparations]	Increased Coagulation Factor Concentration
8628	praziquantel	Calcium Channel Interactions	Anthelmintic|P [Preparations]	Increased Cell Membrane Integrity
60212	atovaquone	Nucleic Acid Synthesis Inhibitors	Antimalarial|Antiprotozoal|A [Preparations]	Decreased Metabolic Rate
853491	canakinumab	Interleukin 1 Receptor Antagonists	C [Preparations]	Decreased Immunologic Activity
2683	colchicine	Cytochrome P450 3A4 Inhibitors|P-Glycoprotein Interactions|Unknown Cellular or Molecular Interaction|Tubulin Interactions	C [Preparations]|Alkaloid	Cellular Growth Phase Arrest|Decreased Phagocytosis
11065	ursodiol	Unknown Cellular or Molecular Interaction	Bile Acid|U [Preparations]	Decreased Cholesterol Absorption
1592736	nintedanib esylate	Receptor Tyrosine Kinase Inhibitors	N [Preparations]	Decreased Endothelial Proliferation
1592737	nintedanib	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	N [Preparations]|Kinase Inhibitor	Decreased Endothelial Proliferation
204144	cefuroxime sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2194	cefuroxime	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
20493	cefuroxime axetil	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
4328	fenfluramine	Serotonin Uptake Inhibitors|Serotonin Receptor Interactions	F [Preparations]	Appetite Suppression|Increased Serotonin Activity
82018	fenfluramine hydrochloride	Serotonin Uptake Inhibitors|Serotonin Receptor Interactions	F [Preparations]	Appetite Suppression|Increased Serotonin Activity
596	alprazolam	GABA A Modulators|GABA A Agonists	Benzodiazepine|A [Preparations]	Increased Central Nervous System GABA Activity
37935	tetrahydrozoline	Adrenergic alpha-Agonists	T [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
57983	tetrahydrozoline hydrochloride	Adrenergic alpha-Agonists	T [Preparations]	Conjunctival Arterial Vasoconstriction|Decreased Nasal and Sinus Secretions
4601	furazolidone	Monoamine Oxidase Inhibitors	F [Preparations]	DNA Replication Alteration
82092	quinacrine monohydrochloride	Enzyme Inhibitors|Sclerosing Activity	Q [Preparations]	Decreased Cell Membrane Integrity|Decreased DNA Integrity
10612	tinidazole	Unknown Cellular or Molecular Interaction	Nitroimidazole Antimicrobial|T [Preparations]	DNA Integrity Alteration|Decreased Protein Synthesis|Increased Cellular Death
31819	nitazoxanide	Uncouplers	Antiprotozoal|N [Preparations]	Decreased Metabolic Rate
9061	quinacrine	Enzyme Inhibitors|Sclerosing Activity	Q [Preparations]	Decreased Cell Membrane Integrity|Decreased DNA Integrity
7909	paraldehyde	Unknown Cellular or Molecular Interaction	P [Preparations]	Neurotransmitter & Neuromuscular Transmitter Activity Alteration
1426853	magnesium cation	Magnesium Ion Exchange Activity|Osmotic Activity	Osmotic Laxative|Calculi Dissolution Agent|M [Preparations]	Increased Large Intestinal Motility|Inhibition Small Intestine Fluid/Electrolyte Absorption|Inhibition Large Intestine Fluid/Electrolyte Absorption|Stimulation Large Intestine Fluid/Electrolyte Secretion
236279	devil's claw preparation	Unknown Cellular or Molecular Interaction	D [Preparations]	Unknown Physiological Effect
236665	black cohosh extract	Estrogen Receptor Agonists	B [Preparations]	Female Reproductive System Activity Alteration|Decreased Luteinizing Hormone Secretion
221077	cisapride monohydrate	Serotonin Agonists	C [Preparations]	Increased Esophageal Motility|Increased Enteric Nervous System Acetylcholine Activity|Increased LES Tone
114203	feverfew extract	Unknown Cellular or Molecular Interaction	F [Preparations]	Unknown Physiological Effect
19478	bismuth subsalicylate	Cyclooxygenase Inhibitors|Acid-Base Activity	Bismuth|B [Preparations]	Inhibition Gastric Acid Secretion
29155	magnesium carbonate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	M [Preparations]	Cellular Activity Alteration|Gastric Acid Alteration
29170	magnesium trisilicate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	M [Preparations]	Antacid|Cellular Activity Alteration|Small Intestine Fluid/Electrolyte Absorption Alteration
35255	cisapride	Serotonin Agonists	C [Preparations]	Increased Esophageal Motility|Increased Enteric Nervous System Acetylcholine Activity|Increased LES Tone
1311141	octopamine	Adrenergic alpha-Agonists	O [Preparations]	Vasoconstriction
6582	magnesium oxide	Electrolyte Activity|Acid-Base Activity|Osmotic Activity|Enzyme Interactions	M [Preparations]	Antacid|Cellular Activity Alteration
1744461	octopamine hydrochloride	Adrenergic alpha-Agonists	O [Preparations]	Vasoconstriction
5470	hydralazine	Unknown Cellular or Molecular Interaction	H [Preparations]|Arteriolar Vasodilator	Decreased Blood Pressure|Arteriolar Vasodilation|Arterial Vasodilation|Decreased Vascular Smooth Muscle Tone
236883	nebivolol hydrochloride	Adrenergic beta-Antagonists	N [Preparations]	Decreased Blood Pressure
203151	fenoldopam mesylate	Dopamine Agonists	F [Preparations]	Decreased Blood Pressure|Increased Collecting Duct Water Permeability|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
227240	phentolamine mesylate	Adrenergic alpha-Antagonists	P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Positive Chronotropy|Positive Inotropy
3327	diazoxide	Potassium Channel Openers|Carbonic Anhydrase Inhibitors	D [Preparations]	Vasodilation|Decreased Blood Pressure|Decreased Insulin Secretion
202693	labetalol hydrochloride	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic beta1-Antagonists|Adrenergic alpha1-Antagonists	L [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Inotropy|Negative Chronotropy
71512	phenoxybenzamine hydrochloride	Adrenergic alpha-Antagonists	P [Preparations]	Decreased Blood Pressure|Decreased Bladder Sphincter Tone|Decreased Urethra Smooth Muscle Tone
82027	hydralazine hydrochloride	Unknown Cellular or Molecular Interaction	H [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation|Arterial Vasodilation|Decreased Vascular Smooth Muscle Tone
91240	mecamylamine hydrochloride	Cholinergic Ganglionic Nicotinic Antagonists|Cholinergic Nicotinic Antagonists	M [Preparations]	Decreased Blood Pressure|Decreased Autonomic Ganglionic Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Autonomic Nervous System Acetylcholine Activity
38680	trimethaphan camsylate	Noncompetitive Cholinergic Nicotinic Antagonists	T [Preparations]	Vasodilation|Decreased Blood Pressure|Decreased Parasympathetic Activity|Decreased Sympathetic Activity
24853	fenoldopam	Dopamine Agonists	Dopaminergic Agonist|F [Preparations]	Decreased Blood Pressure|Increased Collecting Duct Water Permeability|Increased Renal Na+ Excretion|Renal Arterial Vasodilation
1651695	minoxidil sulfate	Potassium Channel Interactions	M [Preparations]	Decreased Blood Pressure|Cutaneous Arterial Vasodilation
31555	nebivolol	Adrenergic beta-Antagonists	beta-Adrenergic Blocker|N [Preparations]	Decreased Blood Pressure
9895	sodium nitroprusside	Unknown Cellular or Molecular Interaction	S [Preparations]	Decreased Blood Pressure|Systemic Arterial Vasodilation|Systemic Venous Vasodilation
8149	phenoxybenzamine	Adrenergic alpha-Antagonists	alpha-Adrenergic Blocker|P [Preparations]	Decreased Blood Pressure|Decreased Bladder Sphincter Tone|Decreased Urethra Smooth Muscle Tone
8153	phentolamine	Adrenergic alpha-Antagonists	alpha-Adrenergic Blocker|P [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Positive Chronotropy|Positive Inotropy
6673	mecamylamine	Cholinergic Ganglionic Nicotinic Antagonists|Cholinergic Nicotinic Antagonists	Autonomic Ganglionic Blocker|M [Preparations]	Decreased Blood Pressure|Decreased Autonomic Ganglionic Activity|Decreased Central Nervous System Acetylcholine Activity|Decreased Autonomic Nervous System Acetylcholine Activity
6984	minoxidil	Potassium Channel Interactions	Arteriolar Vasodilator|M [Preparations]	Decreased Blood Pressure|Arteriolar Vasodilation|Cutaneous Arterial Vasodilation
1926479	minoxidil sulfate ester	Potassium Channel Interactions	M [Preparations]	Decreased Blood Pressure|Cutaneous Arterial Vasodilation
6185	labetalol	Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Adrenergic alpha1-Antagonists|Adrenergic beta1-Antagonists	beta-Adrenergic Blocker|L [Preparations]	Decreased Blood Pressure|Arterial Vasodilation|Negative Chronotropy|Negative Inotropy
54251	oxybutynin chloride	Cholinergic Muscarinic Antagonists	O [Preparations]	Decreased Smooth Muscle Acetylcholine Activity
1292	baclofen	GABA B Agonists|GABA A Agonists	gamma-Aminobutyric Acid-ergic Agonist|B [Preparations]	Central Nervous System Depression|Decreased Organized Electrical Activity|Decreased Striated Muscle Contraction|Increased Spinal Cord GABA Activity
32675	oxybutynin	Cholinergic Muscarinic Antagonists	Cholinergic Muscarinic Antagonist|O [Preparations]	Decreased Smooth Muscle Acetylcholine Activity
1303097	aclidinium bromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	A [Preparations]	Bronchodilation
1303098	aclidinium	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|A [Preparations]	Bronchodilation
1091836	roflumilast	Phosphodiesterase 4 Inhibitors	Phosphodiesterase 4 Inhibitor|R [Preparations]	Decreased Tracheo-Bronchial Secretions
2102775	revefenacin	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|R [Preparations]	Bronchodilation
3105	dantrolene	Calcium Channel Antagonists	Skeletal Muscle Relaxant|D [Preparations]	Striated Muscle Metabolic Alteration|Decreased Striated Muscle Tone|Decreased Striated Muscle Contraction
3106	dantrolene sodium	Calcium Channel Antagonists	D [Preparations]	Striated Muscle Metabolic Alteration|Decreased Striated Muscle Tone|Decreased Striated Muscle Contraction
1442981	ibrutinib	Protein Kinase Inhibitors	I [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1546028	mercaptopurine anhydrous	Nucleic Acid Synthesis Inhibitors	Nucleoside Metabolic Inhibitor|M [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity|Increased Cellular Death
117055	alemtuzumab	CD52-directed Antibody Interactions|Antibody-Receptor Interactions	A [Preparations]|CD52-directed Cytolytic Antibody	Increased Lymphocyte Cell Destruction
44157	cladribine	Nucleic Acid Synthesis Inhibitors	Purine Antimetabolite|C [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
24698	fludarabine	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	Nucleoside Metabolic Inhibitor|F [Preparations]	Decreased DNA Integrity
25102	fludarabine phosphate	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	F [Preparations]	Decreased DNA Integrity
34132	pegaspargase	Enzymatic Activity	Asparagine-specific Enzyme|P [Preparations]	Decreased Protein Synthesis
103	mercaptopurine	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	M [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity|Increased Cellular Death
2058509	duvelisib	Kinase Inhibitors	D [Preparations]	Cellular Growth Phase Reduction|Decreased Cytokine Activity|Decreased Cellular Migration
1309396	vardenafil hydrochloride trihydrate	Phosphodiesterase 5 Inhibitors	V [Preparations]	Penile Venous Vasodilation
358263	tadalafil	Phosphodiesterase 5 Inhibitors	Phosphodiesterase 5 Inhibitor|T [Preparations]	Penile Venous Vasodilation|Pulmonary Venous Vasodilation
306674	vardenafil	Phosphodiesterase 5 Inhibitors	Phosphodiesterase 5 Inhibitor|V [Preparations]	Penile Venous Vasodilation
307306	vardenafil hydrochloride	Phosphodiesterase 5 Inhibitors	V [Preparations]	Penile Venous Vasodilation
221161	sildenafil citrate	Phosphodiesterase 5 Inhibitors	S [Preparations]	Penile Venous Vasodilation|Pulmonary Venous Vasodilation
136411	sildenafil	Phosphodiesterase 5 Inhibitors	Phosphodiesterase 5 Inhibitor|S [Preparations]	Penile Venous Vasodilation|Pulmonary Venous Vasodilation
8013	pentoxifylline	Unknown Cellular or Molecular Interaction	Blood Viscosity Reducer|P [Preparations]	Decreased Blood Viscosity|Hematologic Activity Alteration
4491	fluorometholone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
221101	fluorometholone acetate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	F [Preparations]	Decreased Glucocorticoid Secretion|Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
22862	dibromopropamidine isethionate		D [Preparations]	
22865	dibrompropamidine		D [Preparations]	
34633	propamidine		P [Preparations]	
34634	propamidine isethionate		P [Preparations]	
7268	natamycin	Ergosterol Synthesis Inhibitors	Polyene Antimicrobial|N [Preparations]	Decreased Cell Membrane Integrity
1483793	atorvastatin calcium propylene glycol solvate	Hydroxymethylglutaryl-CoA Reductase Inhibitors	A [Preparations]	Decreased Cholesterol Synthesis
1297766	atorvastatin calcium trihydrate	Hydroxymethylglutaryl-CoA Reductase Inhibitors	A [Preparations]	Decreased Cholesterol Synthesis
2569977	atorvastatin calcium anhydrous	Hydroxymethylglutaryl-CoA Reductase Inhibitors	A [Preparations]	Decreased Cholesterol Synthesis
861640	pitavastatin calcium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	P [Preparations]	
4301	omega-3 fatty acids	Oxidation Activity|Unknown Cellular or Molecular Interaction	Omega-3 Fatty Acid|O [Preparations]	Cell Membrane Alteration|Cellular Communication Alteration|Decreased Lipogenesis|Increased Lipolysis
4719	gemfibrozil	Peroxisome Proliferator-activated Receptor alpha Agonists	Peroxisome Proliferator Receptor alpha Agonist|G [Preparations]	Increased Lipolysis
317251	nicotinamide hydriodide	Enzyme Activators|Enzyme Interactions	N [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis|Decreased Lipogenesis|Increased Glycogenolysis|Increased Metabolic Rate|Metabolic Rate Alteration|Lipid Metabolism Alteration
323828	rosuvastatin calcium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	R [Preparations]	Decreased Cholesterol Synthesis
861634	pitavastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|P [Preparations]	
301542	rosuvastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|R [Preparations]	Decreased Cholesterol Synthesis
236738	nicotinic acid propyl ester	Enzyme Interactions	N [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis
236834	zinc nicotinate	Enzyme Interactions	Z [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis
203144	pravastatin sodium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	P [Preparations]	Decreased Cholesterol Synthesis
221072	cerivastatin sodium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	C [Preparations]	Decreased Cholesterol Synthesis
221100	fenofibrate micronized	Peroxisome Proliferator-activated Receptor alpha Agonists	F [Preparations]	Increased Lipolysis
596723	cerivastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	C [Preparations]	Decreased Cholesterol Synthesis
104485	colestipol hydrochloride	Binding Activity|Bile-acid Binding Activity	C [Preparations]	Decreased Cholesterol Absorption
2447	cholestyramine resin	Bile-acid Binding Activity	Bile Acid Sequestrant|C [Preparations]	Decreased Cholesterol Absorption
2594	clofibrate	Peroxisome Proliferator-activated Receptor alpha Agonists	C [Preparations]	Decreased Lipolysis
2685	colestipol	Binding Activity|Bile-acid Binding Activity	Bile Acid Sequestrant|C [Preparations]	Decreased Cholesterol Absorption
83367	atorvastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|A [Preparations]	Decreased Cholesterol Synthesis
83366	atorvastatin calcium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	A [Preparations]	Decreased Cholesterol Synthesis
72875	fluvastatin sodium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	F [Preparations]	Decreased Cholesterol Synthesis
36567	simvastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|S [Preparations]	
41127	fluvastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|F [Preparations]	Decreased Cholesterol Synthesis
24852	fenofibric acid	Peroxisome Proliferator-activated Receptor alpha Agonists	Peroxisome Proliferator Receptor alpha Agonist|F [Preparations]	Increased Lipolysis
42463	pravastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|P [Preparations]	Decreased Cholesterol Synthesis
31767	nicotinic acid benzyl ester	Enzyme Interactions	N [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis
8703	fenofibrate	Peroxisome Proliferator-activated Receptor alpha Agonists	Peroxisome Proliferator Receptor alpha Agonist|F [Preparations]	Increased Lipolysis
7393	niacin	Enzyme Interactions	Nicotinic Acid|N [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis
7405	niacinamide	Enzyme Activators|Enzyme Interactions	N [Preparations]	Glucose Metabolism Alteration|Cellular Activity Alteration|Decreased Cholesterol Synthesis|Decreased Lipogenesis|Increased Glycogenolysis|Increased Metabolic Rate|Lipid Metabolism Alteration
6472	lovastatin	Hydroxymethylglutaryl-CoA Reductase Inhibitors	HMG-CoA Reductase Inhibitor|L [Preparations]	Decreased Cholesterol Synthesis
2001252	pitavastatin magnesium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	P [Preparations]	
1944734	pitavastatin sodium	Hydroxymethylglutaryl-CoA Reductase Inhibitors	P [Preparations]	
9384	rifampin	Nucleic Acid Synthesis Inhibitors	Rifamycin Antibacterial|R [Preparations]	Decreased RNA Replication|Decreased Transcription to RNA
9478	roxithromycin	Protein Synthesis Inhibitors	R [Preparations]	Decreased Protein Synthesis
819911	besifloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	Quinolone Antimicrobial|B [Preparations]	Decreased DNA Replication|Decreased DNA Integrity|Decreased Transcription to RNA
7517	norfloxacin	Topoisomerase 4 Inhibitors|Topoisomerase 2 Inhibitors	N [Preparations]	Decreased DNA Integrity|Decreased DNA Replication|Decreased Protein Synthesis|Decreased Transcription to RNA
236461	propylhexedrine hydrochloride		P [Preparations]	
8792	propylhexedrine		P [Preparations]	
2049549	plazomicin	Protein Synthesis Inhibitors	P [Preparations]	Decreased Protein Synthesis
1545975	cefadroxil anhydrous	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
1546029	meropenem anhydrous	Transpeptidase Inhibitors	Penem Antibacterial|M [Preparations]	Decreased Cell Wall Synthesis & Repair
1297878	cefadroxil hemihydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
407888	cefadroxil hydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
4550	fosfomycin	Enzyme Inhibitors	F [Preparations]	Decreased Cell Wall Synthesis & Repair
295217	temafloxacin hydrochloride	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	T [Preparations]	Decreased DNA Replication|Decreased Transcription to RNA
485026	nafcillin sodium monohydrate	Enzyme Activators|Transpeptidase Inhibitors	N [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
1299048	hetacillin potassium	Transpeptidase Inhibitors	H [Preparations]	Decreased Cell Wall Synthesis & Repair
259281	trimethoprim hydrochloride	Folic Acid Metabolism Inhibitors	T [Preparations]	Increased Cellular Death
258332	carbenicillin disodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
262299	pefloxacin mesylate	DNA Gyrase Inhibitors|Topoisomerase Inhibitors	P [Preparations]	Decreased DNA Replication|Decreased Transcription to RNA
3925	enoxacin	DNA Gyrase Inhibitors	E [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
267257	dicloxacillin sodium	Transpeptidase Inhibitors	D [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
203115	ampicillin trihydrate	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
203133	penicillin G potassium	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
203195	penicillin V potassium	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
204175	cefadroxil monohydrate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2968	cyclacillin	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
220087	sulfadiazine sodium	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
221058	ampicillin (anhydrous)	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
221129	nitrofurantoin, monohydrate	Enzyme Inhibitors|Cellular Structure Molecule Interactions	N [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Protein Synthesis
221176	trimethoprim sulfate	Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	T [Preparations]	Increased Cellular Death
3356	dicloxacillin	Transpeptidase Inhibitors	Penicillin-class Antibacterial|D [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
235559	nitrofurantoin, macrocrystals	Enzyme Inhibitors|Cellular Structure Molecule Interactions	N [Preparations]|Nitrofuran Antibacterial	Decreased Cell Wall Synthesis & Repair|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Protein Synthesis
235855	trimethoprim lactate	Folic Acid Metabolism Inhibitors	T [Preparations]	Increased Cellular Death
142135	fosfomycin tromethamine	Enzyme Inhibitors	F [Preparations]	Decreased Cell Wall Synthesis & Repair
1870193	gentamicin sulfate	Protein Synthesis Inhibitors	G [Preparations]	Decreased Cell Membrane Integrity|Decreased Protein Synthesis
142447	ticarcillin disodium	Transpeptidase Inhibitors	T [Preparations]	Decreased Cell Wall Synthesis & Repair
2177	cefadroxil	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
119771	doripenem	Enzyme Inhibitors	D [Preparations]	Decreased Cell Wall Synthesis & Repair
2540	cilastatin	Dipeptidase Inhibitors	Renal Dehydropeptidase Inhibitor|C [Preparations]	Metabolic Activity Alteration
2550	cinoxacin	DNA Gyrase Inhibitors	C [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
2625	cloxacillin	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
2708	colistimethate	Acid-Base Activity	Polymyxin-class Antibacterial|C [Preparations]	Cellular Structure Alteration
81953	ampicillin sodium	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Synthesis & Repair
82128	cilastatin sodium	Dipeptidase Inhibitors	C [Preparations]	Metabolic Activity Alteration
78902	sulfacytine	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Decreased Folic Acid Modification
2015	carbenicillin	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
37771	temafloxacin	DNA Gyrase Inhibitors|Topoisomerase 4 Inhibitors	T [Preparations]	Decreased DNA Replication|Decreased Transcription to RNA
48305	colistimethate sodium	Acid-Base Activity	C [Preparations]	Cellular Structure Alteration
1043213	cloxacillin benzathine	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
56461	carbenicillin indanyl sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
40595	acetyl sulfisoxazole	Para-Aminobenzoic Acid Inhibitors	A [Preparations]	Cellular Synthetic Activity Alteration|Cellular Growth Phase Arrest|Decreased Folic Acid Modification
10591	ticarcillin	Transpeptidase Inhibitors	Penicillin-class Antibacterial|T [Preparations]	Decreased Cell Wall Synthesis & Repair
10627	tobramycin	Protein Synthesis Inhibitors	Aminoglycoside Antibacterial|T [Preparations]	Cell Membrane Alteration|Decreased Protein Synthesis
1272	aztreonam	Antibody-Receptor Interactions	Monobactam Antibacterial|A [Preparations]	Decreased Cell Wall Synthesis & Repair
29561	meropenem	Transpeptidase Inhibitors	M [Preparations]	Decreased Cell Wall Synthesis & Repair
42553	pivampicillin hydrochloride	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
42580	carbenicillin phenyl sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
10829	trimethoprim	Organic Cation Transporter 2 Inhibitors|Cytochrome P450 2C8 Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	Dihydrofolate Reductase Inhibitor Antibacterial|T [Preparations]	Increased Cellular Death
31901	nitroxoline		N [Preparations]	
9864	cloxacillin sodium	Transpeptidase Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
9893	nafcillin sodium	Enzyme Activators|Transpeptidase Inhibitors	N [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
9898	oxacillin sodium	Enzyme Activators|Transpeptidase Inhibitors	O [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
9900	penicillin G sodium	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
16728	acetohydroxamic acid	Urease Inhibitors	Urease Inhibitor|A [Preparations]	
7773	oxacillin	Enzyme Activators|Transpeptidase Inhibitors	Penicillin-class Antibacterial|O [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
7233	nafcillin	Enzyme Activators|Transpeptidase Inhibitors	Penicillin-class Antibacterial|N [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
7240	nalidixic acid	Topoisomerase Inhibitors	N [Preparations]	Decreased Protein Synthesis
7276	tobramycin sulfate	Protein Synthesis Inhibitors	T [Preparations]	Cell Membrane Alteration|Decreased Protein Synthesis
10171	sulfadiazine	Para-Aminobenzoic Acid Inhibitors	Sulfonamide Antibacterial|S [Preparations]	Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
10179	sulfamethizole	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Decreased Folic Acid Modification
10180	sulfamethoxazole	Cytochrome P450 2C9 Inhibitors|Para-Aminobenzoic Acid Inhibitors	Sulfonamide Antimicrobial|S [Preparations]	Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
10208	sulfisoxazole diolamine	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Cellular Synthetic Activity Alteration|Cellular Growth Phase Arrest|Decreased Folic Acid Modification
10207	sulfisoxazole	Para-Aminobenzoic Acid Inhibitors	Sulfonamide Antimicrobial|S [Preparations]	Cellular Growth Phase Arrest|Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
7960	pefloxacin	DNA Gyrase Inhibitors|Topoisomerase Inhibitors	P [Preparations]	Decreased DNA Replication|Decreased Transcription to RNA
7980	penicillin G	Transpeptidase Inhibitors	Penicillin-class Antibacterial|P [Preparations]	Decreased Cell Wall Synthesis & Repair
7983	penicillin G procaine	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
7454	nitrofurantoin	Enzyme Inhibitors|Cellular Structure Molecule Interactions	N [Preparations]|Nitrofuran Antibacterial	Decreased Cell Wall Synthesis & Repair|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Protein Synthesis
8372	pivampicillin	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair
2198975	methylene blue anhydrous	Alkylating Activity|Binding Activity	M [Preparations]	Cellular Activity Alteration|Increased Metabolic Rate|Oxygen Carrying Capacity Alteration
2052872	plazomicin sulfate	Protein Synthesis Inhibitors	P [Preparations]	Decreased Protein Synthesis
2265863	cefiderocol sulfate tosylate	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2184136	relebactam monohydrate	beta Lactamase Inhibitors	R [Preparations]	
2265702	cefiderocol	Enzyme Inhibitors	Cephalosporin Antibacterial|C [Preparations]	Decreased Cell Wall Synthesis & Repair
6878	methylene blue	Alkylating Activity|Binding Activity	M [Preparations]	Cellular Activity Alteration|Increased Metabolic Rate|Oxygen Carrying Capacity Alteration
2268500	relebactam anhydrous	beta Lactamase Inhibitors	beta Lactamase Inhibitor|R [Preparations]	
2184137	relebactam	beta Lactamase Inhibitors	R [Preparations]	
1546414	methylene blue cation	Alkylating Activity|Binding Activity|Oxidation-Reduction Activity	M [Preparations]|Oxidation-Reduction Agent	Cellular Activity Alteration|Increased Metabolic Rate|Oxygen Carrying Capacity Alteration
1596450	gentamicin	Protein Synthesis Inhibitors	Aminoglycoside Antibacterial|G [Preparations]	Decreased Cell Membrane Integrity|Decreased Protein Synthesis
626	amdinocillin	Transpeptidase Inhibitors	A [Preparations]	Decreased Cell Wall Integrity|Decreased Cell Wall Synthesis & Repair
641	amikacin	Protein Synthesis Inhibitors	Aminoglycoside Antibacterial|A [Preparations]	Decreased Protein Synthesis
643	amikacin sulfate	Protein Synthesis Inhibitors	A [Preparations]	Decreased Protein Synthesis
733	ampicillin	Transpeptidase Inhibitors	Penicillin-class Antibacterial|A [Preparations]	Decreased Cell Wall Synthesis & Repair
2119366	esketamine hydrochloride	Noncompetitive NMDA Receptor Antagonists	E [Preparations]	Central Nervous System Depression|Decreased Central Nervous System Organized Electrical Activity
2119365	esketamine	Noncompetitive NMDA Receptor Antagonists	E [Preparations]	Central Nervous System Depression|Decreased Central Nervous System Organized Electrical Activity
2059268	omadacycline tosylate	Protein Synthesis Inhibitors	O [Preparations]	Decreased Protein Synthesis
2059269	omadacycline	Protein Synthesis Inhibitors	Tetracycline-class Antibacterial|O [Preparations]	Decreased Protein Synthesis
267073	methicillin sodium	Transpeptidase Inhibitors	M [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
20486	ceforanide	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
2198943	lefamulin acetate	Protein Synthesis Inhibitors	L [Preparations]	Decreased Protein Synthesis
2198944	lefamulin	Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A Inhibitors|Protein Synthesis Inhibitors	Pleuromutilin Antibacterial|L [Preparations]	Decreased Protein Synthesis
3098	dacarbazine	Alkylating Activity	Alkylating Drug|D [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis|Decreased RNA Integrity
10114	streptozocin	Alkylating Activity|Nucleic Acid Synthesis Inhibitors	Alkylating Drug|S [Preparations]	Decreased DNA Integrity|Decreased Protein Modification|Decreased RNA Integrity
7994	pentamidine	Unknown Cellular or Molecular Interaction	Antiprotozoal|P [Preparations]	DNA Integrity Alteration|Decreased DNA Replication|Decreased RNA Replication|Decreased Protein Synthesis|RNA Integrity Alteration|Lipid Metabolism Alteration
7995	pentamidine isethionate	Unknown Cellular or Molecular Interaction	P [Preparations]	DNA Integrity Alteration|Decreased DNA Replication|Decreased Protein Synthesis|Decreased RNA Replication|RNA Integrity Alteration|Lipid Metabolism Alteration
1927409	treprostinil diolamine	Prostaglandin Receptor Agonists	T [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation|Systemic Arterial Vasodilation|Decreased Platelet Aggregation
1468845	bosentan anhydrous	Cytochrome P450 2C9 Inducers|Cytochrome P450 3A Inducers|Endothelin Receptor Antagonists	Endothelin Receptor Antagonist|B [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation
1442132	macitentan	Endothelin Receptor Antagonists	Endothelin Receptor Antagonist|M [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation
1439816	riociguat	Guanylate Cyclase Stimulators	Soluble Guanylate Cyclase Stimulator|R [Preparations]	Vasodilation
1729002	selexipag	Prostacyclin Receptor Agonists|Prostaglandin Receptor Agonists	S [Preparations]|Prostacyclin Receptor Agonist	Decreased Blood Pressure|Pulmonary Arterial Vasodilation
4917	nitroglycerin	Guanylate Cyclase Activators|Nitric Oxide Donors	Nitrate Vasodilator|N [Preparations]	Vasodilation|Decreased Blood Pressure|Arterial Vasodilation|Decreased Vascular Smooth Muscle Tone|Increased Nitric Oxide Activity|Venous Vasodilation
498193	bosentan monohydrate	Endothelin Receptor Antagonists	B [Preparations]	
358274	ambrisentan	Endothelin Receptor Antagonists	Endothelin Receptor Antagonist|A [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation
342691	treprostinil sodium	Prostaglandin Receptor Agonists	T [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation|Systemic Arterial Vasodilation|Decreased Platelet Aggregation
343048	treprostinil	Prostaglandin Receptor Agonists	Prostacycline Vasodilator|T [Preparations]	Vasodilation|Decreased Blood Pressure|Systemic Arterial Vasodilation|Pulmonary Arterial Vasodilation|Decreased Platelet Aggregation
104463	epoprostenol sodium	Prostaglandin Receptor Agonists	E [Preparations]	Vasodilation|Decreased Blood Pressure|Arterial Vasodilation|Venous Vasodilation|Decreased Platelet Aggregation
75207	bosentan	Endothelin Receptor Antagonists	B [Preparations]	Decreased Blood Pressure|Pulmonary Arterial Vasodilation
40138	iloprost	Prostacyclin Receptor Agonists	Prostacycline|I [Preparations]	Pulmonary Arterial Vasodilation|Systemic Arterial Vasodilation
8814	epoprostenol	Prostaglandin Receptor Agonists	Prostacycline Vasodilator|E [Preparations]	Vasodilation|Decreased Blood Pressure|Arterial Vasodilation|Venous Vasodilation|Decreased Platelet Aggregation
10869	tropicamide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|T [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity
1426899	quinine salicylate	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
388472	quinine dihydrochloride	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
236327	quinine ascorbate	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
9071	quinine	Nucleic Acid Synthesis Inhibitors	Antimalarial|Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
9074	quinine hydrochloride	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
9075	quinine sulfate	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
9073	quinine bisulfate	Nucleic Acid Synthesis Inhibitors	Q [Preparations]	Carbohydrate Metabolism Alteration|Decreased DNA Replication|Decreased Metabolic Rate|Decreased Striated Muscle Organized Electrical Activity
544488	botulism immune globulin IV human	Bacterial Neurotoxin Neutralization	Human Immunoglobulin G|B [Preparations]	Passively Acquired Immunity
1722699	botulinum neurotoxin C immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722702	botulinum neurotoxin E immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722698	botulinum neurotoxin C immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722701	botulinum neurotoxin D immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722703	botulinum neurotoxin E immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722707	botulinum neurotoxin G immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722683	botulinum neurotoxin B immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722684	botulinum neurotoxin B immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722696	botulinum neurotoxin A immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722705	botulinum neurotoxin F immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722704	botulinum neurotoxin F immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722697	botulinum neurotoxin A immune FAB2	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722700	botulinum neurotoxin D immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1722706	botulinum neurotoxin G immune FAB2, equine	Bacterial Neurotoxin Neutralization	B [Preparations]	Passively Acquired Immunity
1312397	regorafenib	Cytochrome P450 2C9 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors	R [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration|Vascular Growth Decrease
1371319	regorafenib monohydrate	Kinase Inhibitors	R [Preparations]	Cellular Proliferation Alteration|Vascular Growth Decrease
2619313	tremelimumab	CTLA-4-directed Antibody Interactions	T [Preparations]	Cellular Proliferation Alteration
2619312	tremelimumab-actl	CTLA-4-directed Antibody Interactions	T [Preparations]	Cellular Proliferation Alteration
2167673	botulinum toxin type B	Acetylcholine Release Inhibitors	B [Preparations]	Decreased Muscular System Acetylcholine Activity
3100	dactinomycin	Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors	Actinomycin|D [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis|Decreased RNA Integrity
3478	dinoprostone	Prostaglandin Receptor Agonists	Prostaglandin Analog|D [Preparations]	Increased Cervical Dilation|Increased GI Smooth Muscle Tone|Increased Uterine Smooth Muscle Contraction or Tone
1298965	aminophylline dihydrate	Phosphodiesterase Inhibitors	A [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy|Renal/Urological Activity Alteration
388049	aminophylline hydrate	Phosphodiesterase Inhibitors	A [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy|Renal/Urological Activity Alteration
337623	dornase alfa	Enzymatic Activity	Recombinant Human Deoxyribonuclease 1|D [Preparations]	DNA Integrity Alteration|Decreased Respiratory Secretion Viscosity
3714	dyphylline	Adenosine Receptor Antagonists|Phosphodiesterase Inhibitors	D [Preparations]	Vasodilation|Bronchodilation
237163	acetylcysteine sodium	Free Radical Scavenging Activity	A [Preparations]	Decreased Respiratory Secretion Viscosity
1490795	acetylcysteine zinc	Free Radical Scavenging Activity	A [Preparations]	Decreased Respiratory Secretion Viscosity
155075	theophylline sodium glycinate	Phosphodiesterase Inhibitors	T [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy
235862	bambuterol hydrochloride	Adrenergic beta2-Agonists	B [Preparations]	Bronchodilation
91178	theophylline anhydrous	Phosphodiesterase Inhibitors	Methylxanthine|T [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy
18751	bambuterol	Adrenergic beta2-Agonists	B [Preparations]	Bronchodilation
10438	theophylline	Phosphodiesterase Inhibitors	T [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy
20976	oxtriphylline	Phosphodiesterase Inhibitors	O [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy|Renal/Urological Activity Alteration
27723	iodinated glycerol	Unknown Cellular or Molecular Interaction	I [Preparations]	Decreased Respiratory Secretion Viscosity|Increased Tracheo-Bronchial Secretions
1809634	acetylcysteine magnesium	Free Radical Scavenging Activity	A [Preparations]	Decreased Respiratory Secretion Viscosity
197	acetylcysteine	Reduction Activity|Free Radical Scavenging Activity	Mucolytic|Antidote|Antidote for Acetaminophen Overdose|A [Preparations]	Increased Glutathione Concentration|Decreased Respiratory Secretion Viscosity
1591923	acetylcysteine amide	Free Radical Scavenging Activity	A [Preparations]	Decreased Respiratory Secretion Viscosity
689	aminophylline	Phosphodiesterase Inhibitors	A [Preparations]	Bronchodilation|Inhibition Gastric Acid Secretion|Positive Chronotropy|Renal/Urological Activity Alteration
1876119	etelcalcetide	Increased Calcium-sensing Receptor Sensitivity	Calcium-sensing Receptor Agonist|E [Preparations]	Decreased PTH Secretion
407990	cinacalcet	Increased Calcium-sensing Receptor Sensitivity	Calcium-sensing Receptor Agonist|C [Preparations]	Decreased PTH Secretion
384379	cinacalcet hydrochloride	Increased Calcium-sensing Receptor Sensitivity	C [Preparations]	Decreased PTH Secretion
1876122	etelcalcetide hydrochloride	Increased Calcium-sensing Receptor Sensitivity	E [Preparations]	Decreased PTH Secretion
N0000180291	Herpes Simplex Virus Pyrophosphate Analog DNA Polymerase Inhibitor			
N0000180187	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor			
2108659	vidarabine anhydrous	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	V [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
11194	vidarabine	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	V [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
194337	vorinostat	Histone Deacetylase Inhibitors	Histone Deacetylase Inhibitor|V [Preparations]	Increased Cellular Death
233272	bexarotene	Receptor Interactions|Unknown Cellular or Molecular Interaction	Retinoid|B [Preparations]	Cellular Growth Phase Arrest|Decreased Transcription to RNA
828529	albumin human, USP	Osmotic Activity|Structural Macromolecules	Human Serum Albumin|A [Preparations]	Increased Intravascular Volume|Increased Oncotic Pressure
7486	nitrous oxide	Nitric Oxide Donors	N [Preparations]	Vasodilation
2054166	albumin human-kjda	Osmotic Activity|Structural Macromolecules	A [Preparations]	Increased Intravascular Volume|Increased Oncotic Pressure
1147320	brentuximab vedotin	CD30-directed Antibody Interactions|Tumor Necrosis Factor Receptor Interactions	CD30-directed Immunoconjugate|B [Preparations]	Microtubule Inhibition
1621	bleomycin sulfate	Nucleic Acid Synthesis Inhibitors	B [Preparations]	Decreased DNA Integrity
1622	bleomycin	Nucleic Acid Synthesis Inhibitors	Cytoprotective Agent|B [Preparations]	Decreased DNA Integrity
69634	sargramostim	Biological Response Modifiers	Leukocyte Growth Factor|S [Preparations]	Increased Cytokine Production|Increased Myeloid Cell Production
11202	vincristine	Tubulin Interactions	Vinca Alkaloid|V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
11203	vincristine sulfate	Tubulin Interactions	V [Preparations]	Cellular Growth Phase Arrest|Decreased Mitosis|Increased Cellular Death
140480	icodextrin	Osmotic Activity	I [Preparations]	Unknown Physiological Effect
1872448	telotristat etiprate	Tryptophan Hydroxylase Inhibitors	T [Preparations]	Decreased Serotonin Production
1872441	telotristat ethyl	Tryptophan Hydroxylase Inhibitors	T [Preparations]	Decreased Serotonin Production
1872382	telotristat	Tryptophan Hydroxylase Inhibitors	T [Preparations]|Tryptophan Hydroxylase Inhibitor	Decreased Serotonin Production
203193	netilmicin sulfate	Protein Synthesis Inhibitors|Unknown Cellular or Molecular Interaction	N [Preparations]	Decreased Protein Synthesis
236084	sulfathiazole sodium	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Cellular Synthetic Activity Alteration
133054	chlorhexidine diacetate	Physiochemical Activity	C [Preparations]	Decreased Cell Wall Integrity
2358	chlorhexidine	Physiochemical Activity	C [Preparations]	Decreased Cell Wall Integrity
2359	chlorhexidine acetate	Physiochemical Activity	C [Preparations]	Decreased Cell Wall Integrity
2361	chlorhexidine hydrochloride	Physiochemical Activity	C [Preparations]	Decreased Cell Wall Integrity
20791	chlorhexidine gluconate	Physiochemical Activity	C [Preparations]	Decreased Cell Wall Integrity
42322	fleroxacin	DNA Gyrase Inhibitors|Topoisomerase Inhibitors	F [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
10193	sulfathiazole	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Cellular Synthetic Activity Alteration
7337	netilmicin	Protein Synthesis Inhibitors	N [Preparations]	Decreased Protein Synthesis
9789	silver nitrate	Protein Synthesis Inhibitors	S [Preparations]	Cellular Growth Phase Arrest
319818	Astragalus preparation	Unknown Cellular or Molecular Interaction	A [Preparations]	Vasodilation|Immunologically Active Molecule Activity Alteration|Respiratory/Pulmonary Activity Alteration
235838	terbinafine hydrochloride	Ergosterol Synthesis Inhibitors	T [Preparations]	Decreased Cell Wall Integrity
37801	terbinafine	Ergosterol Synthesis Inhibitors	Allylamine Antifungal|T [Preparations]	Decreased Cell Wall Integrity
968804	cytarabine liposome	Nucleoside Synthesis Inhibitors|DNA Polymerase Inhibitors	C [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity|Increased Cellular Death
203129	mitoxantrone hydrochloride	Topoisomerase Inhibitors	M [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
3041	cytarabine	Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors|DNA Polymerase Inhibitors	Nucleoside Metabolic Inhibitor|C [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity|Increased Cellular Death
153329	irinotecan hydrochloride	Topoisomerase Inhibitors	I [Preparations]	Cellular Proliferation Alteration|Decreased DNA Integrity|Increased Cellular Death
51499	irinotecan	Topoisomerase Inhibitors	Topoisomerase Inhibitor|I [Preparations]	Cellular Proliferation Alteration|Decreased DNA Integrity|Increased Cellular Death
1156	asparaginase	Enzyme Interactions	Asparagine-specific Enzyme|A [Preparations]	Decreased Protein Synthesis
2561249	asparaginase Erwinia chrysanthemi (recombinant)-rywn	Enzyme Interactions	A [Preparations]	Decreased Protein Synthesis
7005	mitoxantrone	Topoisomerase Inhibitors	Topoisomerase Inhibitor|M [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
142443	procyclidine hydrochloride	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	P [Preparations]	Pupillary Dilation|Decreased GI Smooth Muscle Tone|Decreased Parasympathetic Acetylcholine Activity|Salivation Inhibition
8718	procyclidine	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	P [Preparations]	Pupillary Dilation|Decreased GI Smooth Muscle Tone|Decreased Parasympathetic Acetylcholine Activity|Salivation Inhibition
2610349	betibeglogene autotemcel	Beta-globin Gene Transfer	B [Preparations]	Hemoglobin Function Restoration
5514	hydroxocobalamin	Enzyme Interactions	Antidote|H [Preparations]	Cellular Activity Alteration
236302	hydroxocobalamin acetate	Enzyme Interactions	H [Preparations]	Cellular Activity Alteration
11248	vitamin B12	Enzyme Interactions	Vitamin B12|V [Preparations]	Cellular Activity Alteration
29421	mecobalamin	Enzyme Interactions	M [Preparations]	Cellular Activity Alteration
1947247	hydroxocobalamin hydrochloride	Enzyme Interactions	H [Preparations]	Cellular Activity Alteration
1544460	idelalisib	Cytochrome P450 3A Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitors	I [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration|Increased Cellular Death
1114693	bendamustine hydrochloride	Alkylating Activity	B [Preparations]	
263010	tositumomab	CD20-directed Antibody Interactions|Antibody-Receptor Interactions	T [Preparations]	Increased B Lymphocyte Destruction
234449	iodine-131-tositumomab	CD20-directed Antibody Interactions|Antibody-Receptor Interactions	I [Preparations]	Increased B Lymphocyte Destruction
134547	bendamustine	Alkylating Activity	Alkylating Drug|B [Preparations]	
262323	ibritumomab tiuxetan	Radiopharmaceutical Activity|CD20-directed Antibody Interactions	CD20-directed Radiotherapeutic Antibody|I [Preparations]	Increased B Lymphocyte Destruction|Increased Immunologically Active Molecule Degradation
4451	flucytosine	Protein Synthesis Inhibitors	Nucleoside Analog Antifungal|F [Preparations]	RNA Integrity Alteration
282363	caspofungin acetate	Glucan Synthase Inhibitors	C [Preparations]	Decreased Cell Wall Integrity
140108	caspofungin	Glucan Synthase Inhibitors	Echinocandin Antifungal|C [Preparations]	Decreased Cell Wall Integrity
121243	voriconazole	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|14-alpha Demethylase Inhibitors	Azole Antifungal|V [Preparations]	Decreased Cell Membrane Integrity|Decreased Cell Membrane Synthesis & Repair
2001759	amphotericin B lipid complex		A [Preparations]	Sterol Metabolism Alteration|Increased Cellular Death
1314319	bosutinib monohydrate	Tyrosine Kinase Inhibitors	B [Preparations]	Cellular Proliferation Alteration
5650	idarubicin	Topoisomerase 2 Inhibitors|Topoisomerase Inhibitors	Anthracycline Topoisomerase Inhibitor|I [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
1546005	thioguanine anhydrous	Nucleic Acid Synthesis Inhibitors	Antimetabolite|T [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
1307619	bosutinib	Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors|Bcr-Abl Tyrosine Kinase Inhibitors	B [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
82124	idarubicin hydrochloride	Topoisomerase 2 Inhibitors|Topoisomerase Inhibitors	I [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
10485	thioguanine	Nucleic Acid Synthesis Inhibitors	T [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
6995	plicamycin	Nucleic Acid Synthesis Inhibitors|Bone Surface Interactions	P [Preparations]	Bone Resorption Inhibition|Decreased DNA Integrity|Decreased RNA Integrity
1435636	citric acid, 1-stearyl ester	Alkylating Activity	C [Preparations]	Increased Renal HCO3- Excretion
236344	saw palmetto extract	5-alpha Reductase Inhibitors	S [Preparations]	Decreased Dihydrotestosterone Secretion
221079	citric acid monohydrate	Alkylating Activity	C [Preparations]	Increased Renal HCO3- Excretion
221163	sodium citrate dihydrate	Alkylating Activity|Acid-Base Activity|Electrolyte Activity	S [Preparations]	Increased Intravascular Volume|Increased Renal HCO3- Excretion|Unknown Physiological Effect
221946	citric acid, anhydrous	Alkylating Activity|Acidifying Activity|Magnesium Ion Exchange Activity|Calcium Chelating Activity|Irrigation	Anti-coagulant|Calculi Dissolution Agent|C [Preparations]	Decreased Coagulation Factor Activity|Increased Renal HCO3- Excretion
21183	citric acid	Alkylating Activity	C [Preparations]	Increased Renal HCO3- Excretion
2049608	disodium citrate sesquihydrate	Alkylating Activity	D [Preparations]	Increased Renal HCO3- Excretion
3131	deferoxamine	Iron Chelating Activity	Iron Chelator|D [Preparations]	Unknown Physiological Effect
3132	deferoxamine mesylate	Iron Chelating Activity	D [Preparations]	Unknown Physiological Effect
2540965	loncastuximab tesirine-lpyl	Alkylating Activity|CD19-directed Antibody Interactions	L [Preparations]	
2637395	epcoritamab-bysp	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	E [Preparations]	
2639781	glofitamab-gxbm	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	G [Preparations]	Increased T Lymphocyte Activation|Increased B Lymphocyte Destruction|Increased T Lymphocyte Production
2639782	glofitamab	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	G [Preparations]	Increased T Lymphocyte Activation|Increased B Lymphocyte Destruction|Increased T Lymphocyte Production
2637392	epcoritamab	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	E [Preparations]	
2540964	loncastuximab tesirine	Alkylating Activity|CD19-directed Antibody Interactions	L [Preparations]	
2387211	tafasitamab	CD19-directed Antibody Interactions	T [Preparations]	Unknown Physiological Effect
2174091	polatuzumab vedotin-piiq	Antibody-Surface Protein Interactions	P [Preparations]	Cellular Proliferation Alteration|Increased Cellular Death
2387334	tafasitamab-cxix	CD19-directed Antibody Interactions	T [Preparations]	Unknown Physiological Effect
2174090	polatuzumab vedotin	Antibody-Surface Protein Interactions	P [Preparations]	Cellular Proliferation Alteration|Increased Cellular Death
7806	oxygen	Free Radical Scavenging Activity	O [Preparations]	Increased Metabolic Rate
237057	lepirudin	Thrombin Inhibitors	L [Preparations]	Decreased Coagulation Factor Activity|Decreased Platelet Aggregation
253202	tirofiban hydrochloride	Platelet Glycoprotein IIb/IIIA Inhibitors	T [Preparations]	Decreased Platelet Aggregation
83929	abciximab	P-Glycoprotein Inhibitors	A [Preparations]	Decreased Platelet Aggregation
73137	tirofiban	Platelet Glycoprotein IIb/IIIA Inhibitors	Platelet Aggregation Inhibitor|T [Preparations]	Decreased Platelet Aggregation
75635	eptifibatide	Platelet Glycoprotein IIb/IIIA Inhibitors	Platelet Aggregation Inhibitor|E [Preparations]	Decreased Platelet Aggregation
60819	bivalirudin	Antithrombins|Thrombin Inhibitors	Anti-coagulant|Direct Thrombin Inhibitor|B [Preparations]	Decreased Coagulation Factor Activity
2380556	bivalirudin trifluoroacetate	Antithrombins|Thrombin Inhibitors	B [Preparations]	Decreased Coagulation Factor Activity
1487512	umeclidinium bromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	U [Preparations]	Bronchodilation
1487514	umeclidinium	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|U [Preparations]	Bronchodilation
1114325	indacaterol maleate	Adrenergic beta2-Agonists	I [Preparations]	Bronchodilation
1546059	olodaterol	Adrenergic beta2-Agonists	beta2-Adrenergic Agonist|O [Preparations]	Bronchodilation
1114326	indacaterol	Adrenergic beta2-Agonists	I [Preparations]	Bronchodilation
1298831	tiotropium bromide monohydrate	Cholinergic Muscarinic Antagonists	T [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
668284	arformoterol tartrate	Adrenergic beta2-Agonists	A [Preparations]	Bronchodilation
393575	tiotropium bromide	Cholinergic Muscarinic Antagonists	T [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
304962	arformoterol	Adrenergic beta2-Agonists	beta2-Adrenergic Agonist|A [Preparations]	Bronchodilation
69120	tiotropium	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|T [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
7688	metaproterenol	Adrenergic beta2-Agonists	M [Preparations]	Bronchodilation
6804	metaproterenol sulfate	Adrenergic beta2-Agonists	M [Preparations]	Bronchodilation
2462023	tiotropium bromide, anhydrous	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	T [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
1546396	olodaterol hydrochloride	Adrenergic beta2-Agonists	O [Preparations]	Bronchodilation
1552007	tiotropium bromide mono	Cholinergic Muscarinic Antagonists	T [Preparations]	Bronchodilation|Decreased Parasympathetic Acetylcholine Activity
236460	tizanidine hydrochloride	Adrenergic alpha2-Agonists	T [Preparations]	Decreased Central Nervous System Organized Electrical Activity|Decreased Striated Muscle Contraction
202723	orphenadrine hydrochloride	Unknown Cellular or Molecular Interaction	O [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
2101	carisoprodol	Unknown Cellular or Molecular Interaction	Muscle Relaxant|C [Preparations]	Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity|Decreased Striated Muscle Contraction
2399	chlorphenesin	Unknown Cellular or Molecular Interaction	C [Preparations]	Striated Muscle Metabolic Alteration|Decreased Central Nervous System Organized Electrical Activity
2410	chlorzoxazone	Unknown Cellular or Molecular Interaction	Muscle Relaxant|C [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
59078	metaxalone	Unknown Cellular or Molecular Interaction	Muscle Relaxant|M [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
52101	cyclobenzaprine hydrochloride	Unknown Cellular or Molecular Interaction	C [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
20880	chlorphenesin carbamate	Unknown Cellular or Molecular Interaction	C [Preparations]	Striated Muscle Metabolic Alteration|Decreased Central Nervous System Organized Electrical Activity
57258	tizanidine	Adrenergic alpha2-Agonists	Central alpha-2 Adrenergic Agonist|T [Preparations]	Decreased Central Nervous System Organized Electrical Activity|Decreased Striated Muscle Contraction
21949	cyclobenzaprine	Unknown Cellular or Molecular Interaction	Muscle Relaxant|C [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
7715	orphenadrine	Unknown Cellular or Molecular Interaction	Muscle Relaxant|O [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
7716	orphenadrine citrate	Unknown Cellular or Molecular Interaction	O [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
6845	methocarbamol	Unknown Cellular or Molecular Interaction	Muscle Relaxant|M [Preparations]	Striated Muscle Metabolic Alteration|Centrally-mediated Muscle Relaxation|Decreased Striated Muscle Tone|Decreased Central Nervous System Organized Electrical Activity
1311371	stannous fluoride dihydrate	Unknown Cellular or Molecular Interaction	S [Preparations]	Bone Alteration
10030	stannous fluoride	Unknown Cellular or Molecular Interaction	S [Preparations]	Bone Alteration
N0000175426	Antiarrhythmic			
236767	fendiline hydrochloride	Calcium Channel Antagonists	F [Preparations]	Coronary Arterial Vasodilation
4327	fendiline	Calcium Channel Antagonists	F [Preparations]	Coronary Arterial Vasodilation
4648	gallopamil	L-Calcium Channel Receptor Antagonists	G [Preparations]	Decreased Blood Pressure|Negative Chronotropy
439837	gallopamil hydrochloride	L-Calcium Channel Receptor Antagonists	G [Preparations]	Decreased Blood Pressure|Negative Chronotropy
142145	tocainide monohydrochloride	Sodium Channel Interactions	T [Preparations]	Cardiac Rhythm Alteration|Organized Electrical Activity Alteration
281189	encainide hydrochloride	Sodium Channel Interactions	E [Preparations]	Cardiac Rhythm Alteration
203178	disopyramide phosphate	Sodium Channel Interactions|Unknown Cellular or Molecular Interaction	D [Preparations]	Cell Membrane Alteration|Cardiac Rhythm Alteration|Negative Inotropy
233698	dronedarone	Unknown Cellular or Molecular Interaction	Antiarrhythmic|D [Preparations]	
3541	disopyramide	Sodium Channel Interactions|Unknown Cellular or Molecular Interaction	Antiarrhythmic|D [Preparations]	Cell Membrane Alteration|Cardiac Rhythm Alteration|Negative Inotropy
142138	mexiletine hydrochloride	Sodium Channel Interactions	M [Preparations]	Cardiac Rhythm Alteration
49247	dofetilide	Potassium Channel Interactions	Antiarrhythmic|D [Preparations]	
51256	ibutilide fumarate	Unknown Cellular or Molecular Interaction	I [Preparations]	Lengthen Conduction System Depolarization Time|Delay Conduction System Repolarization
41289	ibutilide	Unknown Cellular or Molecular Interaction	Antiarrhythmic|I [Preparations]	Delay Conduction System Repolarization|Lengthen Conduction System Depolarization Time
1923401	digitalin	Sodium-Potassium Exchanging ATPase Interactions	D [Preparations]	Conduction System Depolarization|Negative Chronotropy|Positive Inotropy
41875	quinidine polygalacturonate	Cytochrome P450 2D6 Inhibitors|Sodium Channel Interactions|Potassium Channel Interactions|Calcium Channel Interactions	Q [Preparations]	Cardiac Rhythm Alteration
42359	tocainide	Sodium Channel Interactions	T [Preparations]	Cardiac Rhythm Alteration|Organized Electrical Activity Alteration
42368	encainide	Sodium Channel Interactions	E [Preparations]	Cardiac Rhythm Alteration
35220	quinidine gluconate	Cytochrome P450 2D6 Inhibitors|Calcium Channel Interactions|Potassium Channel Interactions|Sodium Channel Interactions	Q [Preparations]	Cardiac Rhythm Alteration
8620	practolol	Adrenergic beta1-Antagonists	P [Preparations]	Decreased Blood Pressure|Negative Chronotropy
9068	quinidine	Cytochrome P450 2D6 Inhibitors|Calcium Channel Interactions|Sodium Channel Interactions|Potassium Channel Interactions	Cytochrome P450 2D6 Inhibitor|Antiarrhythmic|Q [Preparations]	Cardiac Rhythm Alteration
9069	quinidine sulfate	Cytochrome P450 2D6 Inhibitors|Calcium Channel Interactions|Potassium Channel Interactions|Sodium Channel Interactions	Q [Preparations]	Cardiac Rhythm Alteration
6926	mexiletine	Sodium Channel Interactions	Antiarrhythmic|M [Preparations]	Cardiac Rhythm Alteration
5084	halcinonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|H [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
4462	fluocinonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
4500	flurandrenolide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|F [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Glucocorticoid Secretion|Decreased Immunologically Active Molecule Activity
3254	desonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|D [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
3255	desoximetasone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|D [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
108088	alclometasone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|A [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
2590	clobetasol	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|C [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
91311	diflorasone	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|D [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
45318	halobetasol propionate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	H [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
21245	clobetasol propionate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	C [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
21249	clocortolone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|C [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
21250	clocortolone pivalate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	C [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
41208	halobetasol	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|H [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
23033	diflorasone diacetate	Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	D [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
34369	prednicarbate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|P [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
17268	alclometasone dipropionate	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	A [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
17652	amcinonide	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	Corticosteroid|A [Preparations]	Vasoconstriction|Antipruritic Activity|Decreased Immunologically Active Molecule Activity|Decreased Protein Synthesis
2369389	ripretinib	P-Glycoprotein Inhibitors|Cytochrome P450 2C8 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Tyrosine Kinase Inhibitors|Platelet-derived Growth Factor alpha Receptor Inhibitors|Stem Cell Factor (KIT) Receptor Inhibitors	R [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
2272107	avapritinib	P-Glycoprotein Inhibitors|Cytochrome P450 2C9 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Tyrosine Kinase Inhibitors|Platelet-derived Growth Factor alpha Receptor Inhibitors|Bile Salt Export Pump Inhibitors|Multidrug and Toxin Extrusion Transporter 2 K Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	A [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
729596	methoxy polyethylene glycol-epoetin beta	Receptor Interactions	Erythropoiesis-stimulating Agent|M [Preparations]	Increased Erythroid Cell Production
283838	darbepoetin alfa		Erythropoiesis-stimulating Agent|D [Preparations]	Increased Erythroid Cell Production|Increased Erythropoetin Secretion
4162	ethylestrenol		E [Preparations]	
105694	epoetin alfa		Erythropoiesis-stimulating Agent|E [Preparations]	Increased Erythroid Cell Production
77754	ferumoxsil		F [Preparations]	Increased Erythroid Cell Production
31494	nandrolone decanoate	Androgen Receptor Agonists	N [Preparations]	Bone Formation Stimulation|Increased Erythroid Cell Production|Increased Erythropoetin Secretion|Increased Protein Synthesis
31495	nandrolone phenpropionate	Androgen Receptor Agonists	N [Preparations]	Bone Formation Stimulation|Increased Erythropoetin Secretion|Increased Erythroid Cell Production|Increased Protein Synthesis
7813	oxymetholone	Androgen Receptor Agonists	O [Preparations]	Bone Formation Stimulation|Increased Erythropoetin Secretion|Increased Erythroid Cell Production|Increased Protein Synthesis|Stimulate Penile Development
7244	nandrolone	Androgen Receptor Agonists	Androgen|N [Preparations]	Bone Formation Stimulation|Increased Erythropoetin Secretion|Increased Erythroid Cell Production|Increased Protein Synthesis
2262543	luspatercept-aamt	Fusion Protein Interactions	L [Preparations]	Increased Erythroid Cell Production
2628210	daprodustat	Hypoxia-inducible Factor Inhibitors	D [Preparations]	Increased Transcription to RNA
2262544	luspatercept	Fusion Protein Interactions	L [Preparations]|Erythroid Maturation Agent	Increased Erythroid Cell Production
2047589	epoetin alfa-epbx		E [Preparations]	Increased Erythroid Cell Production
1798288	obeticholic acid	Farnesoid X Receptor Agonists	O [Preparations]|Farnesoid X Receptor Agonist	
55377	quinidine bisulfate	Calcium Channel Interactions|Potassium Channel Interactions|Sodium Channel Interactions	Q [Preparations]	Cardiac Rhythm Alteration
1603834	avibactam	beta Lactamase Inhibitors	beta Lactamase Inhibitor|A [Preparations]	
267417	cefsulodin sodium	Enzyme Inhibitors	C [Preparations]	
2190	cefsulodin	Enzyme Inhibitors	C [Preparations]	
1603833	avibactam sodium	beta Lactamase Inhibitors	A [Preparations]	
629565	alglucosidase alfa		Hydrolytic Lysosomal Glycogen-specific Enzyme|A [Preparations]	Increased Glycogenolysis
2565814	avalglucosidase alfa	Enzymatic Activity	Hydrolytic Lysosomal Glycogen-specific Enzyme|A [Preparations]	
2565813	avalglucosidase alfa-ngpt	Enzymatic Activity	A [Preparations]	
281876	fosfestrol tetrasodium	Estrogen Receptor Agonists	F [Preparations]	Bone Formation Stimulation|Vaginal Function Alteration
3390	diethylstilbestrol	Estrogen Receptor Agonists	D [Preparations]	Bone Formation Stimulation|Vaginal Function Alteration
25284	fosfestrol	Estrogen Receptor Agonists	F [Preparations]	Bone Formation Stimulation|Vaginal Function Alteration
31805	nilutamide	Androgen Receptor Antagonists	Androgen Receptor Inhibitor|N [Preparations]	Testicular Endocrine Activity Alteration
2640868	spectinomycin sulfate	Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
1306069	spectinomycin sulfate tetrahydrate	Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
267342	spectinomycin hydrochloride	Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
8698	probenecid	Organic Anion Transporter Interactions	P [Preparations]	Decreased Renal Organic Ion Excretion|Uricosuric Activity
270	spectinomycin	Protein Synthesis Inhibitors	S [Preparations]	Decreased Protein Synthesis
1306123	adenosine phosphate disodium	Adenosine Receptor Agonists|Structural Macromolecules	A [Preparations]	Nodal Repolarization
296	adenosine	Adenosine Receptor Agonists|Structural Macromolecules	Adenosine Receptor Agonist|A [Preparations]	Nodal Repolarization
309	adenosine monophosphate	Adenosine Receptor Agonists|Structural Macromolecules	A [Preparations]	Metabolic Activity Alteration|Nodal Repolarization
318	adenosine triphosphate	Adenosine Receptor Agonists|Structural Macromolecules	A [Preparations]	Nodal Repolarization
1649479	ivabradine hydrochloride	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists	I [Preparations]	Negative Chronotropy
314845	somatropin (recombinant DNA origin)	Growth Hormone Receptor Agonists|Pituitary Hormone Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Increased Erythroid Cell Production|Increased Lipolysis|Increased Protein Synthesis
259321	somatropin, E-coli derived	Growth Hormone Receptor Agonists|Pituitary Hormone Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Increased Erythroid Cell Production|Increased Lipolysis|Increased Protein Synthesis
155120	milrinone lactate	Phosphodiesterase 3 Inhibitors	M [Preparations]	Vasodilation|Increased Blood Pressure|Positive Inotropy
1649480	ivabradine	Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists	I [Preparations]|Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker	Negative Chronotropy
91236	inamrinone lactate	Phosphodiesterase Inhibitors	I [Preparations]	Vasodilation|Positive Chronotropy|Pulmonary Arterial Vasodilation|Positive Inotropy|Systemic Arterial Vasodilation|Pulmonary Venous Vasodilation|Systemic Venous Vasodilation
61148	somatropin	Growth Hormone Receptor Agonists|Pituitary Hormone Receptor Agonists	Recombinant Human Growth Hormone|S [Preparations]	Bone Formation Stimulation|Increased Erythroid Cell Production|Increased Lipolysis|Increased Protein Synthesis
1426599	dimethyl isosorbide	Nitric Oxide Donors	D [Preparations]	Arterial Vasodilation|Increased Nitric Oxide Activity|Venous Vasodilation
52769	milrinone	Phosphodiesterase 3 Inhibitors	Phosphodiesterase 3 Inhibitor|M [Preparations]	Vasodilation|Increased Blood Pressure|Positive Inotropy
56570	somatrem	Growth Hormone Receptor Agonists|Pituitary Hormone Receptor Agonists	S [Preparations]	Bone Formation Stimulation|Increased Erythroid Cell Production|Increased Protein Synthesis
25089	flosequinan		F [Preparations]	Vasodilation
28004	isosorbide mononitrate	Guanylate Cyclase Activators|Nitric Oxide Donors	Nitrate Vasodilator|I [Preparations]	Vasodilation|Decreased Blood Pressure|Arterial Vasodilation|Decreased Vascular Smooth Muscle Tone|Increased Nitric Oxide Activity|Venous Vasodilation
6057	isosorbide	Nitric Oxide Donors	I [Preparations]	Arterial Vasodilation|Increased Nitric Oxide Activity|Venous Vasodilation
6058	isosorbide dinitrate	Guanylate Cyclase Activators|Nitric Oxide Donors	Nitrate Vasodilator|I [Preparations]	Vasodilation|Decreased Blood Pressure|Arterial Vasodilation|Decreased Vascular Smooth Muscle Tone|Increased Nitric Oxide Activity|Venous Vasodilation
738	inamrinone	Phosphodiesterase Inhibitors	I [Preparations]	Vasodilation|Positive Inotropy|Positive Chronotropy|Systemic Arterial Vasodilation|Pulmonary Arterial Vasodilation|Pulmonary Venous Vasodilation|Systemic Venous Vasodilation
284157	ibopamine hydrochloride	Dopamine Agonists	I [Preparations]	Vasodilation|Increased Dopamine Activity
51253	ibopamine	Dopamine Agonists	I [Preparations]	Vasodilation|Increased Dopamine Activity
1101886	hydroxyprogesterone acetate	Progestational Hormone Receptor Agonists	H [Preparations]	Decreased Uterine Smooth Muscle Contraction or Tone|Gonadotropin Releasing Hormone Alteration|Inhibit Ovarian Follicular Phase|Stimulate Breast Glandular Development|Stimulate Uterine Secretory Phase|Inhibit Ovulation
12488	hydroxyprogesterone caproate (USP)	Progestational Hormone Receptor Agonists	H [Preparations]	Gonadotropin Releasing Hormone Alteration|Decreased Uterine Smooth Muscle Contraction or Tone|Inhibit Ovarian Follicular Phase|Stimulate Breast Glandular Development|Stimulate Uterine Secretory Phase|Inhibit Ovulation
5542	17-alpha-hydroxyprogesterone	Progestational Hormone Receptor Agonists	Progestin|A [Preparations]	Decreased Uterine Smooth Muscle Contraction or Tone|Gonadotropin Releasing Hormone Alteration|Inhibit Ovarian Follicular Phase|Stimulate Uterine Secretory Phase|Stimulate Breast Glandular Development|Inhibit Ovulation
1442190	beta-D-glucopyranose	Structural Macromolecules	B [Preparations]	Increased Glycogenesis|Increased Metabolic Rate|Organic Ion Synthesis Alteration
4850	glucose	Structural Macromolecules	G [Preparations]	Increased Glycogenesis|Increased Metabolic Rate|Organic Ion Synthesis Alteration
1299920	dextrose monohydrate	Structural Macromolecules	D [Preparations]	Increased Glycogenesis|Increased Metabolic Rate|Organic Ion Synthesis Alteration
1297771	dextrose hydrous	Structural Macromolecules	D [Preparations]	Increased Glycogenesis|Increased Metabolic Rate|Organic Ion Synthesis Alteration
349730	anhydrous dextrose	Structural Macromolecules	A [Preparations]	Increased Glycogenesis|Increased Metabolic Rate|Organic Ion Synthesis Alteration
1307734	carboxymethylcellulose calcium	Demulcent Activity	C [Preparations]	
66955	vancomycin hydrochloride	Enzyme Inhibitors	V [Preparations]	Decreased Cell Wall Synthesis & Repair
11124	vancomycin	Enzyme Inhibitors	V [Preparations]|Glycopeptide Antibacterial	Decreased Cell Wall Synthesis & Repair
8825	protamine sulfate (USP)	Heparin Binding Activity|Acid-Base Activity	P [Preparations]	Reversed Anticoagulation Activity
1546415	iodide ion I-131	Radiopharmaceutical Activity	Radioactive Therapeutic Agent|I [Preparations]	Increased Cellular Death
4952	thyrotropin alfa	Unknown Cellular or Molecular Interaction	Thyroid Stimulating Hormone|T [Preparations]	Increased Thyroid Hormone Iodination|Increased Thyroid Stimulating Hormone Secretion
1098413	vandetanib	P-Glycoprotein Inhibitors|Organic Cation Transporter 2 Inhibitors|Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	V [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration|Vascular Growth Decrease
2370147	selpercatinib	P-Glycoprotein Inhibitors|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Kinase Inhibitors|Rearranged during Transfection (RET) Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	S [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
4494	fluoxymesterone	Androgen Receptor Agonists	Androgen|F [Preparations]	Bone Formation Stimulation|Increased Protein Synthesis|Stimulate Penile Development
2475166	voclosporin	P-Glycoprotein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Calcineurin Inhibitors	Calcineurin Inhibitor Immunosuppressant|V [Preparations]	
4832	glucagon	Glucagon Receptor Interactions	G [Preparations]|Antihypoglycemic Agent|Gastrointestinal Motility Inhibitor	Decreased GI Smooth Muscle Tone|Decreased GI Motility|Decreased Glycolysis|Increased Glycogenolysis|Increased Gluconeogenesis|Positive Inotropy|Positive Chronotropy
3628	dopamine	Dopamine Agonists|Adrenergic Agonists	Catecholamine|D [Preparations]	Positive Chronotropy|Positive Inotropy|Systemic Arterial Vasoconstriction|Renal Arterial Vasodilation
261716	glucagon (rDNA)	Glucagon Receptor Interactions	G [Preparations]	Decreased GI Motility|Decreased GI Smooth Muscle Tone|Increased Glycogenolysis|Increased Gluconeogenesis|Positive Chronotropy|Positive Inotropy
253170	glucagon hydrochloride	Glucagon Receptor Interactions	G [Preparations]	Decreased GI Smooth Muscle Tone|Decreased GI Motility|Increased Gluconeogenesis|Increased Glycogenolysis|Positive Chronotropy|Positive Inotropy
82010	dopamine hydrochloride	Dopamine Agonists|Adrenergic Agonists	D [Preparations]	Positive Chronotropy|Systemic Arterial Vasoconstriction|Positive Inotropy|Renal Arterial Vasodilation
1999003	angiotensin II	G-Protein-linked Receptor Interactions	A [Preparations]|Vasoconstrictor	Vasoconstriction|Increased Blood Pressure
7508	norepinephrine bitartrate	Adrenergic alpha-Agonists|Adrenergic beta1-Agonists	N [Preparations]	Arterial Vasoconstriction|Positive Inotropy|Positive Chronotropy
7512	norepinephrine	Adrenergic alpha-Agonists|Adrenergic beta1-Agonists	Catecholamine|N [Preparations]	Arterial Vasoconstriction|Positive Chronotropy|Positive Inotropy
2256931	noradrenaline hydrochloride	Adrenergic alpha-Agonists|Adrenergic beta1-Agonists	N [Preparations]	Arterial Vasoconstriction|Positive Chronotropy|Positive Inotropy
6805	metaraminol	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	M [Preparations]	Vasoconstriction|Decreased GI Smooth Muscle Tone|Decreased Striated Muscle Contraction|Increased Adrenal Norepinephrine Secretion|Positive Chronotropy|Positive Inotropy
6806	metaraminol bitartrate	Adrenergic alpha-Agonists|Adrenergic alpha1-Agonists	M [Preparations]	Vasoconstriction|Decreased GI Smooth Muscle Tone|Decreased Striated Muscle Contraction|Increased Adrenal Norepinephrine Secretion|Positive Chronotropy|Positive Inotropy
2204740	angiotensin II acetate, human	G-Protein-linked Receptor Interactions	A [Preparations]	Vasoconstriction|Increased Blood Pressure
1657875	norepinephrine, DL-	Adrenergic alpha-Agonists|Adrenergic beta1-Agonists	N [Preparations]	Arterial Vasoconstriction|Positive Chronotropy|Positive Inotropy
235355	thiamine hydrochloride	Enzyme Interactions	T [Preparations]	Cellular Activity Alteration
38041	thiamine disulfide	Enzyme Interactions	T [Preparations]	Cellular Activity Alteration
10454	thiamine	Enzyme Interactions	T [Preparations]	Cellular Activity Alteration
10456	thiamine mononitrate	Enzyme Interactions	T [Preparations]	Cellular Activity Alteration
10459	thiamine pyrophosphate	Enzyme Interactions	T [Preparations]	Cellular Activity Alteration
736680	dronedarone hydrochloride	Unknown Cellular or Molecular Interaction	D [Preparations]	
282416	thiopental sodium	Unknown Cellular or Molecular Interaction	T [Preparations]	Decreased Cerebellum Organized Electrical Activity|Decreased Medullary Respiratory Drive|Decreased Striated Muscle Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
10493	thiopental	Unknown Cellular or Molecular Interaction	T [Preparations]	Decreased Cerebellum Organized Electrical Activity|Decreased Medullary Respiratory Drive|Decreased Striated Muscle Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
1535922	ramucirumab	VEGFR2 Inhibitors	R [Preparations]|Vascular Endothelial Growth Factor Receptor 2 Antagonist	Vascular Growth Decrease
4488	floxuridine	Nucleic Acid Synthesis Inhibitors	Antimetabolite|F [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity
237148	bismuth-formic-iodide	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
235954	bismuth hydroxide	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
1599	bismuth	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
47181	bismuth subcitrate	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
19476	bismuth subgallate	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
19475	bismuth subcarbonate	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
19477	bismuth subnitrate	Acid-Base Activity	B [Preparations]	Digestive/GI System Activity Alteration
89821	witch hazel	Unknown Cellular or Molecular Interaction	W [Preparations]	Astringent Activity
57555	pramoxine hydrochloride	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
34347	pramoxine	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
236632	pantoprazole (as pantoprazole sodium sesquihydrate)	Proton Pump Inhibitors	P [Preparations]	Inhibition Gastric Acid Secretion
253191	pantoprazole sodium	Proton Pump Inhibitors	P [Preparations]	Inhibition Gastric Acid Secretion
40790	pantoprazole	Proton Pump Inhibitors	Proton Pump Inhibitor|P [Preparations]	Inhibition Gastric Acid Secretion
203841	buprenorphine hydrochloride	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists	B [Preparations]	Decreased Organized Electrical Activity
1819	buprenorphine	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists	Partial Opioid Agonist|B [Preparations]	Decreased Organized Electrical Activity
2197878	pitolisant	Histamine H3 Receptor Antagonists	P [Preparations]	Decreased Central Nervous System Histamine Activity
2197879	pitolisant hydrochloride	Histamine H3 Receptor Antagonists	P [Preparations]	Decreased Central Nervous System Histamine Activity
641465	armodafinil	Dopamine Agonists	A [Preparations]	Increased Sympathetic Activity
1606274	dinutuximab	Immunologic Factor Interactions|Glycolipid Disialoganglioside-directed Antibody Interactions	D [Preparations]|Glycolipid Disialoganglioside-directed Antibody	Increased Immunologic Activity|Increased Cellular Death
2474039	naxitamab	Antibody-Surface Glycolipid Interactions|Glycolipid Disialoganglioside-directed Antibody Interactions	N [Preparations]|Glycolipid Disialoganglioside-directed Antibody	
1745099	ixekizumab	Interleukin-17A Antagonists	I [Preparations]|Interleukin-17A Antagonist	
1872251	brodalumab	Interleukin 17 Receptor A Antagonists|Interleukin 17 Receptor A Interactions	B [Preparations]|Interleukin-17 Receptor A Antagonist	
1299898	calcipotriene hydrate	Enzyme Interactions	C [Preparations]	Increased Vitamin Uptake and Modification
4182	etretinate	Unknown Cellular or Molecular Interaction	E [Preparations]	Decreased Skin Keratinization
356988	efalizumab	CD11a-directed Antibody Interactions|Antibody-Receptor Interactions	E [Preparations]	Decreased Adhesion Factor Activity
318340	Aloe vera preparation	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased Histamine Activity|Increased Large Intestinal Motility
299635	alefacept	CD2-directed Antibody Interactions|Unknown Cellular or Molecular Interaction	A [Preparations]	Immunologic Activity Alteration
237112	mycophenolate mofetil hydrochloride	Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors	M [Preparations]	Decreased Immunologically Active Molecule Activity|Decreased Lymphocyte Cell Production|Decreased Immunologic Activity
2669	cod liver oil		C [Preparations]	Bone Resorption Inhibition|Cellular Activity Alteration|Decreased Distal Tubule PO4-- Excretion|Decreased PTH Secretion|Decreased Renal Ca++ Excretion|Decreased Proximal Tubule PO4-- Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
1894	calcitriol	Enzyme Interactions|Structural Macromolecules	Vitamin D3 Analog|C [Preparations]	Bone Resorption Inhibition|Decreased Distal Tubule PO4-- Excretion|Decreased PTH Secretion|Decreased Renal Ca++ Excretion|Decreased Proximal Tubule PO4-- Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
68149	mycophenolate mofetil	Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors	M [Preparations]	Decreased Immunologically Active Molecule Activity|Decreased Lymphocyte Cell Production|Decreased Immunologic Activity
38536	triacetyldithranol	Nucleic Acid Synthesis Inhibitors	T [Preparations]	Decreased DNA Replication|Decreased Mitosis|Decreased Protein Synthesis
873	anthralin	Nucleic Acid Synthesis Inhibitors	A [Preparations]	Decreased DNA Replication|Decreased Mitosis|Decreased Protein Synthesis
1423458	24-homo-1,25-dihydroxyvitamin D3	Enzyme Interactions|Structural Macromolecules	H [Preparations]	Bone Resorption Inhibition|Decreased Distal Tubule PO4-- Excretion|Decreased PTH Secretion|Decreased Renal Ca++ Excretion|Decreased Proximal Tubule PO4-- Excretion|Stimulation Small Intestine Fluid/Electrolyte Absorption
29365	calcipotriene	Enzyme Interactions	Vitamin D Analog|C [Preparations]	Increased Vitamin Uptake and Modification
10844	trioxsalen	Photoabsorption	T [Preparations]	Decreased DNA Integrity
16818	acitretin	Interleukin 6 Receptor Antagonists|Unknown Cellular or Molecular Interaction	Retinoid|A [Preparations]	Decreased Epithelial Proliferation|Decreased Immunologically Active Molecule Activity|Keratin Alteration
2610418	spesolimab-sbzo	Antibody Interactions	S [Preparations]	
7145	mycophenolic acid	Nucleic Acid Synthesis Inhibitors	Antimetabolite Immunosuppressant|M [Preparations]	Decreased Immunologically Active Molecule Activity|Decreased Lymphocyte Cell Production|Decreased Immunologic Activity
2610417	spesolimab	Antibody Interactions|Interleukin-36 Receptor Antagonists	S [Preparations]|Interleukin-36 Receptor Antagonist	
2166132	risankizumab-rzaa	Interleukin-23 Antagonists	R [Preparations]	Decreased Cytokine Activity
2166040	risankizumab	Interleukin-23 Antagonists	R [Preparations]|Interleukin-23 Antagonist	Decreased Cytokine Activity
2053449	tildrakizumab-asmn	Interleukin-23 Antagonists	T [Preparations]	Decreased Cytokine Activity
2053436	tildrakizumab	Interleukin-23 Antagonists	T [Preparations]|Interleukin-23 Antagonist	Decreased Cytokine Activity
2602286	tapinarof	Aryl Hydrocarbon Receptor Agonists	T [Preparations]|Aryl Hydrocarbon Receptor Agonist	Increased Immunologic Activity
1928588	guselkumab	Antibody-Receptor Interactions|Interleukin-23 Antagonists	G [Preparations]|Interleukin-23 Antagonist	
134933	omoconazole mononitrate		O [Preparations]	
32411	omoconazole		O [Preparations]	
1546207	argatroban anhydrous	Antithrombins|Thrombin Inhibitors	Anti-coagulant|Direct Thrombin Inhibitor|A [Preparations]	Decreased Coagulation Factor Activity|Decreased Platelet Aggregation
2055929	fostamatinib disodium	Tyrosine Kinase Inhibitors|Adenosine Receptor Antagonists	F [Preparations]	Vasodilation
2044896	fostamatinib	Tyrosine Kinase Inhibitors|Adenosine Receptor Antagonists	F [Preparations]	Vasodilation
3251	desmopressin	Pituitary Hormone Receptor Agonists	Factor VIII Activator|Vasopressin Analog|D [Preparations]	Increased Coagulation Factor VIII Activity|Increased Coagulation Factor VIII Concentration|Increased Collecting Duct Water Permeability|Increased Coagulation Factor Concentration
42634	desmopressin acetate	Pituitary Hormone Receptor Agonists	D [Preparations]	Increased Coagulation Factor VIII Concentration|Increased Coagulation Factor VIII Activity|Increased Collecting Duct Water Permeability|Increased Coagulation Factor Concentration
15202	argatroban	Antithrombins|Thrombin Inhibitors	Anti-coagulant|Direct Thrombin Inhibitor|A [Preparations]	Decreased Coagulation Factor Activity|Decreased Platelet Aggregation
2045727	avatrombopag maleate	Thrombopoietin Receptor Agonists|ATP-Binding Cassette (ABC) Transporter Interactions	A [Preparations]	Increased Platelet Production|Increased Megakaryocte Cell Production
2054984	lusutrombopag	Thrombopoietin Receptor Agonists	L [Preparations]	Increased Platelet Production|Increased Megakaryocyte Maturation|Increased Megakaryocte Cell Production
2045726	avatrombopag	Thrombopoietin Receptor Agonists|ATP-Binding Cassette (ABC) Transporter Interactions	A [Preparations]	Increased Platelet Production|Increased Megakaryocte Cell Production
2121777	brexanolone	GABA A Modulators|GABA A Receptor Positive Modulators	B [Preparations]|Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator	Increased Central Nervous System GABA Activity
288262	cinoxate	Physiochemical Activity	C [Preparations]	Sunscreening Activity
45045	avobenzone	Physiochemical Activity	A [Preparations]	Sunscreening Activity
11246	vitamin A	Free Radical Scavenging Activity|Enzyme Interactions	Vitamin A|V [Preparations]	Cellular Activity Alteration
32673	oxybenzone	Physiochemical Activity	O [Preparations]	Sunscreening Activity
32786	padimate-O	Physiochemical Activity	P [Preparations]	Sunscreening Activity
35400	retinol acetate	Free Radical Scavenging Activity|Enzyme Interactions	R [Preparations]	Cellular Activity Alteration
35406	vitamin A palmitate	Free Radical Scavenging Activity|Enzyme Interactions	V [Preparations]	Cellular Activity Alteration
1813433	vitamin A myristate	Free Radical Scavenging Activity|Enzyme Interactions	V [Preparations]	Cellular Activity Alteration
74	4-aminobenzoic acid	Physiochemical Activity	Vitamin B Complex Member|A [Preparations]	Sunscreening Activity
10402	dronabinol	Cannabinoid Receptor Agonists	Cannabinoid|D [Preparations]	Decreased Endorphin Activity|Decreased Prostaglandin Production|Emesis Suppression
1300700	lorcaserin hydrochloride	Serotonin 2c Receptor Agonists	L [Preparations]	Appetite Suppression
1300701	lorcaserin	Serotonin 2c Receptor Agonists|Cytochrome P450 2D6 Inhibitors	Serotonin-2c Receptor Agonist|L [Preparations]	Appetite Suppression
297716	phendimetrazine hydrochloride	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
203198	phenmetrazine hydrochloride	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	P [Preparations]	Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
155142	dexfenfluramine hydrochloride	Serotonin Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Appetite Suppression|Decreased Serotonin Degradation|Increased Serotonin Activity
3268	dexfenfluramine	Serotonin Agonists|Serotonin Uptake Inhibitors	D [Preparations]	Appetite Suppression|Decreased Serotonin Degradation|Increased Serotonin Activity
221138	phentermine resin	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
221160	sibutramine hydrochloride monohydrate	Norepinephrine Uptake Inhibitors	S [Preparations]	Increased Cerebral Cortex Norepinephrine Activity
3389	diethylpropion	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	Sympathomimetic Amine Anorectic|D [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
142425	benzphetamine hydrochloride	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Adrenergic Receptor Interactions	B [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Bronchodilation|Increased Norepinephrine Activity
1422	benzphetamine	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Adrenergic Receptor Interactions	Sympathomimetic Amine Anorectic|B [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Bronchodilation|Increased Norepinephrine Activity
81998	diethylpropion hydrochloride	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	D [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
82078	phentermine hydrochloride	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
36514	sibutramine	Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	S [Preparations]	Appetite Suppression|Increased Cerebral Cortex Norepinephrine Activity
37925	orlistat	Lipase Inhibitors	Intestinal Lipase Inhibitor|O [Preparations]	Inhibition Fat Digestion
1294535	sibutramine hydrochloride	Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors|Serotonin Uptake Inhibitors	S [Preparations]	Appetite Suppression|Increased Cerebral Cortex Norepinephrine Activity
58157	phendimetrazine tartrate	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
33272	phendimetrazine	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	Sympathomimetic Amine Anorectic|P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Dopamine Activity|Increased Cerebral Cortex Norepinephrine Activity
8133	phenmetrazine	Monoamine Oxidase Inhibitors|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors	P [Preparations]	Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
8152	phentermine	Monoamine Oxidase Inhibitors|Norepinephrine Uptake Inhibitors|Dopamine Uptake Inhibitors	Sympathomimetic Amine Anorectic|P [Preparations]	Appetite Suppression|Increased Sympathetic Activity|Increased Cerebral Cortex Norepinephrine Activity|Increased Cerebral Cortex Dopamine Activity
1808546	lorcaserin hydrochloride anhydrous	Serotonin 2c Receptor Agonists	L [Preparations]	Appetite Suppression
1597623	lorcaserin hydrochloride hemihydrate	Serotonin 2c Receptor Agonists	L [Preparations]	Appetite Suppression
4919	glycine	Biological Macromolecular Activity	G [Preparations]	Glycine Activity Alteration|Metabolic Activity Alteration
4955	glycopyrrolate	Cholinergic Muscarinic Antagonists	G [Preparations]	Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Salivation Inhibition
1311532	glycine hydrochloride	Biological Macromolecular Activity	G [Preparations]	Glycine Activity Alteration|Metabolic Activity Alteration
857649	methscopolamine nitrate	Cholinergic Antagonists	M [Preparations]	Pupillary Dilation|Decreased GI Motility|Inhibition Gastric Acid Secretion|Salivation Inhibition
107770	mepenzolate	Cholinergic Antagonists	M [Preparations]	Inhibition Gastric Acid Secretion
2179843	polaprezinc	Transcription Factor Activity|Free Radical Scavenging Activity|Interleukin-6 Antagonists	P [Preparations]	Increased Growth Factor Activity
89780	anisotropine	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	A [Preparations]	Decreased GI Motility|Decreased Smooth Muscle Acetylcholine Activity
89785	methscopolamine	Cholinergic Antagonists	Anticholinergic|M [Preparations]	Pupillary Dilation|Decreased GI Motility|Inhibition Gastric Acid Secretion|Salivation Inhibition
48212	clidinium bromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	C [Preparations]	Decreased Parasympathetic Acetylcholine Activity|GI Motility Alteration|Inhibition Gastric Acid Secretion
52560	mepenzolate bromide	Cholinergic Antagonists	M [Preparations]	Inhibition Gastric Acid Secretion
56092	methscopolamine bromide	Cholinergic Antagonists	M [Preparations]	Pupillary Dilation|Decreased GI Motility|Inhibition Gastric Acid Secretion|Salivation Inhibition
21232	clidinium	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|C [Preparations]	Decreased Parasympathetic Acetylcholine Activity|Digestive/GI System Activity Alteration|GI Motility Alteration|Inhibition Gastric Acid Secretion
17945	octotropine methylbromide	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	O [Preparations]	Decreased GI Motility|Decreased Smooth Muscle Acetylcholine Activity
1494066	miltefosine	Lysophospholipid Receptor Interactions	M [Preparations]|Antileishmanial	
N0000190851	Antileishmanial			
4986	chorionic gonadotropin	Hormone Receptor Agonists	C [Preparations]	Increased Luteinizing Hormone Secretion
340705	human chorionic gonadotropin	Hormone Receptor Agonists	H [Preparations]	Increased Luteinizing Hormone Secretion
283550	choriogonadotropin alfa	Hormone Receptor Agonists	Gonadotropin|C [Preparations]	Increased Luteinizing Hormone Secretion|Stimulate Ovarian Luteal Phase|Stimulate Ovulation|Stimulate Ovarian Follicular Phase
4170	ethynodiol diacetate	Progestational Hormone Receptor Agonists	E [Preparations]	Decreased Placental Human Chorionic Gonadotropin Secretion|Hypothalamic Endocrine Activity Alteration
221168	testosterone (micronized)	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
2397	chlorotrianisene	Estrogen Receptor Agonists	C [Preparations]	Vaginal Function Alteration
75806	testosterone isocaproate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
37858	testosterone decanoate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
835827	testosterone cypionate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
37864	testosterone undecanoate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
37859	testosterone enanthate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
10379	testosterone	Androgen Receptor Agonists	Androgen|T [Preparations]	Stimulate Penile Development
10382	testosterone propionate	Androgen Receptor Agonists	T [Preparations]	Stimulate Penile Development
6904	methyltestosterone	Androgen Receptor Agonists	Androgen|M [Preparations]	Stimulate Penile Development
1298738	camphor (natural)	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
857492	tapentadol hydrochloride	Full Opioid Agonists|Opioid Agonists	T [Preparations]	Analgesia|Decreased Organized Electrical Activity
787390	tapentadol	Full Opioid Agonists|Opioid Agonists	T [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
82110	tramadol hydrochloride	Full Opioid Agonists	T [Preparations]	Analgesia|Decreased Organized Electrical Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
1652097	fentanyl hydrochloride	Full Opioid Agonists	F [Preparations]	Analgesia|Decreased Organized Electrical Activity
592464	articaine	Sodium Channel Interactions	Amide Local Anesthetic|A [Preparations]	Local Anesthesia|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
4337	fentanyl	Full Opioid Agonists	F [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
236540	remifentanil hydrochloride	Full Opioid Agonists	R [Preparations]	Analgesia|Decreased Organized Electrical Activity
259453	levobupivacaine	Sodium Channel Interactions	L [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
259454	levobupivacaine hydrochloride	Sodium Channel Interactions	L [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
236734	amitriptyline oxide	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	A [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
1297880	camphor oil	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
4141	ethyl chloride	Unknown Cellular or Molecular Interaction	E [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
281890	strontium-89 chloride	Radiopharmaceutical Activity	S [Preparations]	
203168	amitriptyline hydrochloride	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	A [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
203170	butorphanol tartrate	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists|Opioid Agonists	B [Preparations]	Decreased Organized Electrical Activity
203184	ketamine hydrochloride	Dopamine Agonists|Ionotropic Glutamate Receptor Antagonists	K [Preparations]	Blood Pressure Alteration|General Anesthesia|Decreased Cerebral Cortex Organized Electrical Activity|Decreased Midbrain Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity|Increased Epinephrine Activity|Increased Norepinephrine Activity
203185	mepivacaine hydrochloride	Sodium Channel Interactions	M [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
203196	pentazocine lactate	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists	P [Preparations]	Decreased Organized Electrical Activity|Increased Medullary Respiratory Drive|Positive Chronotropy
203197	phenazopyridine hydrochloride	Unknown Cellular or Molecular Interaction	P [Preparations]	Analgesia|Renal/Urological Activity Alteration
3339	dibucaine	Immunologic Factor Interactions|Sodium Channel Interactions	Standardized Chemical Allergen|D [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Antipruritic Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
228054	dexmedetomidine hydrochloride	Adrenergic alpha2-Agonists|Adrenergic alpha1-Agonists	D [Preparations]	Decreased Organized Electrical Activity|Increased Norepinephrine Activity
235402	dibucaine hydrochloride	Immunologic Factor Interactions|Sodium Channel Interactions	D [Preparations]	Cell-mediated Immunity|Increased Histamine Release|Antipruritic Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
235416	ethoheptazine citrate		E [Preparations]	Central Nervous System Depression
153973	levorphanol tartrate	Full Opioid Agonists|Opioid mu-Receptor Agonists	L [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
235737	amitriptyline pamoate	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	A [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
142436	fentanyl citrate	Full Opioid Agonists	F [Preparations]	Analgesia|Decreased Organized Electrical Activity
2117	articaine hydrochloride	Sodium Channel Interactions	A [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
103755	meperidine hydrochloride	Full Opioid Agonists	M [Preparations]	Analgesia|Decreased Organized Electrical Activity
104973	pentazocine hydrochloride	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists	P [Preparations]	Decreased Organized Electrical Activity|Increased Medullary Respiratory Drive|Positive Chronotropy
106558	procaine hydrochloride	Sodium Channel Interactions	P [Preparations]	Conduction System Depolarization|Decreased Organized Electrical Activity
2557	prilocaine hydrochloride	Sodium Channel Interactions	P [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
71517	propoxyphene hydrochloride	Full Opioid Agonists|Sodium Channel Antagonists	P [Preparations]	Analgesia|Decreased Organized Electrical Activity
82064	oxymorphone hydrochloride	Full Opioid Agonists|Opioid mu-Receptor Agonists	O [Preparations]	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
82242	chlorophyllin copper complex	Unknown Cellular or Molecular Interaction	C [Preparations]	Unknown Physiological Effect
73032	remifentanil	Full Opioid Agonists	R [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
91189	tetracaine hydrochloride	Sodium Channel Interactions	T [Preparations]	Local Anesthesia|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
239351	liquefied phenol	Unknown Cellular or Molecular Interaction	L [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
1829	butacaine	Sodium Channel Interactions	B [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
1841	butorphanol	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists|Opioid Agonists	Opioid Agonist/Antagonist|B [Preparations]	Decreased Organized Electrical Activity
1952	camphor	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
2045371	cannabidiol	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2B6 Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C8 Inhibitors|Cytochrome P450 2B6 Inducers|Cannabinoid Receptor Antagonists|Serotonin Agonists|UGT1A9 Inhibitors|UGT2B7 Inhibitors	C [Preparations]	Increased Central Nervous System Serotonin Activity
36108	salsalate	Cyclooxygenase Inhibitors	S [Preparations]	Decreased Prostaglandin Production
36122	phenyl salicylate	Cyclooxygenase Inhibitors	P [Preparations]	Decreased Prostaglandin Production|Decreased Thromboxane Production|Decreased Platelet Aggregation
36453	sevoflurane	GABA A Modulators|Glycine Agonists	General Anesthetic|S [Preparations]	Vasodilation|General Anesthesia|Decreased Medullary Respiratory Drive
58964	sufentanil citrate	Full Opioid Agonists	S [Preparations]	Analgesia|Decreased Organized Electrical Activity
38578	trichlorofluoromethane	Unknown Cellular or Molecular Interaction	T [Preparations]	Unknown Physiological Effect
48937	dexmedetomidine	Adrenergic alpha2-Agonists|Adrenergic alpha1-Agonists	Central alpha-2 Adrenergic Agonist|D [Preparations]	General Anesthesia|Decreased Organized Electrical Activity|Increased Norepinephrine Activity
38866	trolamine salicylate	Cyclooxygenase Inhibitors	T [Preparations]	Decreased Prostaglandin Production
52364	magnesium salicylate	Cyclooxygenase Inhibitors	M [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Aggregation
53616	chloroprocaine hydrochloride	Sodium Channel Interactions	C [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
10391	tetracaine	Sodium Channel Interactions	Ester Local Anesthetic|T [Preparations]	Local Anesthesia|Decreased Sensory-Somatic Nervous System Organized Electrical Activity
20859	chloroprocaine	Sodium Channel Interactions	Ester Local Anesthetic|C [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
56795	sufentanil	Full Opioid Agonists	S [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
1001	antipyrine	Unknown Cellular or Molecular Interaction	A [Preparations]	Unknown Physiological Effect
22713	dezocine	Opioid Antagonists|Opioid Agonists	D [Preparations]	Decreased Organized Electrical Activity
24484	ethoheptazine		E [Preparations]	Central Nervous System Depression
10689	tramadol	Full Opioid Agonists	T [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity|Increased Norepinephrine Activity|Increased Serotonin Activity
27340	desflurane	Glycine Agonists|GABA A Modulators	General Anesthetic|D [Preparations]	Vasodilation|General Anesthesia|Cerebral Arterial Vasoconstriction|Decreased Medullary Respiratory Drive
10898	tryptophan		T [Preparations]	Increased Serotonin Production
33290	phenol	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
35827	ketorolac	Cyclooxygenase Inhibitors	Nonsteroidal Anti-inflammatory Drug|Cyclooxygenase Inhibitor|K [Preparations]	Decreased Prostaglandin Production
7814	oxymorphone	Full Opioid Agonists|Opioid mu-Receptor Agonists	O [Preparations]|Opioid Agonist	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
9518	salicylamide	Cyclooxygenase Inhibitors	S [Preparations]	Decreased Prostaglandin Production|Decreased Platelet Aggregation
8686	prilocaine	Sodium Channel Interactions	Amide Local Anesthetic|P [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
8701	procaine	Sodium Channel Interactions	P [Preparations]	Conduction System Depolarization|Decreased Organized Electrical Activity
8785	propoxyphene	Full Opioid Agonists|Sodium Channel Antagonists	P [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
8786	propoxyphene napsylate	Full Opioid Agonists|Sodium Channel Antagonists	P [Preparations]	Analgesia|Decreased Organized Electrical Activity
8001	pentazocine	Opioid Antagonists|Competitive Opioid Antagonists|Partial Opioid Agonists	Partial Opioid Agonist/Antagonist|P [Preparations]	Decreased Organized Electrical Activity|Increased Medullary Respiratory Drive|Positive Chronotropy
8113	phenacetin	Prostaglandin Receptor Antagonists	P [Preparations]	Decreased Prostaglandin Production
8120	phenazopyridine	Unknown Cellular or Molecular Interaction	P [Preparations]	Analgesia|Renal/Urological Activity Alteration
6750	menthol	Calcium Channel Antagonists	M [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
6754	meperidine	Full Opioid Agonists	M [Preparations]|Opioid Agonist	Analgesia|Decreased Organized Electrical Activity
6759	mepivacaine	Sodium Channel Interactions	Amide Local Anesthetic|M [Preparations]	Local Anesthesia|Decreased Organized Electrical Activity
2001352	benzhydrocodone	Opioid mu-Receptor Agonists	B [Preparations]	Analgesia
2122776	benzhydrocodone hydrochloride	Opioid mu-Receptor Agonists	B [Preparations]	Analgesia
1858362	alpha,alpha-dibromo-d-camphor	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
161	acetaminophen	Prostaglandin Receptor Antagonists	A [Preparations]	Central Nervous System Activity Alteration|Peripheral Nervous System Activity Alteration|Decreased Prostaglandin Production|Hypothalamic Endocrine Activity Alteration
6130	ketamine	Dopamine Agonists|Ionotropic Glutamate Receptor Antagonists	General Anesthetic|K [Preparations]	Blood Pressure Alteration|General Anesthesia|Decreased Cerebral Cortex Organized Electrical Activity|Decreased Midbrain Organized Electrical Activity|Decreased Sensory-Somatic Nervous System Organized Electrical Activity|Increased Epinephrine Activity|Increased Norepinephrine Activity
1648123	menthol, (+)-	Calcium Channel Antagonists	M [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
704	amitriptyline	Norepinephrine Uptake Inhibitors|Serotonin Uptake Inhibitors	Tricyclic Antidepressant|A [Preparations]	Decreased Serotonin Degradation|Increased Central Nervous System Norepinephrine Activity
6378	levorphanol	Full Opioid Agonists|Opioid mu-Receptor Agonists	L [Preparations]|Opioid Agonist	Analgesia|Decreased Medullary Respiratory Drive|Decreased Organized Electrical Activity
3353	dichlorphenamide	Carbonic Anhydrase Inhibitors	Carbonic Anhydrase Inhibitor|D [Preparations]	Increased Renal HCO3- Excretion|Increased Renal K+ Excretion|Increased Renal Na+ Excretion|Decreased Intraocular Aqueous Secretion
106047	physostigmine sulfate	Cholinesterase Inhibitors	P [Preparations]	Pupillary Constriction
91406	acetazolamide sodium	Carbonic Anhydrase Inhibitors	A [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Central Nervous System Organized Electrical Activity|Increased Collecting Duct Water Permeability|Increased Renal HCO3- Excretion|Increased Renal Na+ Excretion|Increased Renal K+ Excretion|Decreased Intraocular Fluid Pressure
89778	ecothiopate	Cholinesterase Inhibitors	Cholinesterase Inhibitor|E [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity|Decreased Intraocular Fluid Pressure
1999	carbachol	Cholinergic Muscarinic Agonists	C [Preparations]	Pupillary Constriction|Decreased Intraocular Fluid Pressure
33656	physostigmine salicylate	Cholinesterase Inhibitors	P [Preparations]	Pupillary Constriction
8299	physostigmine	Cholinesterase Inhibitors	P [Preparations]	Pupillary Constriction
6027	isoflurophate	Cholinesterase Inhibitors	I [Preparations]	Pupillary Constriction
167	acetazolamide	Carbonic Anhydrase Inhibitors	Carbonic Anhydrase Inhibitor|A [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity|Decreased Central Nervous System Organized Electrical Activity|Increased Collecting Duct Water Permeability|Increased Renal HCO3- Excretion|Increased Renal Na+ Excretion|Increased Renal K+ Excretion|Decreased Intraocular Fluid Pressure
161623	methenamine mandelate		M [Preparations]	Cellular Activity Alteration
235562	methenamine sulfosalicylate		M [Preparations]	Cellular Activity Alteration
2051	carboprost	Prostaglandin Receptor Agonists	Prostaglandin Analog|C [Preparations]	Increased GI Smooth Muscle Tone|Increased Prostaglandin Activity|Increased Uterine Smooth Muscle Contraction or Tone
20259	carboprost tromethamine	Prostaglandin Receptor Agonists	C [Preparations]	Increased GI Smooth Muscle Tone|Increased Prostaglandin Activity|Increased Uterine Smooth Muscle Contraction or Tone
29652	methenamine hippurate		M [Preparations]	Cellular Activity Alteration
6832	methenamine		M [Preparations]	Cellular Activity Alteration
44	mesna	Binding Activity	M [Preparations]	Increased Renal Organic Ion Excretion
2121416	calaspargase pegol	Enzyme Interactions	Asparagine-specific Enzyme|C [Preparations]	Cellular Proliferation Alteration|Decreased Protein Synthesis|Increased Cellular Death
1942950	inotuzumab ozogamicin	CD22-directed Antibody Interactions	I [Preparations]|CD22-directed Immunoconjugate	Decreased DNA Integrity|Increased Cellular Death
1364321	daunorubicin citrate	Topoisomerase 2 Inhibitors|DNA Polymerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased Mitosis|Decreased RNA Integrity
3109	daunorubicin	Topoisomerase 2 Inhibitors|DNA Polymerase Inhibitors|Topoisomerase Inhibitors	Anthracycline Topoisomerase Inhibitor|D [Preparations]	Decreased DNA Integrity|Decreased Mitosis|Decreased RNA Integrity
214468	daunorubicin liposomal	Topoisomerase 2 Inhibitors|DNA Polymerase Inhibitors|Topoisomerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased Mitosis|Decreased RNA Integrity
221087	daunorubicin citrate liposome	Topoisomerase 2 Inhibitors|DNA Polymerase Inhibitors|Topoisomerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased Mitosis|Decreased RNA Integrity
81992	daunorubicin hydrochloride	Topoisomerase 2 Inhibitors|DNA Polymerase Inhibitors|Topoisomerase Inhibitors	D [Preparations]	Decreased DNA Integrity|Decreased Mitosis|Decreased RNA Integrity
2121417	calaspargase pegol-mknl	Enzyme Interactions	C [Preparations]	Cellular Proliferation Alteration|Decreased Protein Synthesis|Increased Cellular Death
1652103	asunaprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors	A [Preparations]	
283579	milk thistle extract	Unknown Cellular or Molecular Interaction	M [Preparations]	Unknown Physiological Effect
1543173	tavaborole	Protein Synthesis Inhibitors	T [Preparations]|Oxaborole Antifungal	Cellular Synthetic Activity Alteration
1539753	efinaconazole	14-alpha Demethylase Inhibitors|Ergosterol Synthesis Inhibitors	Azole Antifungal|E [Preparations]	Decreased Cell Membrane Integrity
3108	dapsone	Para-Aminobenzoic Acid Inhibitors	Sulfone|D [Preparations]	Cellular Synthetic Activity Alteration|Decreased Folic Acid Modification
10188	sulfapyridine	Para-Aminobenzoic Acid Inhibitors	S [Preparations]	Decreased Folic Acid Modification
2621549	mirvetuximab soravtansine-gynx	Antibody-Receptor Interactions	M [Preparations]	Microtubule Inhibition
2621548	mirvetuximab soravtansine	Antibody-Receptor Interactions	M [Preparations]	Microtubule Inhibition
9060	quercetin		Q [Preparations]	
3292	dextrothyroxine	Thyroid Hormone Receptor Agonists	D [Preparations]	Increased Cholesterol Elimination
40070	dextrothyroxine sodium	Thyroid Hormone Receptor Agonists|Unknown Cellular or Molecular Interaction	D [Preparations]	Increased Cholesterol Elimination
8699	probucol	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Cholesterol Synthesis|Decreased Cholesterol Absorption
66912	paromomycin sulfate	Protein Synthesis Inhibitors	P [Preparations]	Decreased Protein Synthesis
7934	paromomycin	Protein Synthesis Inhibitors	Antiprotozoal|P [Preparations]	Decreased Protein Synthesis
614373	deferasirox	Cytochrome P450 3A4 Inducers|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2C8 Inhibitors|Iron Chelating Activity	Iron Chelator|D [Preparations]	
11645	deferiprone	Iron Chelating Activity	Iron Chelator|D [Preparations]	
2267021	2,2-bis(4-hydroxy-3-tert-butylphenyl)propane		B [Preparations]	
720825	silodosin	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	alpha-Adrenergic Blocker|S [Preparations]	Decreased Bladder Sphincter Tone|Decreased Urethra Smooth Muscle Tone
236495	tamsulosin hydrochloride	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	T [Preparations]	Decreased Bladder Sphincter Tone|Decreased Urethra Smooth Muscle Tone
228790	dutasteride	5-alpha Reductase Inhibitors	D [Preparations]|5-alpha Reductase Inhibitor	Decreased Prostatic Size|Decreased Dihydrotestosterone Secretion
77492	tamsulosin	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	alpha-Adrenergic Blocker|T [Preparations]	Decreased Bladder Sphincter Tone|Decreased Urethra Smooth Muscle Tone
46043	alfuzosin hydrochloride	Adrenergic alpha1-Antagonists	A [Preparations]	Decreased Bladder Sphincter Tone|Prostatic Alteration|Decreased Urethra Smooth Muscle Tone
25025	finasteride	5-alpha Reductase Inhibitors	F [Preparations]|5-alpha Reductase Inhibitor	Decreased Dihydrotestosterone Secretion
17300	alfuzosin	Adrenergic alpha-Antagonists|Adrenergic alpha1-Antagonists	alpha-Adrenergic Blocker|A [Preparations]	Decreased Bladder Sphincter Tone|Prostatic Alteration|Decreased Urethra Smooth Muscle Tone
1855735	olaratumab	Platelet-derived Growth Factor alpha Receptor Inhibitors|Immunologic and Biological Factor Interactions	O [Preparations]	Cellular Proliferation Alteration
2274379	tazemetostat hydrobromide	Enzyme Inhibitors	T [Preparations]	Cellular Cycle Alteration
2274378	tazemetostat	Enzyme Inhibitors|Methyltransferase Inhibitors|Multidrug and Toxin Extrusion Transporter 2 K Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	T [Preparations]|Methyltransferase Inhibitor	Cellular Cycle Alteration
1304475	ziv-aflibercept	Vascular Endothelial Growth Factor Inhibitors	Z [Preparations]	Decreased Vascular Permeability
595060	ranibizumab	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	R [Preparations]|Vascular Endothelial Growth Factor Inhibitor	Vascular Growth Decrease
1232150	aflibercept	Vascular Endothelial Growth Factor Inhibitors	A [Preparations]|Vascular Endothelial Growth Factor Inhibitor	Decreased Vascular Permeability
2612673	ranibizumab-eqrn	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	R [Preparations]	Vascular Growth Decrease
2602351	ranibizumab-nuna	Vascular Endothelial Growth Factor-directed Antibody Interactions|Vascular Endothelial Growth Factor Receptor Inhibitors|Vascular Endothelial Growth Factor Inhibitors	R [Preparations]	Vascular Growth Decrease
319780	Capsicum extract	Neurotransmitter Transporter Interactions	Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|C [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release|Decreased Sensory-Somatic Nervous System Organized Electrical Activity|Increased Sensory-Somatic Nervous System Substance P Activity
235787	Capsicum oleoresin	Neurotransmitter Transporter Interactions	C [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity|Increased Sensory-Somatic Nervous System Substance P Activity
115238	becaplermin		Human Platelet-derived Growth Factor|B [Preparations]	Increased Epithelial Proliferation
1992	capsaicin	Neurotransmitter Transporter Interactions	C [Preparations]	Decreased Sensory-Somatic Nervous System Organized Electrical Activity
4452	fludrocortisone	Mineralocorticoid Receptor Agonists	F [Preparations]	Decreased Distal Tubule Na+ Excretion|Decreased Mineralocorticoid Secretion|Increased Distal Tubule K+ Excretion
165516	fludrocortisone acetate	Mineralocorticoid Receptor Agonists	F [Preparations]	Decreased Distal Tubule Na+ Excretion|Decreased Mineralocorticoid Secretion|Increased Distal Tubule K+ Excretion
22537	desoxycorticosterone pivalate	Mineralocorticoid Receptor Agonists	D [Preparations]	Decreased Renal Na+ Excretion|Increased Renal K+ Excretion
1364503	bedaquiline fumarate	Enzyme Inhibitors	B [Preparations]	
1364504	bedaquiline	Enzyme Inhibitors	Diarylquinoline Antimycobacterial|B [Preparations]	
55681	rimexolone	Lipoxygenase Inhibitors|Corticosteroid Hormone Receptor Agonists|Glucocorticoid Receptor Agonists	R [Preparations]	Decreased Leukotriene Activity|Decreased Prostaglandin Activity|Decreased Thromboxane Activity
N0000181811	Pediculicide			
299081	spinosad		Pediculicide|S [Preparations]	Nervous System Activity Alteration
1388	lindane	Unknown Cellular or Molecular Interaction	L [Preparations]	Increased Central Nervous System Disorganized Electrical Activity
33199	permethrin	Enzyme Inhibitors|Chloride Channel Antagonists	Pyrethroid|P [Preparations]	Decreased Striated Muscle Organized Electrical Activity
8991	pyrethrins	Sodium Channel Interactions	P [Preparations]	Decreased Striated Muscle Organized Electrical Activity
8345	piperonyl butoxide	Enzyme Inhibitors	P [Preparations]	Antipruritic Activity
6606	malathion	Cholinesterase Inhibitors	Cholinesterase Inhibitor|M [Preparations]	Increased Acetylcholine Activity
N0000182639	Hepatitis C Virus NS3/4A Protease Inhibitor			
1484911	sofosbuvir	RNA Replicase Inhibitors	S [Preparations]|Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor	
1606218	daclatasvir	P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors	D [Preparations]	Unknown Physiological Effect
1482790	simeprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors	S [Preparations]	
1102261	telaprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Cytochrome P450 3A Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors	T [Preparations]	
1102129	boceprevir	HCV NS3/4A Protease Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A5 Inhibitors	B [Preparations]	
1939323	voxilaprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors	Hepatitis C Virus NS3/4A Protease Inhibitor|V [Preparations]	Decreased RNA Replication
1940635	glecaprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 3A Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Breast Cancer Resistance Protein Inhibitors|UGT1A1 Inhibitors	Hepatitis C Virus NS3/4A Protease Inhibitor|G [Preparations]	
1940636	pibrentasvir	P-Glycoprotein Inhibitors|Cytochrome P450 1A2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 3A Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|UGT1A1 Inhibitors	P [Preparations]|Hepatitis C Virus NS5A Inhibitor	Nucleic Acid Replication Alteration
1591922	ledipasvir	P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors	L [Preparations]|Hepatitis C Virus NS5A Inhibitor	Decreased RNA Replication
1597371	ombitasvir	UGT1A1 Inhibitors	O [Preparations]	Unknown Physiological Effect
1597381	dasabuvir	RNA Replicase Inhibitors	D [Preparations]	
N0000191493	Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor			
1799206	velpatasvir	P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors	V [Preparations]|Hepatitis C Virus NS5A Inhibitor	Unknown Physiological Effect
1734630	grazoprevir	HCV NS3/4A Protease Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 3A Inhibitors	G [Preparations]	
1734628	elbasvir	P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors	E [Preparations]|Hepatitis C Virus NS5A Inhibitor	Unknown Physiological Effect
1597373	paritaprevir	HCV NS3/4A Protease Inhibitors|P-Glycoprotein Inhibitors|Breast Cancer Resistance Protein Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|UGT1A1 Inhibitors	P [Preparations]	
N0000191257	Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor			
N0000191256	Hepatitis C Virus NS5A Inhibitor			
1368126	alcohol, x-ray exposed (1000 rad)	Neurotransmitter Transporter Interactions|GABA A Agonists	A [Preparations]	Cell Membrane Alteration
1310469	dehydrated alcohol	Neurotransmitter Transporter Interactions|GABA A Agonists	D [Preparations]	Cell Membrane Alteration
448	ethanol	Neurotransmitter Transporter Interactions|GABA A Agonists	E [Preparations]	Cell Membrane Alteration
267036	metoclopramide hydrochloride	Dopamine Antagonists|Dopamine D2 Antagonists	M [Preparations]	Increased GI Motility
267035	metoclopramide dihydrochloride	Dopamine Antagonists	M [Preparations]	Increased GI Motility
6915	metoclopramide	Dopamine Antagonists|Dopamine D2 Antagonists	Dopamine-2 Receptor Antagonist|M [Preparations]	Increased GI Motility
48203	clavulanate	beta Lactamase Inhibitors	C [Preparations]	
831418	clavulanate potassium	beta Lactamase Inhibitors	C [Preparations]	
21216	clavulanic acid	beta Lactamase Inhibitors	beta Lactamase Inhibitor|C [Preparations]	
1989100	benralizumab	Interleukin 5 Receptor alpha-directed Antibody Interactions	B [Preparations]|Interleukin-5 Receptor alpha-directed Cytolytic Antibody	
1746889	reslizumab	Interleukin-5 Antagonists	R [Preparations]|Interleukin-5 Antagonist	
998038	formoterol fumarate dihydrate	Adrenergic beta2-Agonists	F [Preparations]	Bronchodilation
4333	fenoterol	Adrenergic beta2-Agonists	F [Preparations]	Bronchodilation|Decreased Uterine Smooth Muscle Contraction or Tone
289080	ethylnorepinephrine hydrochloride	Adrenergic Agonists|Adrenergic alpha-Agonists	E [Preparations]	Central Nervous System Stimulation
302379	omalizumab	IgE-directed Antibody Interactions	Anti-IgE|O [Preparations]	Decreased IgE Activity
1720597	mepolizumab	Interleukin-5 Antagonists	M [Preparations]|Interleukin-5 Antagonist	
203124	fenoterol hydrobromide	Adrenergic beta2-Agonists	F [Preparations]	Bronchodilation|Decreased Uterine Smooth Muscle Contraction or Tone
156240	ethylnorepinephrine	Adrenergic Agonists	E [Preparations]	Central Nervous System Stimulation
221142	pirbuterol acetate	Adrenergic beta2-Agonists	P [Preparations]	Bronchodilation
235447	pirbuterol HCl	Adrenergic beta2-Agonists	P [Preparations]	Bronchodilation
236216	formoterol fumarate	Adrenergic beta2-Agonists	F [Preparations]	Bronchodilation
142153	albuterol sulfate	Adrenergic beta2-Agonists	A [Preparations]	Bronchodilation
102397	isoetharine hydrochloride	Adrenergic beta2-Agonists	I [Preparations]	Bronchodilation
114970	zafirlukast	Cytochrome P450 2C9 Inhibitors|Leukotriene Receptor Antagonists	Leukotriene Receptor Antagonist|Z [Preparations]	Bronchodilation|Decreased Tracheo-Bronchial Mucosal Edema
72616	salmeterol xinafoate	Adrenergic beta2-Agonists	S [Preparations]	Bronchodilation
36117	salmeterol	Adrenergic beta2-Agonists	beta2-Adrenergic Agonist|S [Preparations]	Bronchodilation
47187	bitolterol mesylate	Adrenergic beta2-Agonists	B [Preparations]	Bronchodilation
19499	bitolterol	Adrenergic beta2-Agonists	B [Preparations]	Bronchodilation
10369	terbutaline sulfate	Adrenergic beta2-Agonists	T [Preparations]	Bronchodilation|Decreased Uterine Smooth Muscle Contraction or Tone
10368	terbutaline	Adrenergic beta2-Agonists	T [Preparations]	Bronchodilation|Decreased Uterine Smooth Muscle Contraction or Tone
21285	cloprednol	Glucocorticoid Receptor Agonists	C [Preparations]	
40575	zileuton	5-Lipoxygenase Inhibitors	5-Lipoxygenase Inhibitor|Z [Preparations]	Decreased Capillary Permeability|Bronchodilation|Decreased Leukotriene Production|Decreased Cellular Migration
24611	etofylline		E [Preparations]	Bronchodilation
25255	formoterol	Adrenergic beta2-Agonists	beta2-Adrenergic Agonist|F [Preparations]	Bronchodilation
33767	pirbuterol	Adrenergic beta2-Agonists	P [Preparations]	Bronchodilation
2587790	tezepelumab-ekko	Antibody-Receptor Interactions	T [Preparations]	Respiratory/Pulmonary Activity Alteration
2587789	tezepelumab	Antibody-Receptor Interactions|Thymic Stromal Lymphopoietin Blockers	T [Preparations]|Thymic Stromal Lymphopoietin Blocker	Respiratory/Pulmonary Activity Alteration
6024	isoetharine mesylate	Adrenergic beta2-Agonists	I [Preparations]	Bronchodilation
6023	isoetharine	Adrenergic beta2-Agonists	I [Preparations]	Bronchodilation
435	albuterol	Adrenergic beta2-Agonists	beta2-Adrenergic Agonist|A [Preparations]	Bronchodilation
263034	panitumumab	HER1 Antagonists	Epidermal Growth Factor Receptor Antagonist|P [Preparations]	
194000	capecitabine	Thymidylate Synthetase Inhibitors|Nucleic Acid Synthesis Inhibitors|Nucleoside Synthesis Inhibitors	Nucleoside Metabolic Inhibitor|C [Preparations]	Decreased DNA Integrity|Decreased RNA Integrity|Increased Cellular Death
1670303	tipiracil hydrochloride	Thymidine Phosphorylase Inhibitors	T [Preparations]	
1670304	tipiracil	Thymidine Phosphorylase Inhibitors	T [Preparations]|Thymidine Phosphorylase Inhibitor	
1311259	magnesium sulfate monohydrate	Acid-Base Activity|Electrolyte Activity|Enzyme Interactions	M [Preparations]	Decreased Blood Pressure|Atrial Repolarization|Decreased Cardiac Muscle Acetylcholine Activity|Cellular Activity Alteration|Decreased Muscular System Acetylcholine Activity|Increased GI Motility|Increased Vitamin Uptake and Modification|Small Intestine Fluid/Electrolyte Absorption Alteration|Stimulation Large Intestine Fluid/Electrolyte Absorption
1311625	magnesium sulfate anhydrous	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	M [Preparations]	Decreased Blood Pressure|Atrial Repolarization|Decreased Cardiac Muscle Acetylcholine Activity|Cellular Activity Alteration|Decreased Muscular System Acetylcholine Activity|Increased GI Motility|Increased Vitamin Uptake and Modification|Small Intestine Fluid/Electrolyte Absorption Alteration|Stimulation Large Intestine Fluid/Electrolyte Absorption
1739745	brivaracetam	Epoxide Hydrolase Inhibitors	B [Preparations]	Central Nervous System Depression
203164	pyridoxine hydrochloride	Enzyme Interactions	P [Preparations]	Cellular Activity Alteration
1310578	medium chain triglycerides	Structural Macromolecules	M [Preparations]	Increased Lipolysis
235404	barbital sodium	Cholinergic Antagonists|Neurotransmitter Transporter Interactions	B [Preparations]	Electrical Activity Alteration
2604689	ganaxolone	GABA A Receptor Positive Modulators	G [Preparations]|Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator	
69036	rufinamide	Sodium Channel Interactions	R [Preparations]	
2054968	stiripentol	GABA A Agonists	S [Preparations]	Increased Central Nervous System GABA Activity
21241	clobazam	Cytochrome P450 3A4 Inducers|Cytochrome P450 2D6 Inhibitors|GABA A Modulators|GABA A Agonists	Benzodiazepine|C [Preparations]	Increased GABA Activity
1325	barbital	Cholinergic Antagonists|Neurotransmitter Transporter Interactions	B [Preparations]	Electrical Activity Alteration
9004	pyridoxal phosphate	Enzyme Interactions	P [Preparations]	Cellular Activity Alteration
684879	pyridoxine	Enzyme Interactions	P [Preparations]|Vitamin B6 Analog	Cellular Activity Alteration
6585	magnesium sulfate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	M [Preparations]	Decreased Blood Pressure|Atrial Repolarization|Decreased Cardiac Muscle Acetylcholine Activity|Cellular Activity Alteration|Decreased Muscular System Acetylcholine Activity|Increased GI Motility|Increased Vitamin Uptake and Modification|Small Intestine Fluid/Electrolyte Absorption Alteration|Stimulation Large Intestine Fluid/Electrolyte Absorption
2107060	magnesium sulfate dihydrate	Electrolyte Activity|Acid-Base Activity|Enzyme Interactions	M [Preparations]	Decreased Blood Pressure|Atrial Repolarization|Decreased Cardiac Muscle Acetylcholine Activity|Cellular Activity Alteration|Decreased Muscular System Acetylcholine Activity|Increased GI Motility|Increased Vitamin Uptake and Modification|Small Intestine Fluid/Electrolyte Absorption Alteration|Stimulation Large Intestine Fluid/Electrolyte Absorption
7440	nitrazepam	GABA A Modulators|GABA A Agonists	N [Preparations]	Increased GABA Activity
1482502	eslicarbazepine	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C19 Inhibitors|Sodium Channel Antagonists	E [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity
1482501	eslicarbazepine acetate	Cytochrome P450 3A4 Inducers|Cytochrome P450 2C19 Inhibitors|Sodium Channel Antagonists	E [Preparations]	Decreased Central Nervous System Disorganized Electrical Activity
9010	pyrimethamine	Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	Dihydrofolate Reductase Inhibitor Antimalarial|P [Preparations]	
2592	clofazimine	Nucleic Acid Synthesis Inhibitors	C [Preparations]	Cellular Synthetic Activity Alteration
2531274	vitamin E acetate	Free Radical Scavenging Activity	V [Preparations]	Decreased Vitamin Uptake and Modification
1427235	alpha-tocopherol linoleate, D-	Free Radical Scavenging Activity	A [Preparations]	Decreased Vitamin Uptake and Modification
1441649	d-alpha-tocopheryl acetate	Free Radical Scavenging Activity	D [Preparations]	Decreased Vitamin Uptake and Modification
1426447	alpha-tocopherol succinate, D-	Free Radical Scavenging Activity	A [Preparations]	Decreased Vitamin Uptake and Modification
1046243	alpha-tocopherol acetate	Free Radical Scavenging Activity	A [Preparations]	Decreased Vitamin Uptake and Modification
4637	galantamine	Cholinesterase Inhibitors	Cholinesterase Inhibitor|G [Preparations]	Increased Central Nervous System Acetylcholine Activity|Increased Glutamate Activity|Increased Serotonin Activity
402899	tocopherol,DL-alpha	Free Radical Scavenging Activity	T [Preparations]	Decreased Vitamin Uptake and Modification
317841	dl-alpha tocopheryl acetate	Free Radical Scavenging Activity	D [Preparations]	Decreased Vitamin Uptake and Modification
860693	galantamine hydrobromide	Cholinesterase Inhibitors	G [Preparations]	Increased Central Nervous System Acetylcholine Activity|Increased Glutamate Activity|Increased Serotonin Activity
314875	tocopheryl acid succinate,D-alpha	Free Radical Scavenging Activity	T [Preparations]	Decreased Vitamin Uptake and Modification
236559	donepezil hydrochloride	Cholinesterase Inhibitors	D [Preparations]	Increased Central Nervous System Acetylcholine Activity
236685	memantine hydrochloride	NMDA Receptor Antagonists	M [Preparations]	Decreased Central Nervous System Glutamate Activity
994808	rivastigmine tartrate	Cholinesterase Inhibitors	R [Preparations]	Increased Central Nervous System Acetylcholine Activity
183379	rivastigmine	Cholinesterase Inhibitors	Cholinesterase Inhibitor|R [Preparations]	Increased Central Nervous System Acetylcholine Activity
220892	vitamin E d-alpha	Free Radical Scavenging Activity	V [Preparations]	Decreased Vitamin Uptake and Modification
220893	vitamin E DL-alpha	Free Radical Scavenging Activity	V [Preparations]	Decreased Vitamin Uptake and Modification
235972	tacrine hydrochloride	Cholinesterase Inhibitors	T [Preparations]	Increased Central Nervous System Acetylcholine Activity
135447	donepezil	Cholinesterase Inhibitors	Cholinesterase Inhibitor|D [Preparations]	Increased Central Nervous System Acetylcholine Activity
1314420	tricaprylin		T [Preparations]	
39625	tocopherol acetate	Free Radical Scavenging Activity	T [Preparations]	Decreased Vitamin Uptake and Modification
39626	alpha-tocopherol succinate	Free Radical Scavenging Activity	A [Preparations]	Decreased Vitamin Uptake and Modification
11256	vitamin E	Free Radical Scavenging Activity	V [Preparations]	Decreased Vitamin Uptake and Modification
2267703	huperzine A	Cholinesterase Inhibitors	H [Preparations]	Increased Central Nervous System Acetylcholine Activity
2626142	lecanemab-irmb	Amyloid Beta-directed Antibody Interactions	L [Preparations]	
10318	tacrine	Cholinesterase Inhibitors	T [Preparations]	Increased Central Nervous System Acetylcholine Activity
2557218	aducanumab-avwa		A [Preparations]	
2626143	lecanemab	Amyloid Beta-directed Antibody Interactions	L [Preparations]|Amyloid Beta-directed Antibody	
2370134	alpha-tocopherol succinate, DL-	Free Radical Scavenging Activity	A [Preparations]	Decreased Vitamin Uptake and Modification
6719	memantine	NMDA Receptor Antagonists	N-methyl-D-aspartate Receptor Antagonist|M [Preparations]	Decreased Central Nervous System Glutamate Activity
2557217	aducanumab	Amyloid Beta-directed Antibody Interactions	A [Preparations]|Amyloid Beta-directed Antibody	
1364894	etidronate tetrasodium	Bone Surface Interactions	E [Preparations]	Bone Resorption Inhibition
1356715	etidronic acid	Bone Surface Interactions	Bisphosphonate|E [Preparations]	Bone Resorption Inhibition
25544	gallium nitrate	Unknown Cellular or Molecular Interaction	G [Preparations]	Bone Resorption Inhibition
42682	etidronate	Bone Surface Interactions	E [Preparations]	Bone Resorption Inhibition
9872	etidronate disodium	Bone Surface Interactions	E [Preparations]	Bone Resorption Inhibition
N0000175482	Antimalarial			
N0000175934	Dihydrofolate Reductase Inhibitor Antimalarial			
2054091	tafenoquine succinate	Unknown Cellular or Molecular Interaction	T [Preparations]	
2054023	tafenoquine	Unknown Cellular or Molecular Interaction	T [Preparations]	
847728	lumefantrine	Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors	Antimalarial|L [Preparations]	
2382	proguanil	Dihydrofolate Reductase Inhibitors	Antimalarial|P [Preparations]	Decreased DNA Integrity
82130	mefloquine hydrochloride	Unknown Cellular or Molecular Interaction	M [Preparations]	
50749	halofantrine	Unknown Cellular or Molecular Interaction	H [Preparations]	
58130	halofantrine hydrochloride	Unknown Cellular or Molecular Interaction	H [Preparations]	
18343	artemether	Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors	Antimalarial|A [Preparations]	
8687	primaquine	Unknown Cellular or Molecular Interaction	Antimalarial|P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
8689	primaquine phosphate	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
6694	mefloquine	Unknown Cellular or Molecular Interaction	Antimalarial|M [Preparations]	
1425098	trametinib dimethyl sulfoxide	Protein Kinase Inhibitors	T [Preparations]	Cellular Proliferation Alteration
1430441	afatinib dimaleate	Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	A [Preparations]	Cellular Proliferation Alteration
1148495	crizotinib	P-Glycoprotein Inhibitors|Cytochrome P450 2B6 Inhibitors|Organic Cation Transporter 2 Inhibitors|Cytochrome P450 3A Inhibitors|Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors|Organic Cation Transporter 1 Inhibitors	C [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
2058849	dacomitinib	Protein Kinase Inhibitors	D [Preparations]	Increased Cellular Death
1430438	afatinib	Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	A [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1535457	ceritinib	Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A Inhibitors|Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	C [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1425099	trametinib	Protein Kinase Inhibitors	T [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1723738	necitumumab	HER1 Antagonists	Epidermal Growth Factor Receptor Antagonist|N [Preparations]	
477320	erlotinib hydrochloride	HER1 Antagonists	E [Preparations]	Vascular Growth Decrease|Cellular Growth Phase Reduction|Cellular Division Phase Alteration|Increased Cellular Death
328134	gefitinib	Protein Kinase Inhibitors|HER1 Antagonists	G [Preparations]|Kinase Inhibitor	Cellular Synthetic Activity Alteration|Decreased Intercellular Communication|Increased Cellular Death
282443	pemetrexed disodium	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Dihydrofolate Reductase Inhibitors	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
337525	erlotinib	Protein Kinase Inhibitors|HER1 Antagonists	E [Preparations]|Kinase Inhibitor	Vascular Growth Decrease|Cellular Growth Phase Reduction|Cellular Division Phase Alteration|Increased Cellular Death
68446	pemetrexed	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	Folate Analog Metabolic Inhibitor|P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
2590669	pemetrexed monohydrate	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
2549199	amivantamab	Antibody-Receptor Interactions	A [Preparations]	
2549198	amivantamab-vmjw	Antibody-Receptor Interactions	A [Preparations]	
2604776	pemetrexed tromethamine anhydrous	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
2570736	mobocertinib	Cytochrome P450 3A Inducers|HER1 Antagonists|Kinase Inhibitors	M [Preparations]|Kinase Inhibitor	
2550714	sotorasib		S [Preparations]	
2625882	adagrasib		A [Preparations]	
2570737	mobocertinib succinate	Kinase Inhibitors	M [Preparations]	
2056898	pemetrexed disodium hemipentahydrate	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Folic Acid Metabolism Inhibitors|Dihydrofolate Reductase Inhibitors	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
2394936	pralsetinib	Kinase Inhibitors|Rearranged during Transfection (RET) Inhibitors	P [Preparations]|Kinase Inhibitor	
2058848	dacomitinib anhydrous	Protein Kinase Inhibitors	D [Preparations]	Increased Cellular Death
2197862	entrectinib	Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors	E [Preparations]	Cellular Proliferation Alteration
1921217	brigatinib	Cytochrome P450 3A Inducers|Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors	B [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
2362259	capmatinib hydrochloride	Kinase Inhibitors	C [Preparations]	Cellular Proliferation Alteration
2362165	capmatinib	P-Glycoprotein Inhibitors|Cytochrome P450 1A2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Kinase Inhibitors|Mesenchymal Epithelial Transition Inhibitors|Multidrug and Toxin Extrusion Transporter 2 K Inhibitors|Multidrug and Toxin Extrusion Transporter 1 Inhibitors	C [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1721559	osimertinib mesylate	Cytochrome P450 3A4 Inducers|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Kinase Inhibitors|Cytochrome P450 1A2 Inducers	O [Preparations]	Cellular Proliferation Alteration
1721560	osimertinib	Cytochrome P450 3A4 Inducers|Cytochrome P450 3A Inhibitors|Breast Cancer Resistance Protein Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitors|Cytochrome P450 1A2 Inducers	O [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1727454	alectinib hydrochloride	Tyrosine Kinase Inhibitors	A [Preparations]	Cellular Proliferation Alteration
1666923	pemetrexed disodium heptahydrate	Thymidylate Synthetase Inhibitors|Protein Synthesis Inhibitors|Dihydrofolate Reductase Inhibitors	P [Preparations]	Decreased DNA Integrity|Decreased Protein Synthesis
1727455	alectinib	Tyrosine Kinase Inhibitors|Protein Kinase Inhibitors|Kinase Inhibitors	A [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
5333	histamine		H [Preparations]	
350466	histamine hydrochloride		H [Preparations]	
142136	histamine dihydrochloride		H [Preparations]	
26925	histamine phosphate		H [Preparations]	
29528	mequitazine	Histamine H1 Receptor Antagonists	M [Preparations]	Decreased Histamine Activity
1111	arsenic	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased DNA Integrity
18330	arsenic trioxide	Unknown Cellular or Molecular Interaction	A [Preparations]	Decreased DNA Integrity
236517	penicillin V calcium	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
82036	lincomycin hydrochloride	Unknown Cellular or Molecular Interaction	L [Preparations]	
18926	penicillin V benzathine	Transpeptidase Inhibitors	P [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
7984	penicillin V	Transpeptidase Inhibitors	Penicillin-class Antibacterial|P [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Cell Wall Integrity
6398	lincomycin	Unknown Cellular or Molecular Interaction	L [Preparations]	
2373	chlormezanone	Unknown Cellular or Molecular Interaction	C [Preparations]	Centrally-mediated Muscle Relaxation|Decreased Organized Electrical Activity
6760	meprobamate	Unknown Cellular or Molecular Interaction	M [Preparations]	Decreased Spinal Cord Organized Electrical Activity
4530	formaldehyde	Immunologic Factor Interactions|Unknown Cellular or Molecular Interaction	Standardized Chemical Allergen|F [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release
314636	formalin	Immunologic Factor Interactions|Unknown Cellular or Molecular Interaction	F [Preparations]	Increased IgG Production|Cell-mediated Immunity|Increased Histamine Release
1984	cantharidin	Enzyme Inhibitors	C [Preparations]	Decreased Mitosis
8463	podofilox	Unknown Cellular or Molecular Interaction	P [Preparations]	Decreased Mitosis
7456	nitrogen	Unknown Cellular or Molecular Interaction	N [Preparations]	Unknown Physiological Effect
591781	eculizumab	Complement Inhibitors	Complement Inhibitor|E [Preparations]	
2557372	pegcetacoplan	Complement Inhibitors	Complement Inhibitor|P [Preparations]	
2107301	ravulizumab	Complement Inhibitors	Complement Inhibitor|R [Preparations]	Decreased Protein Modification
2107316	ravulizumab-cwvz	Complement Inhibitors	R [Preparations]	Decreased Protein Modification
352374	drotrecogin alfa	Enzyme Activators	D [Preparations]	Decreased Adhesion Factor Activity|Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
353106	drotrecogin alfa (activated), lyophilized	Enzyme Activators	D [Preparations]	Decreased Adhesion Factor Activity|Decreased Coagulation Factor Activity|Decreased Coagulation Factor Concentration
816346	dexlansoprazole	Proton Pump Inhibitors	Proton Pump Inhibitor|D [Preparations]	Inhibition Gastric Acid Secretion
3637	doxapram	Receptor Interactions|Unknown Cellular or Molecular Interaction	Respiratory Stimulant|D [Preparations]	Increased Medullary Respiratory Drive|Increased Organized Electrical Activity
82011	doxapram hydrochloride	Receptor Interactions|Unknown Cellular or Molecular Interaction	D [Preparations]	Increased Medullary Respiratory Drive|Increased Organized Electrical Activity
974779	obinutuzumab	CD20-directed Antibody Interactions	CD20-directed Cytolytic Antibody|O [Preparations]	
2625125	mosunetuzumab-axgb	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	M [Preparations]	Increased Cytokine Production
2625122	mosunetuzumab	CD20-directed Antibody Interactions|CD3-directed Antibody Interactions	M [Preparations]	Increased Cytokine Production
2478438	umbralisib tosylate	Kinase Inhibitors	U [Preparations]	
2478439	umbralisib	Kinase Inhibitors	U [Preparations]|Kinase Inhibitor	
1945077	copanlisib	Protein Kinase Inhibitors|Kinase Inhibitors	C [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
2606074	SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein		S [Preparations]	Acquired Immunity
2606073	SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2373		S [Preparations]	Acquired Immunity
2463114	bamlanivimab	Antibody-Soluble Protein Interactions	B [Preparations]	Immunologic Activity Alteration
2465242	casirivimab	Antibody Interactions	C [Preparations]	Cellular Activity Alteration
2465249	imdevimab	Antibody Interactions	I [Preparations]	Cellular Activity Alteration
2610243	SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5)		S [Preparations]	Acquired Immunity
2610326	SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5)		S [Preparations]	Acquired Immunity
2639620	vilobelimab	Antibody-Receptor Interactions	V [Preparations]	Cellular Activity Alteration|Decreased Complement Activity|Immunologic Activity Alteration
1242987	vismodegib	Smoothened Receptor Antagonists	Hedgehog Pathway Inhibitor|V [Preparations]	
1659192	sonidegib phosphate	Smoothened Receptor Antagonists	S [Preparations]	
1659191	sonidegib	Smoothened Receptor Antagonists	Hedgehog Pathway Inhibitor|S [Preparations]	
42330	terfenadine	Histamine H1 Receptor Antagonists	T [Preparations]	Decreased Histamine Activity
2629338	pirtobrutinib	P-Glycoprotein Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C8 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 3A Inhibitors|Bruton's Tyrosine Kinase Inhibitors	P [Preparations]|Kinase Inhibitor	
2387277	brexucabtagene autoleucel	CD19-directed Antibody Interactions	B [Preparations]	Immunologic Activity Alteration
2262435	zanubrutinib	Tyrosine Kinase Inhibitors|Bruton's Tyrosine Kinase Inhibitors	Z [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1986808	acalabrutinib	Tyrosine Kinase Inhibitors	A [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
236558	butenafine hydrochloride	Ergosterol Synthesis Inhibitors	B [Preparations]	Decreased Cell Wall Integrity
36726	sodium thiosulfate	Chelating Activity	S [Preparations]	
47461	butenafine	Ergosterol Synthesis Inhibitors	Benzylamine Antifungal|B [Preparations]	Decreased Cell Wall Integrity
10637	tolnaftate	Squalene Monooxygenase Inhibitors	T [Preparations]	Cellular Growth Phase Arrest
9876	gold sodium thiosulfate	Chelating Activity	G [Preparations]	
1807514	sodium thiosulfate anhydrous	Chelating Activity	S [Preparations]	
153971	atropine sulfate	Cholinergic Muscarinic Antagonists	A [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Positive Chronotropy|Salivation Inhibition
1223	atropine	Cholinergic Antagonists|Cholinergic Muscarinic Antagonists	Cholinergic Muscarinic Antagonist|Anticholinergic|A [Preparations]	Pupillary Dilation|Decreased Parasympathetic Acetylcholine Activity|Decreased Respiratory Secretions|Positive Chronotropy|Salivation Inhibition
285223	cat's claw preparation	Unknown Cellular or Molecular Interaction	C [Preparations]	Immunologic Activity Alteration
235426	pilocarpine hydrochloride	Cholinergic Muscarinic Agonists|Cholinergic Agonists	P [Preparations]	Pupillary Constriction|Decreased Intraocular Fluid Pressure
103244	pilocarpine nitrate	Cholinergic Muscarinic Agonists|Cholinergic Agonists	P [Preparations]	Pupillary Constriction|Decreased Intraocular Fluid Pressure
107771	demecarium	Cholinesterase Inhibitors	D [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity
22482	demecarium bromide	Cholinesterase Inhibitors	D [Preparations]	Pupillary Constriction|Increased Acetylcholine Activity
8328	pilocarpine	Cholinergic Muscarinic Agonists|Cholinergic Agonists	Cholinergic Receptor Agonist|P [Preparations]	Pupillary Constriction|Decreased Intraocular Fluid Pressure
10390	tetrabenazine	Vesicular Monoamine Transporter 2 Inhibitors	T [Preparations]|Vesicular Monoamine Transporter 2 Inhibitor	Decreased Norepinephrine Activity|Decreased Dopamine Activity|Decreased Histamine Activity|Decreased Serotonin Activity
68091	dolasetron	Serotonin 5HT-3 Antagonists|Serotonin 3 Receptor Antagonists	Serotonin-3 Receptor Antagonist|D [Preparations]	Decreased Serotonin Activity|Emesis Suppression
29398	dolasetron mesylate	Serotonin 5HT-3 Antagonists|Serotonin 3 Receptor Antagonists	D [Preparations]	Decreased Serotonin Activity|Emesis Suppression
1011650	pegloticase	Enzyme Activators	Uric Acid-specific Enzyme|P [Preparations]	
80566	allopurinol sodium	Xanthine Oxidase Inhibitors	A [Preparations]	Decreased Uric Acid Synthesis
73689	febuxostat	Xanthine Oxidase Inhibitors	Xanthine Oxidase Inhibitor|F [Preparations]	Decreased Uric Acid Synthesis
2174385	colchiceine	Unknown Cellular or Molecular Interaction	C [Preparations]	Decreased Granulocytic Cell Production|Decreased Cellular Migration
10205	sulfinpyrazone	Organic Anion Transporter Interactions	S [Preparations]	Decreased Renal Organic Ion Excretion|Uricosuric Activity|Decreased Platelet Aggregation
519	allopurinol	Xanthine Oxidase Inhibitors	Xanthine Oxidase Inhibitor|A [Preparations]	Decreased Uric Acid Synthesis
2632980	retifanlimab-dlwr	Programmed Death Receptor-1-directed Antibody Interactions	R [Preparations]	Decreased T Lymphocyte Activation|Cellular Proliferation Alteration|Decreased Cytokine Production
2632981	retifanlimab	Programmed Death Receptor-1-directed Antibody Interactions	R [Preparations]|Programmed Death Receptor-1 Blocking Antibody	Decreased T Lymphocyte Activation|Cellular Proliferation Alteration|Decreased Cytokine Production
1875534	avelumab	Programmed Death Ligand-1-directed Antibody Interactions|Programmed Death Ligand-1 Antagonists	A [Preparations]|Programmed Death Ligand-1 Blocker	Increased Immunologic Activity
2123125	erdafitinib	Cytochrome P450 3A4 Inducers|P-Glycoprotein Inhibitors|Cytochrome P450 3A4 Inhibitors|Organic Cation Transporter 2 Inhibitors|Tyrosine Kinase Inhibitors|Fibroblast Growth Factor Receptor Inhibitors	E [Preparations]|Kinase Inhibitor	Cellular Proliferation Alteration
1919503	durvalumab	Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1-directed Antibody Interactions	D [Preparations]|Programmed Death Ligand-1 Blocker	Increased Immunologic Activity|Increased Cellular Death
1592257	levomefolate	Enzyme Interactions	L [Preparations]	Cellular Activity Alteration
1025342	levomefolic acid	Enzyme Interactions	Folate Analog|L [Preparations]	Cellular Activity Alteration
1028454	levomefolate calcium	Enzyme Interactions	L [Preparations]	Cellular Activity Alteration
4511	folic acid	Enzyme Interactions	F [Preparations]	Cellular Activity Alteration
225852	leucovorin calcium	Phosphate Chelating Activity|Enzyme Interactions	L [Preparations]	Cellular Activity Alteration
1300473	sodium folate	Enzyme Interactions	S [Preparations]	Cellular Activity Alteration
1549106	levomefolate magnesium	Enzyme Interactions	L [Preparations]	Cellular Activity Alteration
1592256	levomefolate glucosamine	Enzyme Interactions	L [Preparations]	Cellular Activity Alteration
6313	leucovorin	Enzyme Interactions	Folate Analog|L [Preparations]	Cellular Activity Alteration
1546007	cidofovir anhydrous	DNA Polymerase Inhibitors	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|C [Preparations]	DNA Integrity Alteration
4678	ganciclovir	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|G [Preparations]|Nucleoside Analog Antiviral	Decreased DNA Replication|Decreased Protein Synthesis
283815	valganciclovir hydrochloride	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	V [Preparations]	Decreased DNA Replication|Decreased DNA Integrity
314633	fomivirsen sodium	Protein Synthesis Inhibitors	F [Preparations]	Decreased Protein Synthesis
275891	valganciclovir	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|V [Preparations]	Decreased DNA Integrity|Decreased DNA Replication
82131	ganciclovir sodium	Nucleic Acid Synthesis Inhibitors|DNA Polymerase Inhibitors	G [Preparations]	Decreased DNA Replication|Decreased Protein Synthesis
83171	cidofovir	DNA Polymerase Inhibitors	C [Preparations]	DNA Integrity Alteration
85763	fomivirsen	Protein Synthesis Inhibitors	F [Preparations]	Decreased Protein Synthesis
227227	levamisole hydrochloride	Immunologic Adjuvants	L [Preparations]	Increased Immunologically Active Molecule Activity
1535214	levamisole phosphate	Immunologic Adjuvants	L [Preparations]	Increased Immunologically Active Molecule Activity
6371	levamisole	Immunologic Adjuvants	L [Preparations]	Increased Immunologically Active Molecule Activity
1300476	kanamycin A sulfate	Protein Synthesis Inhibitors	K [Preparations]	Cell Membrane Alteration|Decreased Protein Synthesis
203140	cefmetazole sodium	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
203183	kanamycin sulfate	Protein Synthesis Inhibitors	K [Preparations]	Cell Membrane Alteration|Decreased Protein Synthesis
2182	cefmetazole	Enzyme Inhibitors	C [Preparations]	Decreased Cell Wall Synthesis & Repair
6099	kanamycin	Protein Synthesis Inhibitors	Aminoglycoside Antibacterial|K [Preparations]	Cell Membrane Alteration|Decreased Protein Synthesis
1727573	kanamycin A	Protein Synthesis Inhibitors	K [Preparations]	Decreased Cell Wall Synthesis & Repair|Decreased Protein Synthesis
203116	buspirone hydrochloride	Serotonin Agonists|Unknown Cellular or Molecular Interaction	B [Preparations]	Increased Serotonin Activity
1827	buspirone	Serotonin Agonists|Unknown Cellular or Molecular Interaction	B [Preparations]	Increased Serotonin Activity
386938	follitropin alfa	Hormone Receptor Modulators	F [Preparations]	Increase Spermatogenesis|Increased Follicle Stimulating Hormone Secretion|Stimulate Ovarian Follicular Phase
227518	follicle stimulating hormone	Hormone Receptor Modulators|Hormone Receptor Agonists	Gonadotropin|F [Preparations]	Increase Spermatogenesis|Increased Follicle Stimulating Hormone Secretion|Stimulate Ovarian Follicular Phase
58932	sermorelin acetate	Hormone Receptor Agonists	S [Preparations]	Increased Growth Hormone Secretion
56188	sermorelin	Hormone Receptor Agonists	S [Preparations]	Increased Growth Hormone Secretion
25357	follitropin beta	Hormone Receptor Modulators	F [Preparations]	Increase Spermatogenesis|Increased Follicle Stimulating Hormone Secretion|Stimulate Ovarian Follicular Phase
1594665	follicle stimulating hormone, porcine	Hormone Receptor Modulators|Hormone Receptor Agonists	F [Preparations]	Increase Spermatogenesis|Increased Follicle Stimulating Hormone Secretion|Stimulate Ovarian Follicular Phase
266604	metyrosine	Enzyme Inhibitors|Catecholamine Synthesis Inhibitors	Catecholamine Synthesis Inhibitor|M [Preparations]	Decreased Norepinephrine Activity|Decreased Epinephrine Activity
2053281	iobenguane I-131	Radiopharmaceutical Activity|Receptor Interactions	Radioactive Diagnostic Agent|I [Preparations]	Increased Cellular Death
3820	emetine	Unknown Cellular or Molecular Interaction	E [Preparations]	
82015	emetine hydrochloride	Unknown Cellular or Molecular Interaction	E [Preparations]	
7701	ornidazole		O [Preparations]	
1488293	coagulation factor XIII a-subunit (recombinant)	Enzyme Activators	C [Preparations]	Increased Coagulation Factor Concentration
1091605	factor XIII, human	Enzyme Activators	Human Blood Coagulation Factor|F [Preparations]	Increased Fibrin Polymerization Activity|Increased Coagulation Activity|Increased Coagulation Factor Activity|Increased Coagulation Factor Concentration
1426166	coagulation factor X, human	Enzyme Activators	Human Blood Coagulation Factor|C [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor Concentration|Increased Coagulation Factor Activity
825006	thrombin, human	Unknown Cellular or Molecular Interaction	Human Blood Coagulation Factor|T [Preparations]	Increased Coagulation Factor Concentration|Increased Coagulation Factor Activity
2264108	fibrinogen, human	Enzyme Activators	Human Blood Coagulation Factor|F [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor Activity|Increased Coagulation Factor Concentration
1367075	thrombin alfa	Unknown Cellular or Molecular Interaction	Blood Coagulation Factor|T [Preparations]	Increased Coagulation Factor Concentration|Increased Coagulation Factor Activity
4256	factor VIIa	Enzyme Activators	F [Preparations]	Increased Coagulation Factor Concentration
4262	factor X	Enzyme Activators	F [Preparations]	Increased Coagulation Factor Concentration
4271	factor XIII	Enzyme Activators	F [Preparations]	Increased Coagulation Factor Concentration
4385	fibrinogen	Enzyme Activators	F [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor Activity|Increased Coagulation Factor Concentration
2264114	thrombin, bovine	Unknown Cellular or Molecular Interaction	T [Preparations]	Increased Coagulation Factor Concentration
314623	fibrinogen,I-125	Enzyme Activators	F [Preparations]	Increased Coagulation Activity|Increased Coagulation Factor Concentration|Increased Coagulation Factor Activity
253149	eptacog alfa activated	Enzyme Activators	Human Blood Coagulation Factor|E [Preparations]	Increased Coagulation Factor X Activity|Increased Coagulation Factor IX Activity|Increased Coagulation Factor Concentration
826072	von Willebrand factor, human		Human Blood Coagulation Factor|V [Preparations]	Increased Coagulation Activity|Increased Platelet Aggregation
10528	thrombin	Unknown Cellular or Molecular Interaction	Blood Coagulation Factor|T [Preparations]	Increased Coagulation Factor Activity|Increased Coagulation Factor Concentration
1056	aprotinin	Serine Proteinase Inhibitors	Antifibrinolytic Agent|A [Preparations]	Decreased Fibrinolysis|Hemostasis Alteration
11274	von Willebrand factor		V [Preparations]	Increased Coagulation Factor Activity|Increased Platelet Aggregation
2386863	coagulation factor VIIa (recombinant)-jncw	Enzyme Activators	C [Preparations]	Increased Coagulation Factor Concentration
2045125	coagulation factor Xa (recombinant), inactivated-zhzo	Enzyme Activators	C [Preparations]	Reversed Anticoagulation Activity|Increased Coagulation Activity
1670383	factor IX complex		F [Preparations]	Increased Coagulation Factor X Concentration|Increased Coagulation Factor IX Concentration
99	6-aminocaproic acid	Enzyme Inhibitors	Antifibrinolytic Agent|A [Preparations]	Decreased Fibrinolysis
2045114	andexanet alfa	Enzyme Activators	A [Preparations]	Reversed Anticoagulation Activity|Increased Coagulation Activity
2632248	dibasic calcium phosphate, dihydrate		D [Preparations]	
9601	scopolamine	Cholinergic Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists|Cholinergic Muscarinic Antagonists	Anticholinergic|S [Preparations]	Pupillary Dilation|Decreased GI Motility|Decreased Histamine Activity|Decreased Parasympathetic Acetylcholine Activity|Decreased Nasal and Sinus Secretions|Decreased Serotonin Activity|Positive Chronotropy|Salivation Inhibition
9603	scopolamine hydrobromide	Cholinergic Antagonists|Histamine H1 Receptor Antagonists|Serotonin Antagonists|Cholinergic Muscarinic Antagonists	S [Preparations]	Pupillary Dilation|Decreased GI Motility|Decreased Histamine Activity|Decreased Parasympathetic Acetylcholine Activity|Decreased Serotonin Activity|Decreased Nasal and Sinus Secretions|Positive Chronotropy|Salivation Inhibition
2532300	ponesimod	Sphingosine 1-Phosphate Receptor Modulators	Sphingosine 1-phosphate Receptor Modulator|P [Preparations]	
1310520	teriflunomide	Dihydroorotate Dehydrogenase Inhibitors	Pyrimidine Synthesis Inhibitor|T [Preparations]	
1012892	fingolimod	Sphingosine 1-Phosphate Receptor Modulators	Sphingosine 1-phosphate Receptor Modulator|F [Preparations]	Decreased Lymphocyte Activation
214582	glatiramer	Immunologic Adjuvants	G [Preparations]	Decreased Immunologically Active Molecule Activity
1012891	fingolimod hydrochloride	Sphingosine 1-Phosphate Receptor Modulators	F [Preparations]	Decreased Lymphocyte Activation
84375	glatiramer acetate	Immunologic Adjuvants	G [Preparations]	Decreased Immunologically Active Molecule Activity
2288235	ozanimod hydrochloride	Sphingosine 1-Phosphate Receptor Modulators	O [Preparations]	Decreased Lymphocyte Activation
2610292	fingolimod lauryl sulfate	Sphingosine 1-Phosphate Receptor Modulators	F [Preparations]	Decreased Lymphocyte Activation
2288236	ozanimod	Sphingosine 1-Phosphate Receptor Modulators	Sphingosine 1-phosphate Receptor Modulator|O [Preparations]	Decreased Lymphocyte Activation
2282403	bempedoic acid	Enzyme Inhibitors|Adenosine Triphosphate-Citrate Lyase Inhibitors	B [Preparations]|Adenosine Triphosphate-Citrate Lyase Inhibitor	Decreased Cholesterol Synthesis
341248	ezetimibe	Cellular or Molecular Interactions	Dietary Cholesterol Absorption Inhibitor|E [Preparations]	Decreased Cholesterol Absorption
1540	bile salts		B [Preparations]	
28393	lactic acid	Acidifying Activity|Unknown Cellular or Molecular Interaction	L [Preparations]	Emollient Activity|Decreased Skin Keratinization
1537034	vorapaxar	Protease-activated Receptor-1 Antagonists	V [Preparations]|Protease-activated Receptor-1 Antagonist	Decreased Platelet Aggregation
1537050	vorapaxar sulfate	Protease-activated Receptor-1 Antagonists	V [Preparations]	Decreased Platelet Aggregation
259280	tenecteplase	Tissue Plasminogen Activators	T [Preparations]	Increased Thrombolysis
76895	reteplase	Plasminogen Activators|Tissue Plasminogen Activators	R [Preparations]	Increased Fibrinolysis|Increased Thrombolysis
19666	nesiritide	Receptor Interactions	N [Preparations]	Decreased Vascular Smooth Muscle Tone|Systemic Arterial Vasodilation|Pulmonary Arterial Vasodilation
